0001193125-14-197913.txt : 20140514 0001193125-14-197913.hdr.sgml : 20140514 20140514060613 ACCESSION NUMBER: 0001193125-14-197913 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140514 DATE AS OF CHANGE: 20140514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NANOPHASE TECHNOLOGIES CORPORATION CENTRAL INDEX KEY: 0000883107 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRIMARY METAL PRODUCTS [3390] IRS NUMBER: 363687863 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-22333 FILM NUMBER: 14839115 BUSINESS ADDRESS: STREET 1: 453 COMMERCE ST CITY: BURR RIDGE STATE: IL ZIP: 60521 BUSINESS PHONE: 6303231200 MAIL ADDRESS: STREET 1: 453 COMMERCE STREET CITY: BURR RIDGE STATE: IL ZIP: 60521 10-Q 1 d710094d10q.htm 10-Q 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended: March 31, 2014

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 000-22333

 

 

Nanophase Technologies Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   36-3687863

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1319 Marquette Drive, Romeoville, Illinois 60446

(Address of principal executive offices, and zip code)

Registrant’s telephone number, including area code: (630) 771-6708

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer”, “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨      Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of May 9, 2014, there were 28,481,496 shares outstanding of Common Stock, par value $.01, of the registrant.

 

 

 


Table of Contents

NANOPHASE TECHNOLOGIES CORPORATION

QUARTER ENDED MARCH 31, 2014

INDEX

 

         Page  

PART I—FINANCIAL INFORMATION

     3   

Item 1.

  Financial Statements      3   
  Balance Sheets as of March 31, 2014 (unaudited) and December 31, 2013      3   
  Unaudited Statements of Operations for the three months ended March 31, 2014 and 2013      4   
  Unaudited Statements of Cash Flows for the three months ended March 31, 2014 and 2013      5   
  Notes to unaudited Financial Statements      6   

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations      9   

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk      13   

Item 4.

  Controls and Procedures      13   

PART II—OTHER INFORMATION

     13   

Item 1.

  Legal Proceedings      13   

Item 1A.

  Risk Factors      13   

Item 2.

  Unregistered Sales of Equity Securities and Use of Proceeds      14   

Item 3.

  Defaults Upon Senior Securities.      14   

Item 4.

  Mine Safety Disclosures.      14   

Item 5.

  Other Information.      14   

Item 6.

  Exhibits.      14   

SIGNATURES

     15   

 

2


Table of Contents

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements

NANOPHASE TECHNOLOGIES CORPORATION

BALANCE SHEETS

 

     (in thousands except share
and per share data)
 
     March 31,        
     2014     December 31,  
     (Unaudited)     2013  
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 2,148      $ 3,276   

Investments

     30        30   

Trade accounts receivable, less allowance for doubtful accounts of $6 on March 31, 2014 and December 31, 2013

     1,130        52   

Other receivables

     —          1   

Inventories, net

     931        976   

Prepaid expenses and other current assets

     250        202   
  

 

 

   

 

 

 

Total current assets

     4,489        4,537   

Equipment and leasehold improvements, net

     2,319        2,464   

Other assets, net

     27        27   
  

 

 

   

 

 

 
   $ 6,835      $ 7,028   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Current portion of capital lease obligations

   $ 31      $ 31   

Accounts payable

     754        503   

Accrued expenses

     259        323   
  

 

 

   

 

 

 

Total current liabilities

     1,044        857   
  

 

 

   

 

 

 

Long-term portion of capital lease obligations

     3        10   

Long-term deferred rent

     630        633   

Asset retirement obligations

     161        160   
  

 

 

   

 

 

 

Total long-term liabilities

     794        803   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding

     —          —     

Common stock, $.01 par value, 35,000,000 shares authorized; 28,481,496 shares issued and outstanding on March 31, 2014 and December 31, 2013

     285        285   

Additional paid-in capital

     95,819        95,761   

Accumulated deficit

     (91,107     (90,678
  

 

 

   

 

 

 

Total stockholders’ equity

     4,997        5,368   
  

 

 

   

 

 

 
   $ 6,835      $ 7,028   
  

 

 

   

 

 

 

See Notes to Financial Statements.

 

3


Table of Contents

NANOPHASE TECHNOLOGIES CORPORATION

STATEMENTS OF OPERATIONS

(Unaudited)

 

     (in thousands except share and per share
data)
 
     Three months ended  
     March 31,  
     2014     2013  

Revenue:

    

Product revenue

   $ 2,576      $ 2,976   

Other revenue

     9        3   
  

 

 

   

 

 

 

Total revenue

     2,585        2,979   

Operating expense:

    

Cost of revenue

     1,877        2,073   
  

 

 

   

 

 

 

Gross profit

     708        906   

Research and development expenses

     337        429   

Selling, general and administrative expenses

     798        960   
  

 

 

   

 

 

 

Loss from operations

     (427     (483

Interest expense

     (2     (7

Other, net

     —          6   
  

 

 

   

 

 

 

Loss before provision for income taxes

     (429     (484

Provision for income taxes

     —          —     
  

 

 

   

 

 

 

Net loss

   $ (429   $ (484
  

 

 

   

 

 

 

Net loss per share-basic and diluted

   $ (0.02   $ (0.02
  

 

 

   

 

 

 

Weighted average number of basic and diluted common shares outstanding

     28,481,496        28,466,717   
  

 

 

   

 

 

 

See Notes to Financial Statements.

 

4


Table of Contents

NANOPHASE TECHNOLOGIES CORPORATION

STATEMENTS OF CASH FLOWS

(Unaudited)

 

     (in thousands)  
     Three months ended     Three months ended  
     March 31,     March 31,  
     2014     2013  

Operating activities:

    

Net loss

   $ (429   $ (484

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization

     187        226   

Gain on disposal of equipment

     —          (6

Stock compensation expense

     57        77   

Changes in assets and liabilities related to operations:

    

Trade accounts receivable

     (1,078     (202

Other accounts receivable

     1        25   

Inventories

     45        117   

Prepaid expenses and other assets

     (48     (119

Accounts payable

     264        54   

Accrued expenses

     (67     (117
  

 

 

   

 

 

 

Net cash used in operating activities

     (1,068     (429
  

 

 

   

 

 

 

Investing activities:

    

Proceeds from disposal of equipment

     —          6   

Acquisition of equipment and leasehold improvements

     (30     (42

Payment of accounts payable incurred for the purchase of equipment and leasehold improvements

     (23     (20
  

 

 

   

 

 

 

Net cash used in investing activities

     (53     (56
  

 

 

   

 

 

 

Financing activities:

    

Principal payments on capital leases

     (7     (34

Proceeds from exercise of stock options

     —          3   
  

 

 

   

 

 

 

Net cash used in financing activities

     (7     (31
  

 

 

   

 

 

 

Decrease in cash and cash equivalents

     (1,128     (516

Cash and cash equivalents at beginning of period

     3,276        4,124   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 2,148      $ 3,608   
  

 

 

   

 

 

 

Supplemental cash flow information:

    

Interest paid

   $ 1      $ 7   
  

 

 

   

 

 

 

Supplemental non-cash investing and financing activities:

    

Accounts payable incurred for the purchase of equipment and leasehold improvements

   $ 10      $ 7   
  

 

 

   

 

 

 

See Notes to Financial Statements.

 

5


Table of Contents

NANOPHASE TECHNOLOGIES CORPORATION

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

(in thousands, except share and per share data or as otherwise noted herein)

(1) Basis of Presentation

The accompanying unaudited interim financial statements of Nanophase Technologies Corporation (“Nanophase” or the “Company”, including “we”, “our” or “us”) reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management, are necessary for a fair presentation of our financial position and operating results for the interim periods presented. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.

These financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2013, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission.

(2) Description of Business

Nanophase is a nanomaterials and applications developer and commercial manufacturer with an integrated family of nanomaterial technologies. We produce engineered nano and sub-micron materials for use in a variety of diverse existing and developing markets: personal care including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy and a variety of surface finishing technologies (polishing) applications. We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products possible and opened potential new markets. Although our primary strategic focus has been the North American market, we currently sell our material to customers overseas and have been working to expand our reach within foreign markets.

The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation in November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.

While product sales comprise the overwhelming majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason we classify such revenue as “other revenue” in our Statement of Operations, as it does not represent revenue directly from our nanocrystalline materials.

The presentation of certain prior year disclosures has been modified to conform to current year presentation, as financial data is now presented in thousands of dollars rather than in dollars.

 

6


Table of Contents

(3) Financial Instruments

We follow the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

Our financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. The fair values of all financial instruments were not materially different from their carrying values.

(4) Investments

Investments on March 31, 2014 and December 31, 2013 were comprised of certificates of deposit in the amount of $30, pledged as collateral for our rent and restricted as to withdrawal or usage.

(5) Inventories

Inventories consist of the following:

 

     March 31,
2014
    December 31,
2013
 

Raw materials

   $ 160      $ 132   

Finished goods

     823        896   
  

 

 

   

 

 

 
     983        1,028   

Allowance for excess inventory quantities

     (52     (52
  

 

 

   

 

 

 
   $ 931      $ 976   
  

 

 

   

 

 

 

(6) Share-Based Compensation

We follow FASB ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $57 and $69 for the three month periods ended March 31, 2014 and 2013, respectively.

As of March 31, 2014, there was approximately $410 of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.3 years.

Stock Options and Stock Grants

During the three months ended March 31, 2014, no stock options were exercised, compared to proceeds of $3 realized and 10,000 shares of common stock issued pursuant to option exercises during the same period in 2013. For the three months ended March 31, 2014, 568,000 stock options were granted compared to 543,000 stock options granted during the same period in 2013. During the three months ended March 31, 2014, no stock options were forfeited compared to 54,000 stock options forfeited during the same period in 2013.

Stock Appreciation Rights

Prior to 2011, we granted our outside directors stock appreciation rights (SARs). The change in fair value of the awards granted during prior years is included in non-cash compensation expense for the quarters ended March 31, 2014 and 2013. The SARs granted vested immediately and are payable upon the directors’ removal or resignation from the position of director. These awards are accounted for as liability awards, included in accrued expenses as of March 31, 2014 and 2013, and adjusted to fair value each reporting period. The fair value of the liability on March 31, 2014 was $7, compared to $8 on December 31, 2013.

 

7


Table of Contents

As of March 31, 2014, we did not have any unvested restricted stock or performance shares outstanding.

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month periods ended:

 

     March 31,
2014
  March 31,
2013

Weighted-average risk-free interest rates:

   2.01%   1.32%

Dividend yield:

   —     —  

Weighted-average expected life of the option:

   7 years   7 years

Weighted-average expected stock price volatility:

   95.16%   92.27%

Weighted-average fair value of the options granted:

   $0.42   $0.33

(7) Significant Customers and Contingencies

Sales to three customers constituted approximately 80%, 6% and 2%, respectively, of our total revenue for the three months ended March 31, 2014. Amounts included in accounts receivable on March 31, 2014 relating to these three customers were approximately $784, $144 and $57, respectively. Revenue from these three customers constituted approximately 79%, 7% and 5%, respectively, of our total revenue for the three months ended March 31, 2013. Amounts included in accounts receivable on March 31, 2013 relating to these three customers were approximately $857, $201 and $78, respectively. The loss of one of these significant customers or the failure to attract new customers could have a material adverse effect on our business, results of operations and financial condition.

We currently have exclusive supply agreements with BASF Corporation (“BASF”), our largest customer, that have contingencies outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended to provide capacity sufficient to meet the customer’s production needs. This outcome may occur if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants in one of our supply agreements with BASF “trigger” a technology transfer right (license and equipment sale at BASF’s option) in the event (a) that earnings for the twelve month period ending with our most recently published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements with BASF also “trigger” a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment’s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the equipment’s net book value, depending on the contract and related equipment.

We believe that we have sufficient cash, (See Liquidity and Capital Resources in Management’s Discussion and Analysis in Part I, Item 2 of this Form 10-Q for a further discussion) to operate our business during 2014. If a triggering event were to occur and BASF elected to proceed with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Given the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.

 

8


Table of Contents

(8) Business Segmentation and Geographical Distribution

Revenue from international sources approximated $111 and $78 for the three months ended March 31, 2014 and 2013, respectively. All of this revenue was product revenue.

Our operations comprise a single business segment and all of our long-lived assets are located within the United States.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Nanophase is an advanced materials and applications developer and commercial manufacturer with an integrated family of materials technologies. We produce engineered nano and sub-micron materials for use in a variety of diverse markets: personal care including sunscreens, architectural coatings, industrial coating ingredients, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and a variety of surface finishing technologies (polishing) applications. We target markets in which we feel practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products possible and opened potential new markets. For example, we have applied our skills at producing precisely defined nanomaterials to now create and sell sub-micron material products. Our focus is on customer need where we believe we have an advantage, as opposed to finding uses for one particular technology. We expect growth in end-user (manufacturing customers, including customers of our customers) adoption in 2014 and beyond. Our initiatives in targeted market areas are progressing at differing rates of speed, but we have been broadly moving through testing and development cycles, and in a number of cases believe we are approaching first revenue or next stage revenue with particular customers in the industries referenced above. For example, we developed new solutions in the surface finishing technologies (polishing) and energy-management areas during 2013 and have received commercial orders related to the former and significant commercial interest related to the latter. We expect that we will both work more deeply with current customers and attract additional customers, which should help us achieve growth in these markets in 2014 and beyond.

Results of Operations

Total revenue decreased to $2,585,000 for the three months ended March 31, 2014, compared to $2,979,000 for the same period in 2013. A substantial majority of our revenue for both periods was from our largest customer in personal care and sunscreen applications. Product revenue, the primary component of our total revenue, decreased to $2,576,000 for the three months ended March 31, 2014, compared to $2,976,000 for the same period in 2013. The first quarter of 2013 was the highest revenue quarter of that year, a dynamic we do not expect to occur during 2014. Revenue from our top three customers was approximately 80%, 6% and 2%, respectively, during the three months ended March 31, 2014, compared to 79%, 7% and 5%, respectively, during the same period in 2013.

Other revenue increased to $9,000 for the three months ended March 31, 2014, compared to $3,000 for the same period in 2013. This was comprised primarily of shipping costs paid by customers.

 

9


Table of Contents

We use certain elements classified as “Rare Earth” elements in some of our processes, specifically cerium oxide in polishing applications. On a worldwide basis, the vast majority of these elements are currently supplied by China. Due to export limitations imposed by China during the summer of 2010, the supply of all Rare Earth elements was drastically reduced during 2011. This created significant issues with availability of acceptable materials and, if available, a substantial increase in cost. We have historically been successful in passing material costs through to our customers. While pricing and availability concerns eased significantly during 2012 (continuing into 2013 and 2014), the recent supply issue and severity of the price increase brings incremental uncertainty for customer acceptance of our related polishing business going forward. The long-term success of this area will be directly impacted by the supply and cost of Rare Earth elements, specifically cerium oxide.

Cost of revenue generally includes costs associated with commercial production and customer development arrangements. Cost of revenue decreased to $1,877,000 for the three months ended March 31, 2014, compared to $2,073,000 for the same period in 2013. The decrease in cost of revenue was primarily driven by the decrease in revenue volume, net of efficiencies related to improvements in our processes. We expect to continue new nanomaterial development, primarily using our NanoArc® synthesis and dispersion technologies, for targeted applications and new markets during 2014 and beyond. At current revenue levels we have generated a positive gross margin, though margins have been impeded by not having enough revenue to efficiently absorb manufacturing overhead that is required to work with current customers and expected future customers. We believe that our current fixed manufacturing cost structure is sufficient to support significantly higher levels of production. The extent to which margins grow, as a percentage of total revenue, will be dependent upon revenue mix, revenue volume, our ability to continue to cut costs and pass commodity market-driven raw materials increases on to customers. We expect that product revenue volume increases would result in our fixed manufacturing costs being more efficiently absorbed, leading to increased margins. We expect to continue to focus on reducing controllable variable product manufacturing costs, with potential variability related to the commodity metals markets, but may or may not continue to realize absolute dollar gross margin growth through 2014 and beyond, dependent upon the factors discussed above.

Research and development expense, which includes all expenses relating to the technology and advanced engineering groups, primarily consists of costs associated with the development or acquisition of new product applications and coating formulations and the cost of enhancing the Company’s manufacturing processes. As an example, we have been, and continue to be, engaged in research to enhance our ability to disperse material in a variety of organic and inorganic media for use as coatings and polishing materials, including window cleaning and polishing products. Much of this work has led to several new products and additional potential new products.

Having demonstrated the capability to produce pilot quantities of mixed-metal oxides in a single crystal phase, we do not expect development of further variations on these materials to present material technological challenges. Many of these materials exhibit performance characteristics that can enable them to serve in various catalytic applications. We are now working on several related commercial opportunities using the same materials. We expect that this technique should enable us to scale to large quantity commercial volumes once application viability and firm demand are established. We also have an ongoing advanced engineering effort that is primarily focused on the development of new nanomaterials as well as the refinement of existing nanomaterials, as dictated by our customer-driven marketing strategy. We are not certain when or if any significant revenue will be generated from the production of the materials described above.

Research and development expense decreased to $337,000 for the three months ended March 31, 2014, compared to $429,000 for the same period in 2013. The decrease was primarily attributed to more focused product development activities coupled with the transfer of projects out of research and development and into commercial operations, resulting in lower costs for salaries and materials. We expect research and development expense to increase slightly during the remainder of 2014, but to remain near current levels and below 2013 expense levels.

 

10


Table of Contents

Selling, general and administrative expense decreased to $798,000 for the three month period ended March 31, 2014, compared to $960,000 for the same period in 2013. The net decrease was primarily attributed to decreased salary and related personnel costs, benefitting from more focused activities. We expect total selling, general and administrative expense to increase slightly during the remainder of 2014, but to remain near current levels and below 2013 expense levels.

Inflation

We believe inflation has not had a material effect on our operations or financial position. However, supplier price increases and wage and benefit inflation, both of which represent a significant component of our costs of operations, may have a material effect on our operations and financial position in 2014 and beyond if we are unable to pass through any applicable increases under our present contracts or through to our markets in general.

Liquidity and Capital Resources

Our cash, cash equivalents and short-term investments amounted to $2,178,000 on March 31, 2014, compared to $3,306,000 on December 31, 2013 and $3,638,000 on March 31, 2013. The net cash used in our operating activities was $1,068,000 for the three months ended March 31, 2014, compared to $429,000 for the same period in 2013. The increase was due to working capital fluctuation and, in particular, changes in accounts receivable as we finished 2013 with atypically low accounts receivable balances that grew to normal levels during the first three months of 2014. Net cash used in investing activities amounted to $53,000 for the three months ended March 31, 2014, compared to $56,000 for the same period in 2013. Capital expenditures amounted to $30,000 and $42,000 for the three months ended March 31, 2014 and 2013, respectively. Net cash used in financing activities amounted to $7,000 and $31,000 for the three months ended March 31, 2014 and 2013, respectively.

Our supply agreements with our largest customer, BASF, contain certain financial covenants which could potentially impact our liquidity. The most restrictive financial covenants under these agreements require that we maintain a minimum of $1 million in cash, cash equivalents and certain investments, and that we not have the acceleration of any debt maturity having a principal amount of more than $10 million, in order to avoid triggering the customer’s potential right to transfer certain technology and equipment to that customer at a contractually defined price. We had approximately $2.2 million in cash, cash equivalents and short-term investments on March 31, 2014, with no debt. This supply agreement and its covenants are more fully described in Note 7 to our Financial Statements in Part I, Item 1 of this Form 10-Q.

We believe that cash from operations and cash, cash equivalents and investments on hand will be adequate to fund our operating plans through 2014. Our actual future capital requirements in 2014 and beyond will depend, however, on many factors, including customer acceptance of our current and potential nanomaterials and product applications, continued progress in research and development activities and product testing programs, the magnitude of these activities and programs, and the costs necessary to increase and expand our manufacturing capabilities and to market and sell our materials and product applications. Other important issues that will drive future capital requirements will be the development of new markets and new customers as well as the potential for significant unplanned growth with existing customers. Depending on the success of certain projects, we expect that capital spending relating to currently known capital needs for the remainder of 2014 will be between $200,000 and $250,000. If those projects are delayed or ultimately prove unsuccessful, we would expect our capital requirements to be lower. If other projects are successful the total capital spending may be higher than $250,000 for the remainder of 2014.

 

11


Table of Contents

Should events arise that make it appropriate for us to seek additional financing, such additional financing may not be available on acceptable terms or even at all, and any such additional financing could be dilutive to our shareholders. Such a financing could be necessitated by such things as the loss of existing customers; currently unknown capital requirements in light of the factors described above; new regulatory requirements that are outside our control; the need to meet previously discussed cash requirements to avoid a triggering event under our BASF agreement; or various other circumstances coming to pass that we currently do not anticipate. The failure to have access to sufficient capital to fund our business plans may result in a curtailment or other change in those plans.

On March 31, 2014, we had a net operating loss carryforward of approximately $79 million for income tax purposes. Because we may have experienced “ownership changes” within the meaning of the U.S. Internal Revenue Code in connection with our various prior equity offerings, future utilization of this carryforward may be subject to certain limitations as defined by the Internal Revenue Code. If not utilized, the carryforward will expire at various dates between January 1, 2018 and December 31, 2033. As a result of the annual limitation and uncertainty as to the amount of future taxable income that will be earned prior to the expiration of the carryforward, we have concluded that it is likely that some portion of this carryforward will expire before ultimately becoming available to reduce income tax liabilities. Changes in Illinois state law beginning in 2011 will impact net loss carryforward duration and utilization on the state tax level.

Off-Balance Sheet Arrangements

We have not created, and are not party to, any special-purpose or off-balance sheet entities for the purposes of raising capital, incurring debt or operating our business. We do not have any off-balance sheet arrangements or relationships with entities that are not consolidated into our financial statements that are reasonably likely to materially affect our liquidity or the availability of capital resources.

Safe Harbor Provision

We want to provide investors with more meaningful and useful information. As a result, this Quarterly Report on Form 10-Q (the “Form 10-Q”) contains and incorporates by reference certain “forward-looking statements”, as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements reflect our current expectations of the future results of our operations, performance and achievements. Forward-looking statements are covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We have tried, wherever possible, to identify these statements by using words such as “anticipates”, “believes”, “estimates”, “expects”, “plans”, “intends” and similar expressions. These statements reflect management’s current beliefs and are based on information now available to it. Accordingly, these statements are subject to certain risks, uncertainties and contingencies that could cause our actual results, performance or achievements in future reporting periods to differ materially from those expressed in, or implied by, such statements. These risks, uncertainties and factors include, without limitation: our ability to become profitable despite the losses we have incurred since our incorporation; our dependence on our principal customers and the terms of our supply agreements with BASF which could trigger a requirement to transfer technology and/or sell equipment to that customer; our potential inability to obtain working capital when needed on acceptable terms or at all; our ability to obtain materials at costs we can pass through to our customers, including Rare Earth elements, specifically cerium oxide; uncertain demand for, and acceptance of, our nanocrystalline materials; our limited manufacturing capacity and product mix flexibility in light of customer demand; our limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; our dependence on patents and protection of proprietary information; the resolution of litigation in which we may become involved; our ability to maintain an appropriate electronic trading venue for our securities; and the impact of any potential new governmental regulations that could be difficult to respond to or costly to comply with. In addition, our forward-looking statements could be affected by general industry and market conditions and growth rates. Readers of this Quarterly Report on Form 10-Q should not place undue reliance on any forward-looking statements. Except as required by federal securities laws, we undertake no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.

 

12


Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for a smaller reporting company.

 

Item 4. Controls and Procedures

Disclosure controls

We are responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed by us in the reports filed by us under the Exchange Act is: (a) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (b) accumulated and communicated to our management, including our principal executive and principal financial officers, to allow timely decisions regarding required disclosures. It should be noted that in designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that our management necessarily was required to apply its judgment regarding the design of our disclosure controls and procedures. As of the end of the period covered by this report, we conducted an evaluation, under the supervision (and with the participation) of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at reaching that level of reasonable assurance.

Internal control over financial reporting

The Company’s management, including the CEO and CFO, confirm that there was no change in the Company’s internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

None.

 

Item 1A. Risk Factors

In addition to the information set forth in this Quarterly Report on Form 10-Q and before deciding to invest in, or retain, shares of our common stock, you also should carefully review and consider the information contained in our other reports and periodic filings that we make with the Securities and Exchange Commission, including, without limitation, the information contained under the caption Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013. Those risk factors could materially affect our business, financial condition and results of operations. Additional risks and uncertainties that we do not currently know about, we currently believe are immaterial or we have not predicted may also harm our business operations or adversely affect us. If any of these risks or uncertainties actually occurs, our business, financial condition, results of operations, cash flows or stock price could be materially adversely affected. There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2013.

 

13


Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

 

Item 3. Defaults Upon Senior Securities

None.

 

Item 4. Mine Safety Disclosures

Not applicable.

 

Item 5. Other Information

None.

 

Item 6. Exhibits

 

Exhibit 31.1    Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.
Exhibit 31.2    Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.
Exhibit 32    Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350.
Exhibit 101    The following materials from Nanophase Technologies Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, formatted in XBRL (Extensible Business Reporting Language): (1) the Balance Sheets, (2) the Statements of Operations, (3) the Statements of Cash Flows, and (4) the Notes to Unaudited Financial Statements.

 

14


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  NANOPHASE TECHNOLOGIES CORPORATION

Date: May 14, 2014

    By:  

/s/ JESS A. JANKOWSKI

      Jess A. Jankowski
      President and Chief Executive Officer

Date: May 14, 2014

    By:  

/s/ FRANK J. CESARIO

      Frank J. Cesario
      Chief Financial Officer

 

15

EX-31.1 2 d710094dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification of the Chief Executive Officer

Pursuant to

Rules 13a-14(a) and 15d-14(a) under the Exchange Act

I, Jess A. Jankowski, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Nanophase Technologies Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 14, 2014

 

/s/ JESS A. JANKOWSKI
Jess A. Jankowski
Chief Executive Officer
EX-31.2 3 d710094dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification of the Chief Financial Officer

Pursuant to

Rules 13a-14(a) and 15d-14(a) under the Exchange Act

I, Frank J. Cesario, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Nanophase Technologies Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) or the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 14, 2014

 

/s/ FRANK J. CESARIO
Frank J. Cesario
Chief Financial Officer
EX-32 4 d710094dex32.htm EX-32 EX-32

Exhibit 32

Certification Pursuant to 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with this quarterly report of Nanophase Technologies Corporation (the “Company”) on Form 10-Q for the quarter ending March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jess A. Jankowski, Chief Executive Officer of the Company, and I, Frank J. Cesario, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to our knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 14, 2014

 

/s/ JESS A. JANKOWSKI
Jess A. Jankowski
Chief Executive Officer

 

/s/ FRANK J. CESARIO
Frank J. Cesario
Chief Financial Officer
EX-101.INS 5 nanx-20140331.xml XBRL INSTANCE DOCUMENT 28481496 3608000 857000 78000 201000 28481496 28481496 24088 35000000 0.01 0.01 259000 31000 95819000 754000 1044000 3000 4997000 6000 -91107000 630000 285000 6835000 52000 794000 161000 4489000 27000 6835000 2148000 160000 30000 1130000 931000 983000 250000 30000 410000 823000 2319000 1000000 10000000 784000 57000 144000 7000 0 0 4124000 28481496 28481496 24088 35000000 0.01 0.01 323000 31000 95761000 503000 857000 10000 5368000 6000 -90678000 633000 285000 7028000 52000 803000 160000 4537000 27000 7028000 3276000 132000 30000 52000 976000 1028000 202000 30000 1000 896000 2464000 8000 0.0132 P7Y 28466717 -429000 0.33 -0.02 543000 0.9227 10000 54000 119000 906000 -25000 6000 7000 2976000 6000 -483000 3000 7000 -484000 202000 -484000 34000 -117000 2979000 42000 20000 -31000 77000 -516000 -56000 -117000 7000 54000 6000 2073000 429000 3000 226000 69000 960000 78000 0.79 0.05 0.07 NANX NANOPHASE TECHNOLOGIES CORPORATION false Smaller Reporting Company 2014 10-Q 2014-03-31 0000883107 --12-31 Q1 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(6) Share-Based Compensation</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> We follow FASB ASC Topic 718,&#xA0;<i>Share-Based Payments</i>, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $57 and $69 for the three month periods ended March&#xA0;31, 2014 and 2013, respectively.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> As of March&#xA0;31, 2014, there was approximately $410 of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.3 years.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <u>Stock Options and Stock Grants</u></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> During the three months ended March&#xA0;31, 2014, no stock options were exercised, compared to proceeds of $3 realized and 10,000 shares of common stock issued pursuant to option exercises during the same period in 2013. For the three months ended March&#xA0;31, 2014, 568,000 stock options were granted compared to 543,000 stock options granted during the same period in 2013. During the three months ended March&#xA0;31, 2014, no stock options were forfeited compared to 54,000 stock options forfeited during the same period in 2013.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <u>Stock Appreciation Rights</u></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Prior to 2011, we granted our outside directors stock appreciation rights (SARs). The change in fair value of the awards granted during prior years is included in non-cash compensation expense for the quarters ended March&#xA0;31, 2014 and 2013. The SARs granted vested immediately and are payable upon the directors&#x2019; removal or resignation from the position of director. These awards are accounted for as liability awards, included in accrued expenses as of March&#xA0;31, 2014 and 2013, and adjusted to fair value each reporting period. The fair value of the liability on March&#xA0;31, 2014 was $7, compared to $8 on December&#xA0;31, 2013.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> As of March&#xA0;31, 2014, we did not have any unvested restricted stock or performance shares outstanding.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month periods ended:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center">March&#xA0;31,<br /> 2014</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center">March&#xA0;31,<br /> 2013</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average risk-free interest rates:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">2.01%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">1.32%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Dividend yield:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> &#x2014;&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average expected life of the option:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">7&#xA0;years</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">7&#xA0;years</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average expected stock price volatility:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">95.16%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">92.27%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average fair value of the options granted:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">$0.42</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">$0.33</td> </tr> </table> <br class="Apple-interchange-newline" /></div> <div> We follow FASB ASC Topic 718,&#xA0;<i style="FONT-SIZE: 13px; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); LETTER-SPACING: normal; LINE-HEIGHT: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px">Share-Based Payments</i>, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $57 and $69 for the three month periods ended March&#xA0;31, 2014 and 2013, respectively.</div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <b>(8) Business Segmentation and Geographical Distribution</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Revenue from international sources approximated $111 and $78 for the three months ended March&#xA0;31, 2014 and 2013, respectively. All of this revenue was product revenue.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Our operations comprise a single business segment and all of our long-lived assets are located within the United States.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> We follow the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) Accounting Standards Codification (&#x201C;ASC&#x201D;) Topic 820, <i>Fair Value Measurements and Disclosures</i>, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.</p> </div> 0.0201 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(2) Description of Business</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Nanophase is a nanomaterials and applications developer and commercial manufacturer with an integrated family of nanomaterial technologies. We produce engineered nano and sub-micron materials for use in a variety of diverse existing and developing markets: personal care including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy and a variety of surface finishing technologies (polishing) applications. We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products possible and opened potential new markets. Although our primary strategic focus has been the North American market, we currently sell our material to customers overseas and have been working to expand our reach within foreign markets.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The Company was incorporated in Illinois on November&#xA0;25, 1989, and became a Delaware corporation in November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> While product sales comprise the overwhelming majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason we classify such revenue as &#x201C;other revenue&#x201D; in our Statement of Operations, as it does not represent revenue directly from our nanocrystalline materials.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The presentation of certain prior year disclosures has been modified to conform to current year presentation, as financial data is now presented in thousands of dollars rather than in dollars.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(3) Financial Instruments</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> We follow the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) Accounting Standards Codification (&#x201C;ASC&#x201D;) Topic 820,&#xA0;<i>Fair Value Measurements and Disclosures</i>, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Our financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. The fair values of all financial instruments were not materially different from their carrying values.</p> </div> P7Y <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month periods ended:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center">March&#xA0;31,<br /> 2014</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center">March&#xA0;31,<br /> 2013</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average risk-free interest rates:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">2.01%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">1.32%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Dividend yield:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> &#x2014;&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average expected life of the option:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">7&#xA0;years</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">7&#xA0;years</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average expected stock price volatility:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">95.16%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">92.27%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Weighted-average fair value of the options granted:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center">$0.42</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="center">$0.33</td> </tr> </table> <br class="Apple-interchange-newline" /> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>(5) Inventories</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Inventories consist of the following:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2013</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Raw materials</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">160</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">132</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Finished goods</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">823</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">896</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">983</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,028</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Allowance for excess inventory quantities</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(52</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(52</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">931</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">976</td> </tr> </table> </div> 28481496 -1068000 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Inventories consist of the following:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2013</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Raw materials</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">160</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">132</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Finished goods</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">823</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">896</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">983</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,028</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Allowance for excess inventory quantities</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(52</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(52</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">931</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">976</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 0.42 -0.02 568000 P2Y3M18D 0.9516 0 0 <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b>(1) Basis of Presentation</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The accompanying unaudited interim financial statements of Nanophase Technologies Corporation (&#x201C;Nanophase&#x201D; or the &#x201C;Company&#x201D;, including &#x201C;we&#x201D;, &#x201C;our&#x201D; or &#x201C;us&#x201D;) reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management, are necessary for a fair presentation of our financial position and operating results for the interim periods presented. Operating results for the three months ended March&#xA0;31, 2014 are not necessarily indicative of the results that may be expected for the year ending December&#xA0;31, 2014.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> These financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December&#xA0;31, 2013, included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2013, as filed with the Securities and Exchange Commission.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>(4) Investments</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Investments on March&#xA0;31, 2014 and December&#xA0;31, 2013 were comprised of certificates of deposit in the amount of $30, pledged as collateral for our rent and restricted as to withdrawal or usage.</p> </div> 48000 708000 -1000 10000 2576000 -427000 9000 1000 -429000 1078000 -429000 7000 -45000 2585000 30000 23000 -7000 57000 -1128000 -53000 -67000 2000 264000 1877000 337000 187000 57000 798000 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(7) Significant Customers and Contingencies</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> Sales to three customers constituted approximately 80%, 6% and 2%, respectively, of our total revenue for the three months ended March&#xA0;31, 2014. Amounts included in accounts receivable on March&#xA0;31, 2014 relating to these three customers were approximately $784, $144 and $57, respectively. Revenue from these three customers constituted approximately 79%, 7% and 5%, respectively, of our total revenue for the three months ended March&#xA0;31, 2013. Amounts included in accounts receivable on March&#xA0;31, 2013 relating to these three customers were approximately $857, $201 and $78, respectively. The loss of one of these significant customers or the failure to attract new customers could have a material adverse effect on our business, results of operations and financial condition.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> We currently have exclusive supply agreements with BASF Corporation (&#x201C;BASF&#x201D;), our largest customer, that have contingencies outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended to provide capacity sufficient to meet the customer&#x2019;s production needs. This outcome may occur if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants in one of our supply agreements with BASF &#x201C;trigger&#x201D; a technology transfer right (license and equipment sale at BASF&#x2019;s option) in the event (a)&#xA0;that earnings for the twelve month period ending with our most recently published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b)&#xA0;of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements with BASF also &#x201C;trigger&#x201D; a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment&#x2019;s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the equipment&#x2019;s net book value, depending on the contract and related equipment.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> We believe that we have sufficient cash, (See Liquidity and Capital Resources in Management&#x2019;s Discussion and Analysis in Part I, Item&#xA0;2 of this Form 10-Q for a further discussion<b>)&#xA0;</b>to operate our business during 2014. If a triggering event were to occur and BASF elected to proceed with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Given the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.</p> </div> 3 111000 0.30 0.80 0.02 The financial condition covenants in one of our supply agreements with BASF “trigger” a technology transfer right (license and equipment sale at BASF’s option) in the event (a) that earnings for the twelve month period ending with our most recently published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. 1.15 0 0.06 0000883107 us-gaap:SalesMember nanx:CustomersTwoMember 2014-01-01 2014-03-31 0000883107 nanx:BasfMember 2014-01-01 2014-03-31 0000883107 us-gaap:SalesMember nanx:CustomersThreeMember 2014-01-01 2014-03-31 0000883107 us-gaap:SalesMember nanx:CustomersOneMember 2014-01-01 2014-03-31 0000883107 nanx:BasfMember us-gaap:MinimumMember 2014-01-01 2014-03-31 0000883107 nanx:NondomesticRevenueMember 2014-01-01 2014-03-31 0000883107 2014-01-01 2014-03-31 0000883107 us-gaap:SalesMember nanx:CustomersTwoMember 2013-01-01 2013-03-31 0000883107 us-gaap:SalesMember nanx:CustomersThreeMember 2013-01-01 2013-03-31 0000883107 us-gaap:SalesMember nanx:CustomersOneMember 2013-01-01 2013-03-31 0000883107 nanx:NondomesticRevenueMember 2013-01-01 2013-03-31 0000883107 2013-01-01 2013-03-31 0000883107 us-gaap:StockAppreciationRightsSARSMember 2013-12-31 0000883107 2013-12-31 0000883107 2012-12-31 0000883107 us-gaap:PerformanceSharesMember 2014-03-31 0000883107 us-gaap:RestrictedStockMember 2014-03-31 0000883107 us-gaap:StockAppreciationRightsSARSMember 2014-03-31 0000883107 nanx:CustomersTwoMember 2014-03-31 0000883107 nanx:CustomersThreeMember 2014-03-31 0000883107 nanx:CustomersOneMember 2014-03-31 0000883107 nanx:BasfMember us-gaap:MinimumMember 2014-03-31 0000883107 nanx:BasfMember us-gaap:MaximumMember 2014-03-31 0000883107 2014-03-31 0000883107 nanx:CustomersTwoMember 2013-03-31 0000883107 nanx:CustomersThreeMember 2013-03-31 0000883107 nanx:CustomersOneMember 2013-03-31 0000883107 2013-03-31 0000883107 2014-05-09 shares iso4217:USD iso4217:USD shares pure nanx:Customer EX-101.SCH 6 nanx-20140331.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 104 - Statement - BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - STATEMENTS OF OPERATIONS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 106 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Description of Business link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Financial Instruments link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Investments link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Share-Based Compensation link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Significant Customers and Contingencies link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Business Segmentation and Geographical Distribution link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Financial Instruments (Policies) link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Share-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Investments - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Inventories - Summary of Inventories (Detail) link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Share-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Share-Based Compensation - Schedule of Assumptions Used to Calculate Black-Scholes Option Pricing Model for Stock Options Granted (Detail) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Significant Customers and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Business Segmentation and Geographical Distribution - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 nanx-20140331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 nanx-20140331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 nanx-20140331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 nanx-20140331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ZIP 11 0001193125-14-197913-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-14-197913-xbrl.zip M4$L#!!0````(`,LPKD2'A"TR,#$T,#,S,2YX M;6Q55`D``QU`JJ"5ZJ=JS+[YHL"0MIA"H`%D6_/K]V:"+(%(&V[>5V8>T"]_>9I%W`-.LS")/_6$,[['X=A/@C"^_]3[ZPB9(_OR MLL=EN1<'7I3$^%-OB;,>]Y?/__D?O_P70MQPR#E)'.,HPDON=Q]'./5RS%W& MI(N/X:*_F.$X_\#=>AD.N"3F?K>&5YQX)G#<-,_G%^?GCX^/9VD:K(8Y\Y/9 M.8?0ZA9_*\2[X#CU3`01-RX-DT4<7'#2QD=VBKT^?@L2>_/X1;2>5AJIU>TO/`! M1IXNGWO0UAGVS^Z3A_/RXCF1"_$"DH3G;HLTA=EB]2NODHYBM6.`P^8^<*'A M/OC)GS:W)U<:.H3Q`\[RYB[%M:9.62*+@K9+;46+58?8BY\JK> #X%,Z,6 M1&:>E];CQS";BUGS\$&>GN?+.3Z'1@A:X33TG_N]W*G:(:%`67"&WSAK[T"M-G?*4J5WC'*ZN&I(+07&QTC1O;*H43?/-IM&.Z8W"^!L)$L_MR0>5]H\2;2T8AG%.KSXWS<*FAC"L MFV([S@ZXH67^FD2X79RTA[3%-]]ZA%K M1"N;.WO*@M5E,AN?>EDXFT?XD*HX+U"!"U^X<1[F2XA6LR0>Y8G_;33U4IP- M%CD-Y!#<.3^)<_R4#XGH.(DF-ZXL2C*"/X(L\.@W'L28C,;.A)]04`IO3"`Y M!-@/9UX$=G=YW>]Q8?"I%P83A9<56=`FLFA+CBV:2-%$$]-%U"Z[]YT0*_$K-$)K**&4E;D%U1TF1#%I'C*#:2;;V/#$NU MP>MT5S=)5>2+PO#@1-V&7H6SRUY'3^RRIO`[W_N7\57"J&C!]FB>R(?8Q M=+B-\#7.;9H"\OV`3PQ1$PSE2>`-6=&D%_1@RJ:L\KR#%$4RD*SQ+C(%2P&U M:);M*'S?T8P)"0H3D:4&7=$J6M@%Z;W`&R"3:'2$76-CU_33@VY(!J]U!%UE M0X<[[XF]TP"WY>Q-`4[20$VN92#!Z&M(=C0)61#07F;9`JKIHX(4]P-9B%[%=P,I%,,,!]U.YG[`1'T;&`<5QD4<0L[. MTP5>Y=I=XIN+?)JDX;^//$NBVC1+,J_KZRG:+?X+EG@B.$F5NX534GCZ9XC=AE&8ASC;KZAI M,+>&,J8E%D%C%C&*42]BFL6OKUOF8>Y%5QC6>H/;*+RG6UI%-UX87,9EWV/BE%CF^=E0=*$VJN050QTZ0P3:(`IQG9 M:(VOUM$VPO+$S!@9IA5JY[Y M&CQ550QQ[H4Q#EPOC6$ME4&WQ6P1D8K'P7>A'QX5O\14`#($@:_.^LM0JM"= MLO89@E)L^!GFI^'-(J-XAUF7JNN570B8"Y8W57F=X&-&*U%76.NQADW-C9!M MQL&)!2MF+:CJDL+*/(TPJJ`OXP>8W"1=$H70\%V>,68'@2OV-4.Q-1Y)JJTC MV79X9#H`5[(-%5'1OT(1E(8@[3&3 M!+.L$52^.4ML2EY;FDR3-!_C='9)"2,D^!S54ID)L%:Q-&Y%P;N MTQS'&8;(LY$O3L`8F?LZHE*UQ18X:CD#IWD(BT4(.]G@SL'S)`OS]T@9CJF8 MC@)X9<&UD*P:#M+=OH1I"OWD/B9'9W1) M,YC3LO`@JN/!3AQ9E5"?L(ODOB0A73`MI-NVJ_"Z*^D"9=GLT)XL5-7W+LI@ M1)!^&(?9%`=?DB0X:B1AUI*ZR(@D%='K$269@TTN;R(OSL$121DS)_GOR+%? M8-J$*-5V^'=!V*X\Z[4:K.T[*UHFAJC*DO9D@(SRFI.C2X9>58NZI1;#Y'G3 ML!2DZ::,9,75D:6:)M(,U7)%V7).BZ[S`4/7$73:WYP.A=>6HU M\)U2]&0V]E-@)]:A=TG1D]C0!7G?:5_M7V\FS=7^V;+L`8'DK5LKH!"#EW02 M+55#?JD.$VU'Z_==Y%B.@V1>T4`ADD9^A?"@""X49"\4$QK?M$G?&N2A:8P; MZC#(H=INJHU@FZIJN#)R;5"*+/9YI)N"AD3!,.6^+/5%5]G6QS.YIA,^8X>0 M%477.X$LUE/DVR`?8*M*%,2N*.H4+).K`]6S*&\5!*_MV#/)DZ;K/./<#=F2Z;K>S=+ITW8ZM\>3INAWC_5[INAV;]W=&UWUK:#H" M7?>M(A^7KMM@;OMN_(@[Z+I2;7OK&'3=;J&>+EVW4YR[Z+I:G;KP;G3=;J>2 MR8)4^"VK/3Q=MUMLS&.=^L.?[\W6[18FDWI2.X1X;[INM[[(-E1)K9(;CDG7 M[13S=TC7[7;.=]!U>;7V%/,1Z;J=@MY%UZU&Y'>CZW:+[S3INMT:+K,6U'A1 M9Z6>]Z3KMH/;ZF!7/$FZ;K7?>/[1!5VWTR3!INM* MC"QQ4+INM_G^%.FZG2)D[H344OR[D'4[1<8FZ]:<\$!DW4Z=C$VJJ$?,]V7K M=CIC;+8N7S7&4V#KMD/>BJV[(X:^F:U+-;-VVJ-&4^9.C[!=PVR(?`#Z:Z>^ MR::_&HQ`\S[TUVYK-C;]55;EFG>VI;\>FM=5:N`@O*X=3EL-R&_D=353RLTT M]>)[NCJSENLF-]Z2?$1YYGTO3&E`@+BXF!5,\F&8?>NG&%^"%E,H5(;D+0(\I]L"I%1J9NZ4C3P*@D53;,OER+>_-%BHMC6TG< MK*P.#+]!V[U(?O)S')#"4-A;S?MI5NQ]OM'^J.GQ(,"J"OP[)F^T MQH'Y@%/O'E\O9KPVDR"VAS2BP[$@&<;[T#%XKX>RUB)U4@MDM1! M;-Q/.0?,2ZN`XH3$9.+@37EI/_4+]52TFZJR.HU:48>Z#VC;AM0VH+6A1R%( MM!MI]@4XAW3*5ZZMF?IJ(I3QINZZMBDAQS`4)!N6B2P>BCG1DC5=5%W!M)S: MZGJE($66:EL\G8,^H$/5G/EO202CD8+SV!6?U%#Q&:*H':CBVZF'!EI$P>]S M%BDX0S%3!>]O\W%,]PFG?IAUXN1O,-HF[FN-&/)Z2-TZ>C])[W"8+PAQLC3\ MX^JLB:)?>WOA`3#7-S#\E#!U'%S\A%;%=M9JH=BXK77/=:T@JKT'=,H\RMZL,OKJOLR'P2U.]_W;<`::5N=^*1.6%6=V]1_?% M"^,KT,D@'GD1'MQ5=H2>MX..BIUY[E&;VE9(&DF%U-*#522@>SN!M2@?]"=< MTJ/B9[-UJ@?*;<'4$@$&MQJFZMNJO7],3(-%\FU%]O)G<]\Q0[G,>/,SL8<]44LQ9X*XF6D]=/DUG3EI&%[Y(4%^W&WA/. MOH9QDD*1OQH4JHWJ*`4%[RO.ITFP%]7@$+[+G'PP;+F>C]]+)2\5--N\@*.: M&_O5^GR=C/(RDJW-VQ.)@`*S>-FRE(K0=8KXO%B]9(.[JR2^)YOYC"<)CAM! MV(?C5:RO`/225:].:L,C5^CL7"<(]?BY`P.[.#MVPF.>*D!=9C#KLJUT5Z[# MLW%B^A#'4LP\@S[N.IK]:OH:P:4UGI?U$"S(>0L^A6V$'='Y1?@5&*V.U?IA M[,7^:1^KL0GHJ/;(Y=M`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`D43121;T%6W!0'9LL&#*FQ%EQ3Z!0Z?K\WKWW\YWQ)D+9\+2]E\ M.<3W-*K&^;4W>W5R>*.8`A5SCVX&GRY=$>#(;F^')P M78!HDG:-Q80B,""%8#_R7O'NS]T@-%H9R1; M+D#<@&7RVMD#<;CP=<+CI_G'[F__WHY=M'HQK3="RY.4HBM'R&' M_3Y&XZ%Y/>H/AE_)YS&&IH.A0UM>7G\AO9\^0GZ[&@PON/3^]B?^`_SW\T>N M/[@>7W`"#,[]>1S.8"EPC1^Y83+SXC]_Y$H1QH,;:*,3`:[<\=@=KL>MR'!Y M[;AD.'HS](AOOX4Y(OI$D#Z3;Q@]AD$^I==[&XAOR;]_4G_FZ,P@.C7T%?W7_#O0EMI:6?*?VNKJ[YB[2\@+]KB^.;(X^IPFZ!]^]&;S MC__]9/)41R'ILJG.E:E3!=*K'V#$,.8>IZ$_!;O?.%3#Y9H]S+CT^=N=N"2. MEG#_E*,L=$2?NH0A5@0&VHL\$,7E"4>.,,Z(O!O]FVX!_=/",TFOC&PT<4GY M=5K)'?>#HG%>''`_J`:](!K,FD*F:H[`/1=8JY1R_CO/D\39Y@ MA9.#TK@?(`Z2CCGY2C`89A&SYMB'8+LYO?'J.\5J%E3IY*V?6LBX>U)S0_L% MS&[*)8NT8B+?S+R0/#H&/1_+AVV0 M5SQM4YH4`2B>2=P2LF/V'=G)P4+T@L83JOS5U]T1IRH^*9X3HUI:_)\/TL53 M2_50E>V.4!_@KM7P1VT3'!"O-MP_4#\!OZ&&/2_WYVF4E,"DO8B:.)D4`=3` M\S!`\;@0:>+3UU>6=PB+%\+/%VFV@(DCPY4.M;I9Q@44!8Q!<&1DC5XZ!F0, M$DG/N/YV/&:#A($*F(JJ$^%JH9XB73G[)DQ%EM;-89!5AU7;8*WL1B'KDP%# M[#<=A8AWQ8-2SU%K+68#J.?&#"F+]$OE_&X19&&`N"$%]>9)FI4%Z&_HD!1?5*/?3R!QF/Y]! M[H3UZ)3D7&*.=UZ8<@_TO0(DQ\,UCWX!Z.I&T+^TYCF5A29(DG7#V(\6Q*5@ M$%`H\KV,456"7Y1QY5\++\UQ^H(S/E=OA:Q$[`UIRHHBG,UP$!85"FE/ON]C M7G(E%G.X.[G?LV+*F\"@QD=:@LX2P,P!'HB7X7U<"'R7)C/:C[ZRBGP"*EF- M087)5NJ!0<@=O8+>`/*0:A5*IVCUTIRRW8>*GKR"U[+2#!UE5U&V4<=2C,$_ M%UE9Z&S,&_;\*06UVFXKPDVAO>WY78L(`)F1FQ:"/VC5)/2#3OHXV,?DQ2); M\KXJKCT=SEGG3RWJZZ<#A+7*BNR["%K\^Z\S'HE?!G"3G)M"$0Z6O81ZOW1K MPI!*0[]P]3*]IL2@[XA,L8^?:YSUZVR^HVQZB&4=]7*Z2T!K#AH!PRA:T$-L M$(;X_(,'$6$!)?SZK0/<(J-.32H;+_+IR^II6ROR_&]HY$\3\NSO:N4%DT*& MGR4!CHI-@5KQVE"A-:SL1OZZBOR^]P+ M@M7OM.VGGJ;^JM?ZVC1SQ[P7N?R#H"H1VHTL=,DUT,_%;2XDGFA2)6/..I?WYG9Y5.D+XH)F[UF:^BX9LP2<)%WF>O_96] M-_6Z2D?4,-OFPY-]=N_@J.>JE#U`3NV-^]\5(Q;BEJW58H6!"4ZD./0]]VR- M;=69QG;7+07%B"/IM>@5[<86-!S'R+6M)&"3]0[+9`X+/(1U\M?A<#R>3%J$ M(@F79TVZ]M'Z16C&=^,)JD^VJ&D%&3XJ0M>U.%ODQ5_D&1H$3R"A);)/Z[9@ MIZ+Z\"2J%UWEY8[$Z^'>E`M-;>AM5R)Q/`*0I4F35A[S&RS^7FN>MI")/8WMIU0J>>C?]V;Y!I?[I`?7*T;1`@5-GDW%/-SQ MCZ=MVB6#[U-P_P+;H#RUVL&EP^I=*/WG,SN6>J$:>[0[WY766(^)U8X9#BX= M+[H7NOILPO$"4[8^)!NO:6M:!G%$TM1WXOAO9X/ETF2A2V,#^YY&E$X&7O*\.+6/$'\.^G.T.3F8;>ZTT,3;;& M8U76!]V^;.M#4U84I3^P+:NG*EH3].\F>>2G<:@&.-8$OP1 M(!B8FKSS-IRR\C)KJG2:1DI?7Y\!J.. MPS2:L@J`",06%"&77\,LG05NCI5H$UP\:O!];L)ID?)QX<'5DN?BR#Y[Y`G! M$QC'(_PMG+O&,]MRUH(%N*5XI"B!3,Q])MUDPA%SX>"G?IQ&8"TTX8?!7/:! M?A=C^9@L!8\AQ24^Z+U6%WB>RO@]<_`Q M0G.3(N#_WSW&=CPTE?'$E'OV`*N>@(T=]"U%'D^,[EB'SWK]9U_F]RV4PL#C MA(@D*+!*Q)UX/"7YA$=8=-QNA_`#7GI5[/R';]`Q*/X>O3EO?G<8NKS@$C_O MKS0!;D6U!>YCF&JW0XPA(XA3*?'B`J7)),0717(R22C;36$R739#D2WYU!T) MS![XBE@]")H`/>$LV%T8(9P'S=>">D`*RN^@I(,YA!^QY!8=2LY-F":E)Q'0 M4QKBVB%WWANL?4K+PP_`IORFB;C/B\"B6;Z``C<_$\>L&:#20J&=?+SZ'4MD MY'-4`1W:%\=HK[Q@F2;Q>7:>)K::A*3@'0#-I?8OI'?8*K2BH)K"(!D?XD*@ M)STZ`A)$XCC+;+I#D"8H.&I#TO#:2X$!'TH.G?JN31B\33REAET*//UMG7@?C`P MVY43A,M;AV^I'`G,8;C(B\.2I[-<^L*,@1'@:3<0P!T(^.4"P:I@0&&XZ!OO,_40&_N<<9HHA MS`E?H='$Z8V\\*81S&4^3&'"TIBP1$X,O\J(;4.0#/B1KNNAUTP-+'T'1CB-2Y]*"*;#?8?K.?,@ MI*_!CH-EF0MX78E41.:D$4P`6%LJ$DAXCQ)KI5?+T.>?GU?&1CQ/G&C.$K3C MG"/%]OL./&"P?\`SF!B87QI1'/HIEXB%LT)\_PP<(+#&,8/N\>;+] MZ#X@,I"$(ZO+AW0LPP3WK<@[8&(($A7S`$!"X#X^MGQD8,WQ#"OQ9BM\`,QP M)@F\L0*61%MX,K^YYR1:H1$6D&DC#5:Y``+=F" M<*N\1@P5,=,%X\BBQ$$\)JSJC"D(9HP]="EP3/!^P,IL@$>+J;B`#55R&Z;S M6\%7,)G12N)(HCFXC3.Z$PAK&":"\8W&%6P7$'XX`%ZBRR':(IR7X#P,'F;# MKW`"&5&>@I!6C\,Y1[@PZ@%GD\0K%-XA-1(AY#';[6`287!X2E1\-UIV;W@P M<>&:]L*@7\((-G6D&H%?EYCR)`05#(KM"MA>A7*JO8ZD6*:%B@+9?<.FB&!W MP+;Y"&E%#XRWAD;.*YJ`MRSC@O:X_/+!+QF`#Z0'?5R!R;W^//RG+:8*-!$H M$7[9A\#R/(D!YA3XR2?QCUO/9WD8(W9X&0X1+Z`3"U@OL!GP%]RV_$F)LXLX M@0A\T"H$M1,6(<@\3D+QFQ!O?>5Q&PZ`!FHY+A!_RV'/>7)"BC@@>K,3_-N^'U[=:+<&P4K!DYP$P>,>PS)$E@\!;LM[7>_)@ M8ANR8@PMHVL/C6YW^+WMRO8#L,TW9=IY*?!V&<`;:7$`=-J2'7N(LN&.^RE6 M^7/'*H]U>>[%RJ(W79@]K]!?V;4RB:[=H5C0+ZQ(NTT.O,B^B]Z?J!?2*3[, MKLO1_KYV,XUD%1=!/I]D4/$LJGD\=%T6W:K,0?)7:&>]V8R12<_NUD%S4R>* M5KBF>+N;&^%[C>RQUDAO,^8;!IT/52/]T_26N2GF,&Z.6(\72S]<,48W>#^D M"/R)"0R`??`Q%?U\1CG;_;'_J*OUAV97UBQ[*.LJN$.V/;%E==+O]GM*SQBI M_>_-'3K=$#O=$"NVO*<;8J<;8J<;8J<;8C\'+/MT0^QT0^QT0^QT0^QT0^QT M0^QT0^QT0^QT0^RGN2%V7]1OCY&H>F$77HQVM<>K*N/^8*B,K+X\ZO5'LCX< MJ/)@/.G!GXHQT;NV/C%&SXUA1V#D^LE9[UPJ5>?=]KQL3]#Z6NUCA+EE"S4/ M=#TRA%0>*07AVF[S["0TLT9Y:V#FV:(D^/YC0QO*/9&577U^N+ZWBL/49O8( MHS!_[=(_]P4R0/A`X@*J;[-N#7(EL7EN@%L]J[]%+L]C7"5*LC3-O(Z MMZ=O-U)]+#(\(8`\;#+G8>@^OQ!OY_@7LVVJ#5[_,4KSDPFU^H<7ZRJ`K870 M9Y":^O(0=I,\X<)H?A-&LX']CQ7QO7;X'`+U\W'M,,['QK,'W\Q@Q][LL=^_ M0/"]_7FKZZK',@^C8Q_%HD,P1NET5?/P6OG[<3:PFO,=)UE[J^8^XE/;%CY-735G+R:IVB<+<,# MEJ;\F,[,MOPP&O:5#QR;K1^!W7*K8Q[0V-L8PX1 MI5]*J\*+>YS]IIJZJ>A6OV#!=H35\J6P9.C$MQ_X31;77OT>,_D-9'YH3V;+[0UE3S+%IC?MV MMT_5O[42E[PXU%5X]_=/H[/?9*7;-Z'KTEW%)Y'9=@T@ET%137@_F/Z)8?2Z M=K\/HJ+:(#3:4#:'AB+;IC*P!JHYUFWCF')\G0XB3P>1IX/(TT'DZ2#RV;WF MYXNKG`XB3P>1WWML\'00>3J(/(7L#MKAU4\CN=!"Y9\:<#B)/!Y%' M=O#VO2ZETT'DSV:?3U[-R:LY'40>YT'D:5_9OK0U6-INF-[X[+F4R?8]'I,. M_I'X]NB#^DV/2W=4-8678XO?XIWD^#+X0!FT:B?E].7(25B>`&X'!]GJMNGL M].9C[/\L6?2?[/`?;S;OH*;*=LS98SV;+-M>EO?D2?5LMF._4B]A(WV+O5\# MSPLJ^6,G"K#L!/`N(W/'L)%U0=H4-M+;0))D+-!3B-(#Y.QS4;Z- MPG@7")++J\EZ7;2!.1X/!YH\LJR>K%OV0+:[FB&KMFZ8:G^L#.P199)"J;()7W>N:8\U4^.KZ[8/Z M;^V]8HY*0O>L%.]1?=54Y[_R3"F'KLNE-=3ELGI*?T]UN>[E0XW_F)+B$EX% MI4])+_F<45\Q?7F=F08L;13O1*4^044H#2JBK!T>3(]9CD9Z<;8 MZEE#>:)V+5G'!"?VL#^1556U+65BVZJB/WN6$[4IRXER+J$70,FMRQPC][X` MR!PZWPEF\,6\W535!Y/GIH&3NAZO>8'`E$4I+7><3S$OUE747?M<+APU+-7Q MJ>3CSY\O/AR]D7CA:>1!Z5%19ZC\8*=4T*S\Z%VEN4ZMH3"-ZKV5OT[C\K?G M4L1F/OC2E(_<8_AVT8E4HKGC[G90$ZHOR7 MA'7:\H3[12[Z#B]XP_`0`ZMAX9&&PS-$U0N@\-H[Q4PLP]C+ZSN'&?X6JQBG M/LQ.5LP[F\*BD'=>TN1"NFY];;V",KS96D-9I&?/Z,`">5[@4DF&KWF6*]'% M+UBBV4FRBFMYIK2L9ZK/P@AP+35"SG[AB+LCJ;O,*Q@U+I#X-DQ]K'*%I8BH M@`S(SY]I,*5IH_)Q?%*SY=;8"DXO,)>GTHY8$JYQBN:FD56BLK7(Y^]FPKBV MLJPWL30(@I0*&?(JS5A2:X*EZHFAA&6\7]3\,0*.N#+ M(:]*]#ER4%X'5.=BC[9/T;K]`6P69'LP'LEZ?Z2#ZS"QY=&@.](F?5OIPFM' MD>%+YQF^!#./S.*51H9B?E]I^'8IIZH4O_PEKYSF9E6J>"T:7M/"9:2FLX7G M++`Z!G[Q0NMVI"4LD#FM7B?F4/@$2YC0:N.E"$5E2C5,,9VM%7Y0\&+#U$X`]'8"]$;!KKZ;30;W2K1I0$_---$ M],>\)LQA9]6\YV;3_9-:)Z-*]M!9>HGCTU2[V2Z**LRY=BJB*1]`)@Y*O&JU M48_$EZC?E)K:CAL+1W[DY0W?(O#WBAU6FI4VT:^&(AN&7MO]9IXQ,")< ML'>[B;!N3UOK5,JZ:E1H:QAYC324[#('#CUO:AMM5I6PAG'7E1%/[7_XE6?< MM_+*:J<8\)I>%9,WB<)%TUU*FV%Q8O[<9^<;B]][`15JS1H%`U1MA5OW]RRY M#=VR"W30-=LZ^2#85EU'/Q=+'K)QH@QA7-B'@XK;/=)F/.2\K).R=J_Y2%2@ MTG*^VR`JE4%7Z8'=+0^&QM>S=V$PQ_)DPOZ]0XY_`@N9:NM_FA5W3^" MGH>DNG;?^&"DWV/K>@](1YUO0FVW^49=C3^!QDW.!P_*AQ:4R=EOO2H;FH=>WY#&MQBM M@1_CHDXK/]>KJ\G#3OX]R484U:SM2SK]KXK580^*%O:E4;?>-C'K9'2O&\4D;O#>KFM?I_:N'448]YTQ_)!U&4^ MZ%2V!VKZ^H;;%4%'30F&<7(]$_[206>Q5;4KIE&5ULJ8ZUN5F.'1!*((LLZS)T!B,97NL]V1]-.[)YDCMRK9A*$.CWU4U M6Z,SQ@\2W&F7#JJ%<-Z*E M*=CWV?DFOK7AY:<<#6UI>=H$O!G'#3[XMU\_>?.`SCN#9)C&"5`1T:$A^1MS M!EXZBW=^"FY:ACXV]*'<,_ICH*??DZV)-I`'VL@>:_;`T@SMNZO-;NZEU'=^ M'F^<2Z6YDO+)HN/ERG1M>U;_HQ6VI]@+GK5S*-0TYQB"P!(OH4L*SG(9A=\\ M3.#DKR2S^[(C]5\23]67"%0"#PWA3;#P_55'H+B@S81@8]Q-V09Q=2$-"$D0 M5Z`]CO"-$)&6A:4)*SB$2+WI& MIT+HA92Y8+,H7/"6"?6U*1\-"_AH<#[V]LA';2=\U+;FHXF<>P%-<#X:9IV/ M",WT,>Z.%`>,0RYY#W%I-1?]"![,',]/(X;C<1*P/%/$YMT5SQ%L!;%IM\Y7 M)CEY`C+)<;_"UTQBLQE"(!%Y"(R^26,O8''*`-W0@]DF5K-O(&8Q@B+C=+F$3YTY"`H_AB.DG#WX-"FC9Q%U M6@:KXO<5N&J'9LAWHCG6-,]FN,,QEM3GM*S=<=K2!*MCNARA*@1A&28P")@\ M&!.?Y`RSY'M3\KZX[&4@WQ5.^6LA;K'C$\IS*2*6(#8LCSUG.B!#'6(KM$SR MP1)&E3"%\,621S.DJ8/)0),5,&H&8NYA4_#U@K%$8(6SUZLPQM(8`L;<&!<1 M0K#3!'TL0IV&4Y@5R9O!JD28(JR5O.4I1SLA6G:&`WPP4"U^"-*/^Q;6#H.44^$PYYOZ;.A%H M*^!#,UP6U)Z/*6&@]T#Z'XM"#I`FH.W4B6\[]'\B4004Z8%LTKS2P7BUK1<* MM+#PP+T/@PYJVE"/YBW<9H!H&Y:ZI$2YM'@U047HO,^!Y_GY5@`-8[S=A^`6OAF,M9BZ<0`,: M0P[4U[IY(R$,#>3-K[PR@TF9WA8==$B4N))SXCC$(`!P*5W.(\?EWJ27D.QL M-CYHINBN@VA2L4Y"SEY4[63=.4C4I][RYD[6]X;Y'@@2-X9WC-O#DD'A^N#5 M)_#5WGG`-A=7*.V(^`DZH>%C6`=31KKX?7YQHSI5"(A-"<-.;P]`3E9X\0=> M^0#:2KI$'_825%2A+U0^^_!0AK+_9W;[@Z\Q>,/-F\TW'*\8'E&80AZ`]7HH\42QC#`:Q*@11:X%:*G%UP/0@O%99^"8=34-%-N2U%G MW!7L70#SX(M5S>_!YV+,=L85(?!L;6YYDXGS!>\!9;G2N"-7LL&@K@=@IS#9 M.LX8NB)<_,E5=%9QY@*YG/R;U/-=LJ;"1>/,ABFZ@;T2W>H16I1;,N2(D*!\ MAAG9=$YGI@<=?EH/O'2]:4(R!43C+.>6)9?`$A\NI$\>&$K@..XH8:1@K6"Y M\D&5?#TNZ2[#>2'CE830"JF$;/^#@X>18Z*-JJ/'W=*8O#PQ6FZ.RV:OL,:< MH=PV?"T,%]EHW_O"ZDXVM))M\Q;H,@CC^X6MT+69S4@0T&F7F+CQ#3Q*:=DR M(#I<>%/:)#O\=.MB3?=A:\6KZ-B71 M=#W4G3CPRD)@"W#+O.D7V+-"&V]A:8M;;U.^_YFRS!DJ>$++=$&N!]X=N\%5 MZ#,Q*5Z4Z1::@_@+.$*H8G(2YGD?<>+-%TYE#XZ=X,0$@ON<"E#'L`'AN]H4 M>(0P`A_#"32NVS!*9GCE#Z]IY=K__^U=6V^;2A!^K]3_4/F=L+#<-J*6P*1' M1T=)*R?O$6UH0AM?9)S&^?=G]L(U4%^QUS:1'V+,#CLS'[-S80<:0G#8IP:6 M7C(UL!2J^5X^$<8DA4V*J8RJ]@S/L!`*%-/$1#%L=*5XFF\J06#[@\!$7P*;5,H8Z91Z M?2Q87C+U:GF.+0J;,G1/X"1B+S3-(L2TEY0I;$L+]`'&BND`9\`>4OP!,!I@ M8S`(OIB>C]'?JC2:IE4*'UP0%F;@F_1C(9C@/;- M.;8,;"\(UHF)X9NM$7-!'$R<)7U;B(>01T";MN,9BF%>.8IO>9YB$\N_T@T_ MN-)`N0B5"Z]IOP:,A'I7Y[!:5Q[3XSRL&\;)[_S$3=N`I-QKB!BF#<+`,'T0 MC6Z9Q/Z[,%9#.D+Z^XX\(`RG5'MNYFMO$@#L(YVT(0"C5@#%ICVK"Z!@#&_9 MPL^VK3)[&C![/=VB/EV]%39!OT[1CWI]FC+>/J,VK2[N61LVZO[HX&I^/ M2U>_35C&.$@33-DLS?Q#?X3KOWT2WD M8%`3B$-'T>?>TWP^O535U]?7BR3Z(DYZ M_=(>!4[(56OI;S2!LBO.+\EAG!Z[>YVL=EE7+4O"54M"=Z=Y]R,NMSDL%;1Q M8Y_J4D$:?(!&=C0[$=:>PFE8P1HE_5`XR54+Q%U5X&@GH.+60W(8-6K1#Y.? MYZR].J=7@TF@CUV<,:SJH\D.5]OBZNOX3%'5G*^1'%0[6'C6N=R0MK(J M@_4Z'L>CE]%YXJ:4V90<*EE_L'^BR>,LG#[1HD@!,3>3\0.@*)G'/T36]`QU MVKH2CU,ZN(OT3B;2PZN!"N\=5%VLT`JH]A0KR`JK+E8XYEA!0E1U/M^)Z50N MGT\"Z7#A:+H`/$'8`;N)+6+(CG?6^?_N;5J)4=E[%;QIOEUY2&NXR:TWO&T' M[_$8M`=G,T5I.E-4>JPE11T/9[UMGO.L@[@A3=-QCO2&_);O.^)O M/FG]-LQBY+VI!Q-L':EZAED?;F8Y3U$YW6(FN:(*B2;9%77`S,XA=@ MF_82)`?4CDA['+]Z6LLS'$8Y7:51SDKC(=$`L8QQ?@\\;8N&<'%2:)`IEFV= MY]IZXM%B?J]N'MZW;CHW3V+M=&Z>A,J1R92WSK.!3$3DXAF6+U-!9!V>Z<8) MQG#Z"F(Q9!2%]/UO?7[85=/OG`0=51E?VI)2(2)^NX3?UJ-T#Q._K\SL(:;] MHW+^Z;B;EQ'=:C4I.5E+K\YE4S^>D0TBNO5^W$2X3C8YS?>#7;4P]UK6^>Z5 MBO3HP17$EN]VKHPOV9L&0A\_"TR,#$T,#,S,5]C86PN>&UL550)``,=0'-3'4!S4W5X M"P`!!"4.```$.0$``.U=;6_;.!+^OL#^!YT7.-P!Y]A.VKUKT.PB+TUA(&D, M.UTL[LN"D<8V49GTD7(2[Z^_H21'DBU*="R;4K9?FD89DL\S?!O.#*6/OS[/ M?.<1A*2*,P:^ M#TOG=Q=\$"0`YYX\<\9G2^>2^.[")P'6YMQ0]NV!2/B7H_[U''ST^\7PQCD^ MZCG.-`CFIYW.T]/3D1#>JLHCE\\Z3KN]:NZW"-BI\_/1,6)+_67(%\P[=4Y2 MCRX%1`U[".G4.>[VWK6[[]O=#_?=[FFO>_K^W7_3TGR^%'0R#9Q_N/]$893$ M$B?.\&AXE.+X=V?$F43IV9RPI7/N^\Y0E9+.$"2(1_".XDK]F*Z#&F7RK)5B M^/P@_",N)AULYJ2S$FS]^(,3"9\^2YHI\'2R$N]U?K^]&;E3F)$V93(@S,T4 M5)7E%>U]^/"A$_XUDI;T5(:UW'`WU)(!0$L0RSY MQRC``:?:N!M?4Y1Q*?$'7%+5Q*5/I*1C"M[VT`WK/22)`1'PBD[8HO)@"@%U MB5\]K3ZN:S/8"7Q<1>70+HF<7OO\2?:91P6XP4XH-VO;&?`5E:[/Y4)`GSV" M#%1#\MSSPAXD_FXSU+SNBGFP@`L*;8KC:*J*V0QFN*B:_HM`]7YD?<.$3]QL*(@AY M%TH,!'71J+GE'OC77(P"[GZ+_B(_"\*"URS0UI!6J6,Z8;CZNECQY4(&N+P) M>U(XX7H/S\&%CP-Y>X4=$-N^E?F%!-C>W?ANKHY-:D)7J8Z`IQ7MT1\@X`\^/#I?PL\ M38W`70A,AU"N,@B7!U"0MAV;).]5!U4Z M:PQ:VS?AI&4\AJ4LP2$H6P\-'!G(Q%8-JNX;VK(3*:AS#G0K6_YU74I+F8LINXP)4'/$,=98%YZJ@9/56M5N/) MC-KNK#6^9T2&#LH0!>)`+67:]I4KFHOL2(B;#OW-8R(?0J?S0K8GA,P[RD/? M`3^0JR>AS[[=[<6^YY_BQW^3*EAU"0$4T)Q]\.HG.@5\X6,0&!SPM$,K`^T0$0\-#XBEN,0LCVA[NE=2E M.B8&!6WP&4VY".Y!S%(1!0V#7%$KF$UWU*(]-.4=.A=9Z$2XJPKQOQNNH6Q. M8"S1D2KE1=76I@',5N7'@L\V3FZKQKCNT.1P@9##O-1_=[LMYPE4[F7X._XV M%Y0+Y'+6.FXY"XG@^#PZC->57?'$3\C^YRV0U>SE"ZA+R MO3=$/G_M3+@>OR&NQ1[:A//)&^*\:=\F/-^](9[9,W7"\?T;XFAD32?4?VX. M=5-O0UH;>:?Z%_*]!LWA'-Y4U48JC`4F_ M=]\:=5TX.*'<('/,F+(N"INP;N88W_0,&@SS_!6N0=:+L0**HQL)]P99-<;< MS6+@B0X:9-Z8[6FY[MV$;X,<"V9\-\.."=D&^1?,R&IS4Q*KI4%;MQEG$S]S M0O\UVW@]L^:REV%M`XTOOEK)*Y#8_A#P9%Z05)"6L>&)_RRXE`/!Q]JP1UK" M3KZ`ZL$;!'&-LS#*VEW@A$IN"UW`F*O+JTKNGCR#O*4LG#E]%H``J1S6V5JB M67L+P91[Y6&30R*PIV'$'?M6+H"!?CSHI.T@C]0;0]$BSDK90/H%@F0`:'!F M9:SD`T0CFDU*L>9)6LM@0!.99_$4#XB20M9XC(@/,MX-]!'U7%$[D70):#>I M\-$5(O%Y&!$L5GUQ&2NQZ)0F/W/N2;WFL]U';L'%#IC8SA&*HPYS"I"=[4 M?!H6G(C2K#,;9"/S+PR)EMC\FOR+M]')IK:L)O>SYDK0G"ETQFQR5&ID:J`! MV_PC^6[)@18]X9LO5ZS-%<(!H-[4MBE4[/L*HI\ZG_DV5=BYI#=']=*P-_'_ M/H0#&U>+F7H%PY_QZ]=RN1D5M1(F()2I9?&.J0EQ-\[D@[\D@^LB"&:%+;F^ M,P.FS]8R;O1.\))R]6*3Y,!N32A5M#:G#(O<#4DL_EF5MLL M#*\3&A2L!Y\XY7B5EY2;>FS,T:@R2Z$IM9GBJOQ(TU2:8WT$)W9*]:#::4UTL/+(:E*/9A6^CUDJ[V2NWJ=&S]W MT902@"KV%DJ;4+A`E9>K"YO\BX=;T-)48.D"M0O@A8[!'&/8A.`6-5AGF'H# M^*=G$"Z5R3FVB%=N.3LA[GD\H.[&-YQ-U%U!39ZV-N!M7H.=Z^-Y+X#7!63S MA:UZ7;=[AKIQM^3THQMI48F\^]):<:&=B.SX:LY761#$%NLR9H; M$S7WQ5>O-(-MN9'7)ZLYM&DU56:B-?)&VAYTMH79KKFEW,P96;'.U@YNFNM^ MS535EOZ#M8TS/RNJ0197]5HQBS,U\F4FU2O+-("E2<_\RTTYW;&PD>]/J5X] M9I$V32+07VXPF42*FIDY=`A=96*#S#Y.5R_!& M0M]?$%^"<4B>;DD`@A*_5*496:NHU1M'PFFKTKG%8T&FCK:`Y4,Y]XV( MV0YJI.M@"[9K2U(C#_]Y\S^7;*R.1MZH-":9,U5WO%]I;S/?YFOLM82ZM^^B MVV;[ZL^:6P9^4<6GR*UP..#7P6O&+^=SWS5#6/S1[B:!??GD=LU`[^WKUS7D MJ?V(=8.PQM\(KAGB7;\4_;;HU+./MOOZ<`V\9?_`U!+ M`P04````"`#+,*Y$!KLXSB,+``!]A@``%0`<`&YA;G@M,C`Q-#`S,S%?9&5F M+GAM;%54"0`#'4!S4QU``L``00E#@``!#D!``#M76UOVS@2_K[`_@>= M%SC<`>?83MJ]:]#L(J^%@28.;'>O=U\*6AK;O$BDEY02>W_]#279DF)+EF3) MM)LMT**1A^0S#\GA<&84?_QU[MC&,PA).;MH=$[:#0.8R2W*)A>-+X/FY>"Z MVVW\^LN//WS\2[-I]/O<,;!L6QE<3;!#$!6-(YIQQ9V'7EY.A+"6/9Z8W&D9S>9RM-\" M7.?&SR>G""WV29][S#HWSF*/K@40?V`+$9T;I^W.NV;[?;/]8=ANGW?:Y^_? M_3V;?15*VGT M08)X!NLD[-0.U3604"8O&C$-YR-AGW`Q:>$P9ZVE8./''XQ`^'PN::+!R]E2 MO-/Z>O]Y8$[!(4W*I$N8F6BH.MO4M//APX>6_VE<&G%8[DH\#NM]*_@PD);T M7/IC?N:FSVD.=8Q4"?53=D+JW&+VK`CX+;T(>QX2,^=Q@XP),:Z92YU%UTVYL+Q43<, MU>^7?C;&Z[P;IJH'DI67Y,TCLW79H_KXK MUH.Y7%"0`\]QB%BHZ5T]VU6-K*XKU&(PQ3USI0YC=9X!DSY/E4],D6%JUTZ= MG99G0V]\*:7GS-0S^06%AOR:V*9GXT:XLHGYA(((0O9\B4=!3?2`[KD%]AT7 M`Y>;3\$G\I,@S"UCH+4AK9)C.F%H?4WL^-J3+IHW(2\9JH&')9N@XX@KMOKU M5'K0"C6_\B1E(.4`)KZ#X"]I9GT"/A%D-E6'$`J[@HZ\6C95)>-780>.Q@CQI'N@YA[E[9N)"+$[9' M;'63^4!<'*\W[LW4'4MMZ"KIV-![W0K=$2I^([8'$9NREJG.'DBKFH^X[,Q2 M'L.N`]:M=LP=Z[(;&+FXK^Z)>`*7C&RX_=W#V]0`3$^@70+??H-P"65#052P M`<\\J-T&U(9Q'^0JAW"Q!X)2Q]&IY%!-4*6[)L=H=2LK5/BJ\O(K0JLOO?)(+;=,,*.XPJM6E'FMBSJM$*9EFI0(QX< M"G<'[HVF!6/BV6XQ=.O-]X.5.WCREX8:M*X3J3]"TP%G!*(@S$33&C%.L0MA M>B-HKI@IAG13!R%>:Y5I4HFF!&;<9,`L%:,)GJJNJDD!!$.WDF/7BR=G7/]@ MD27C]'IAAA%YO2#6`^X:\!0(HVM'EQ4=UPJN2*#;QX2H\/!/0+%5AI6+C0;6 M-XMC(D>^;?1DNF^U.F%+]*7S\[=+V.P=K,\[;N?KO MRK3;9`3V1:-@XY8.O5Z(L(8XRN6J_+W*I"0 M`CJSB0X=;F`,0B1G_C,E(VKCN7CM"679T:M_X,P,?DA1K'@_.K2]14^'+P`& M()ZIF;*[$:.REV#Y*PS]?Y?8\<_5Q0]O!O\!=/]-CI>@/_`(!$&Y=<=%^$C) M=5*HVC.([XKG>/)KW_0FQM;!*LZO?]JP4"MY']X,-O*0)JT%N>`F@"7O!'?B M--[.T?>G,CJF7^NPM9T.;?J@LG"F&RZ)S%G8+*L#=91\3G%JA"!L$H0WKA9K M@:W@N%4QK11-J^M?"SO;,*=!1L\3NNCXIYFC"CH^*C["'8JGT!BH2D#B)2@X MF*HF*&.D8V3,K^58J?!)<%GYDLH8Z2`92[43D>_/K$>;L`?BP$T8S2M'69FA M_N2L\%#?3O6PIL[>R]E,@$F#'(Y?X3VX[`\R3^_M[;1ITY72`^O&$WAS##9R MX.45<:]*=+32-XJ]7(JDYD28R_'"(&^9#$#8PQ@]O[0[_W)47O,^-[BP0/BO M3N"?AC%#D@1>:R\:IPW#DZ@>GP7AH#W0D]BQ!\`.[FC]_&S,0FRBJ'(G.$[O M*_ZUL^)G"3>R4)FSFUA=U7&[I*[=#LD+TD[G*BH+UD7#%1Y$#SES8>[>VG[7 M%PT9Y&:U[--DQFY_W.<-!$=KLJ/)DNEB:$\AJ8C@TS\)KC6V&C%]]L:8SA%- MB\AY]\;(*>,<1VR]?VMLU1&TB.C\^4\Z=X^:173^\XW162(Y&9'UKS=&5G8V M.N+EP_'RLD-L:^V(R(X&K>CJZ+KQ'PY=*>FNB*(CODI41%%J9C8B*=]UX+#J MG&I[7U6OKJ5?-M51"66:W,-UBGM/M51E$3E5?]6[7L_$]JL>&?K_7+A#$$ZL&#*M1BM_!WJJSM#*,%>$ M)Y=\NL(E.W6(>,K,YFQM]AWIHBG+M`YKL0*64TL$0],M'P4\4^[)X0O8SW"/TM/7I)?OIQH- ME@=.CT&Z!=T@5>WH0Q3+,WYSA1M M`SQTAQSWXQ7G3_YK[Y$EV;1<\C6L`V-/T`E%)[$;*-W61`^/<^IX3F9E25)&"TJ\9FU%F9#1@5+=NWOCQ"QG MNH;I\D>-7I-'VU=QD@Q#$'VN#5UV]75,XN`1ZJJ-P[,H^TV"N(3>RO4U?^1J MD3P`KA:K5_+#5_1EOIKU\CUK820*80V\VJ.`_]8,2-R!-0?UP6YK2^1KK MB]KFC0HD8OKQ5:P_>I^OG#%OP""9YME&CO:ZLWS5BG4H?Q#%B*EE=P7O8IMK MZW8P@=]Q55T):O/=.(ZA8&Z'=94=YCN&8K8=E,_.K1Q#?=DN%B6G"W$,E62[ M;(`"V:)C*!,K:PC+A=:/H=)KA\61'0`^AKJLLLLA9RSV&*JM*J(@,]2KO[HJ MWX4C/<(;7_8942OMSG6^N\6.>A[$-2+'TMX:7HS,^X:\XS$4<)70,)99C#0\ M7!>NC(;Q[&VDX^$Z)?EUC%<619KI#(>`=9O4W)9S[P*'8N9 MW!"%CVOT*EU7M&3S$#5*IO8BC31=X4J\GKMSI#\YP^ON@/:%JYN4[?'7D*+3 M-TM1S!"&7)SEY4)7<7,E7R*CM4XI!B2<0O6>XRW2(Q!F\WSM1JMU19/;_;S$>0FO!??GPH>>!\LXN[_E%PRS.#Z%[PAG+AS/#N M8VEA+;`$"0N0^6M_4N6/&KVVWSP4_E;H.**,BIIT>7W9RI(6>5O^LH*M^R8R MFA70'UEU[?G,G7RZRJQ]\G70U"VJ_9*0YQW';19R%5Q)=TKT)WKSA5JV6M/$ MO*83HW]>7/7ZEXT%IM^$;&@\*7_:W+!X/U-4W)!X4Y-J^ MJO#@M$S]OL&C01I^F=M!X=WU"_V^)V4.<7Z*?4'>84'/\?5V:8`_MA22$0Z) M/_P?4$L#!!0````(`,LPKD25*'OXAC```-9P`@`5`!P`;F%N>"TR,#$T,#,S M,5]L86(N>&UL550)``,=0'-3'4!S4W5X"P`!!"4.```$.0$``-Q=:6_D.)+] M/L#\AUC/8+`+..V4\J[MZH%==@V,=94-VSW3LXU%09:8MJ:48K:D]#&_?GF( MNE('E:DDU?VANVR9#,8+Q0N2P4,__/5MY<$+"D(7^Q^/C)/A$2#?QH[K/WT\ M^NE^<';_Z>KJZ*\__O$//_S'8`!W=W"!?1]Y'GJ'GVWDH<"*$#Q8;]C'JW>X MMAZ1%\*UZW]_M$)T#/3_#F`??CZ_NP;SQ`!XCJ+UA]/3U]?7DR!PA+03&Z]. M83`0+?V=Z_0!IB^`^/4?PG_9_D<*D)*DQ@KN3NY,,O+_`/?9#4GJUMOQW M./,\N*.U0KA#(0I>D',2"_5BN$",Z8DF=&I*'CTQS\` M+_SA+71S%5Y'HKAQ^O.7ZWO[&:VL@>N'D>7;N8I46%E58[%8G+*_\M*A^R%D M4JZQS:PDH2!4EJ"_#42Q`7TT,,S!R#AY"YVC'VF#/P380W=H"4R'#]'[>\ M"MW5VD-'\;/G`"W+M?""X)36/_71$WF7#FUA05LPIK2%/\6/F9\=`2WYT]U5 M):!%3A:O=,J5].@OU$]S:J*W"/D.+*L]2EUQ5/D1:%XPIQS,#1B(_\I?OSMS+8)$R+"U%OLN;:+ MPK/',`HL.Q*M,8P?CR0JG";ZTRHY!`$*\2:P42N3\-?34HMOWB.MM/)(%1I^ MD#_XZ?X(7.?CD>M\FPS'D[$Q^[8PYXO9_)OQS3CZ,94%0AC\(L3]WP]O#XS-WPW<6Y/W/"FRA)_FQ`6!-1K/9),>8$&)!$$O2RI5]4)DY M5&LNJ`?,J'"L$E:4H=?)B#MD(_>%:O0517*\**VB@1UE>LAZTWPV'!8XDHH# M(J\?5-D;8IXP02+N(+#(S.(1*P)F,&0/@>4@L+;Q'8.'PA`LS\.O="@-2QR` M@S>/T7+CI17P$OX\I1.6+X3SSS`RCMET`BS?@0LB;/6(`O%TU(#Z8%<#4\:3>D?+L:3&$GHX\J]- M&*T(3<,'3#HY`M9E?=R5;^,5NL8A>?[)"I]O`_SB.L@Y?_\I1$3QFS5-8I*Y MZ9D=N2^,[TV)E$,TI92=W>LOF]Q8F&.1O$FU@`<,B1YLK,TU`:H*_2-5!H0V MD'0X7N?CV8%>FI9@Z#'AR+E_M@)T3A=AZ#H&&8>Q%8!+/B2K6OIXB3+/'S&P46<=]B>E#?,?UO)4,Q0:<5D1\OC^<)(BO6WE]D=SO3[D[R$-DG3_CEU$$NYS?YH4AK\NC; M&1DN.'3(\-FSG@HNL?UW!73<:E1VV&@LQK.8:J(ZT/IJ:;2?^J:<^H?V^$K' MH-YL?^+,"1Y36RH)W.4S:.HH+!JM1<'<8/%S?WU\^W.MWX-JTVC9&?0[=,+G.E5'NSBUGA3.CX,T' MG?C*1>)=(&0"WI,8O@\J M%LH_Y5Q?[X)+G5-5!M'+VYE:.JG-E5/I^MF'II;SA2"R5TNI` MZQ-_)Q)T^?K.*$QI%,J\O,Q=#&E3ADX'5U!O!6)+?@Y;K0A;_"*IWN<\TWT M%4?_1!'=M%01YJ2K*^Q`9'62WH@VG2PX&6+)D!4-0C80X4"D`Q'/-N#IZ7@. M@K[TY`BX`CE=08N>$:P)FF=Z)!(O`?VZ<=OXV?ZNE8TULOJ:6CV3R:V?TS=44L_@"DWDMU>+,:'@+1.86YO0N@+> M(7)0HY[RPA7)VE>D2SQD7!YGKZR=9^;6P\'2^: M^*9[+;!;L(QUU]A_&I"&5[]5WM6O"\I93`_[PNJ-OBW"5C\"R1NI/%+YE3D4F10'M-RX0_[>5%U2( MT!Z3R_62=M*I.#I?'9IY"R":`-&&GN7*@UF!K6:*FL`.]?UF:%OOW\WLK3&? M+A(7XXOOW#^3`>T#&=E>^2\H/N]3XR22`A036$XK6<==F--9AK[;HRJ?GH\A M\H$V`)D6]'6P![!`TLL>EXPO?'HX+I%[#"OKS5UM5KI)W,Z_BQ1N841=!/[L MX5SZEF_GSMQ=N*'MX7`3H(:-$'N+54SV?7257:2=D!\S M(8`V"7&;D#3*`D'2;/;`;=JP]OT82BW&#]-MUFN/Y?XM#WSL#YC5W,1J-'8L M$ZOUY%1M5]PJAI2]3:\ET*`@[ZQ4N%E"+%=1OJ69\UV#-K=`XR4X7*Y6UK9PU!PS90VDA7UXM7+Y4(/. M*3"[)Q+Y=JL^O94,E7QLHYBLCPZ'X_A<;$8\GW9G&^A5MWPP.YA%.UB[VT$9 MCW=Q^1RA6YM3%[.Q?Q]A^_NM%=P$]Q$]G<^BS2T*V"G]&G=IJJF8Q0WJR/JL M,$R1\&P3D9F]^V]4N>>MIH8>HA75D.X4IK-I"<&X.$CE:2?57@!+ MR!1RA%8M0@VDJO+`"C*5FJ47)+H*PXT\@>+2.LG#59#.:,RFHVKB<%D](M:H\E\7LV9 MC,">$&=7B-7LP?48M5&HQ`]K>52TC&8RU>8VD>#QHX#M^+QSP^_GR+>?5U;P_0*O++=X-$ZZFE(.UNLBZ\GFQ!![ MF[,2@8J$1";\PJ5J2QQV"-;<"ZPZ/LFY:)Y?$F;J!]_>$]5J3FHW5M/*M[PN MTEFPX7!6S;?WK!=J/.3=*5H)PFD_"2[KH?5T*S%2+^AVBP+ZP'I"ANP+SU;1 M2;.,'M).-QI74RR5!T9/N+4K1,:K._2"_`T"ZLX0X378&S(671$E>D6G$@^L MI5+1)IUC_.G+0.P$&/$2G-<:B]6>+PUA,! M2C23.4W(/GXA6@+1%/"V@#>FX<:*P]O$S'J4G;&-S$9\7"J$`/:1XEO)]M7?R.H? M`I&B\YZR?=&8[="H&:=54B$=A97#[I:)#Z28#!>SY;2Q,:.$9&B>S(;F(D]' M.E+'NOBX*X("(9F87E!R5T!F6T!J65E"BVU>%K%WS,Q7+,/+I)0^5@H5)!V` M3`Z&LSYQ7R<@$J#5%QZ,(\+U)/"Z`PB(\IMX/JV MNZ:?;F$2^*D\`AO[L+*B3>!&[\>PXDE$G?D.&:?,IC\:S:2'64M$;__,?D/S MVK4>78^86=SZ[CN-%P.VEZ.4@RV5D_;:B3D4Q.1-Y+\KFS22?,F`GM_3?97@ M8GN>Q[N83R>Y[VB\(?^ZD32/2ZMHH&R9 M'O*;.,65-PD[[UBGR>3UAH9[0RQHC\0>I-^.XC>I)FT,#`YZWZSS/:Y=\BCAW'IJF+(CG>P3]W?6N_\ MQ'S]71)["E7)VKTTE3]O:HB^,KU'X6:9'\[&30)K$])&0;2J_08*A<8R"\;" M=<8ZYM8:M#*7LJC1"<%R\63_U]#K2'.>5?L!O47G1*OO^_IDA=0^QIIR5:5/ M&QK3Z2[!!LX+]*$M`VNZ[_&F`X/Q>^A8&.%VR#;XFX@?];39*8#4V+63!:.+ M>*&&#(8N_8A,\*_\)0Y63)F*(89\/=6+2C)*R:XS&J989A)2V4@8,;G@IH(5 M+SQUCM'(8:33&BX7,H*UC7L.`]G<'[*21:PVY$R6M:2M=?C-B4(5OBF,WZS] MF3PK'DJH+ZMH>V*E`O+[^,1)U,2UXHU\\;7Q3)KZ_8G=`#-W`:9B@V*CDXD= MBO5V4,T&ND52C@MI22U,2)J7=1=C,1N7\X!M:.T%"W8#5E#J&;#E6.7^ MG[>`.N^_%=\=JMBE7EY.L>?G&I=WD7DQ_L?Q4=_>]/T!F6T!J?3X4F_D#$UKP6]F?%ODW;;.$!Q5!.J^OSX];*FU+*J_39K$L4736!IR,[F)S/ MBR_^/+="UR:SB`O7VT255P8VU5*8W6M01=9O:#J*.WUZA%5<8@M,)ILRQE+U MY.6ZA,HH0D_L>C@,Z4?G^&5.-)=/H-*DAU,-554.3M(YLSDV&1MIX=EJ[>%W MA.Y1\.+:*$WS91.!7S'[\`1RSEZMP`D?Z+?`LG^G&4+^.>L[9.,GGQY/%U.: M('Y$RU7=EZ%8"9510"DR::9-Q%X=H1_$"N92_[D5@D1)X%H"4S-?AIV/%=^V M3W5-9^8!9-35=65(C]\)BW[_0.[3,VEY8+V@@%ZMPC^]"9C\"J_/KOT,&S]( MK6MG7X$;`GI;(SO*W!^)+7)W87EW?E.^CM?]![24*A MO)RB5$QIX_)IC86(27S1,I8#3!`02>K3,_L#,ML"4I&RJ74FD;NIQJ[,V^6O MKY>LI)8''=SO;B8WD@D?ZM--]@?`:E9@/98$JY`^DI?:MS"2*F)]=CT4?")# MBB<<5'3B8YKC`I(,3HHL;N6,Q66-1Y?JG[Y%U]&[0JW[Y# M3R[=#.1'7ZU5V1I5:3&EWIUO6]XE1OGQ42H&J!Q=_KT'&K,=&G4>7NY$>18<^F=/$MT)9['[RNSOT M638?MX6LGL92?EQ.VF:;=7(,Y?+7C;NFF=A[RT,/^"N*SC'^+KY#&]^D7WC! M+2JJ/H@BI97L-93#Q6@\Y4=1$KD0$L$LSXTB>"2RX\M(UHETQ<=2#H#8R".F M@N$!L[OEJ>ST^]*Q=`TG4PZ`.MF-DWFK2#2C[21**WXF1U'DS7.(('(3N$\N M&5GL%DGJ:FL.)S6JR7ZNP#3FXGC;=DS!L?P^!I;.L%=$%R&_KR&F,_PLSMR4 MO&F\3.,-&=OHNX=N1TY719\FR^F8:M!KQ)@NZ7G@IHL]:JLHG%34Z2%]S\1\ M&']XF-VGQMF6D:?]NHW.0)H[@U0U6Y!QQ>P4H=$T?>%3T_45]74T,ZKU30I3 M2L(D'=MUVV7T!NB82U^0155B1ZFP MY]KO_/_2O&JLKX-C34I)IX.&D]$6WS+"@#LWRS7O\9A>./3,>_-\C;`9.(6O=^25Q@EX^$*SY"LK)"M M6^6F2ULI866`=&-Z+1T*[F7*:&28&FS\A?9+^+5 M'U89>.W#]&5TCW$M1794?YJJOZY47YG7;SM'SK4+&'7X[Y5OXQ6B!*,KMO3[ MGJZ_[#>4/C%]7'`+A\B(Q(4TMN(\E(H*Z/W+RAZ MQN0O=&LY&RQ4O&F5&BCDGT)8TC=NCT?QC@XNEO>3;/=&JA^D"@+7$.+23$<0 M2H+0DIV8WA+(506N*V24U1-.^OHVIOS^W)#NKB&_@LO-&E%] M=`8R#5$B&RA5OSU]@?@^(F-'=L5;?:JXJK3R`+>E@NS<%/I80AE^^T>-IZ!SYJ'KH755:.4NV5)`^)3D7WWA, M.V&(14$L2]I6^MDV3&M M]6X]>L5=$O+UU%*G7AG9D=9\,9\E)&*B0,@D(U,04B$6JZW3Z1`MZWX28.MJ M8`K)).>1!5I)V*1?!+M#-G)?=N)8IFHO:);J(S^GF8QEF)9*UMAY=8R:]60/ M@>4@L`3.H!:G?NYM.ZL<_0HVZ@T#@PUYZ_'W[%Q4DW%JKJJ;@05]Y*._,:UG M(!4,&(6Q7U4K>@C?Q.E*%91UDJ M-C/WZU$/N1]BUDUR=+V?^E6Y:`/WRNS3#\[=!FAMN8[X`G.<@3WS':;S&8N6 MTGX@)4PK-V4TE/9>LW:R&#<%R2?(Q<(#7?'G[L[;ZP^/N[=.O$#!+2'FE:SW MQ9SPE1;0Q_$VE*CGO;0]]<0"OK8?:U7I)/E22MF;:UH^GV$F(]]XCTTL01_1 M]@`RSB%!U4C4$:;4;_),V`:LT\5O"0D;W@TKHL&Y:;O2605SLBAX-JVN:[ZV M(P`S!V!=`4"U-V==I,R5$YAZ_)AG7M[3PR*-:8[J&DJ]O%(-Z6\1#!>)T\?" M,F=F>I"VZ`:AN2-"=3QI=,$\;>K-TA,6-1W5JZVBET?M#X8F7^$K=S/M!_`Z M`VGV*N_>['0-Q-%_>BY1ZK/KN^$SE^\D`[_9RW+#LX7H_1\ MB_![)D#7F9.=04SS()ZH@&/^M9E>N'O.:TK=/,6LU;V_HL;Y!2VBP[5)N])Y ME)FQY=BDNN8HWA9`<5!S3&\XU$S-MABF!0P40I^(F?'W4EH*O%I)>6>]?K&( MG[F6U]CUY,KJH&E6`6E7&9G#(E^)'$@$:6;NSICXY;@$R:H.B7*O+W.H4O?? M`JZ5!_3"D?C.[!`%+S7;!2HKZ&#$EA;2R=.Y,2K2(A$&0IJ^-8YN\+'ECC// MPZ\6\6!VH@F]V2BDFW<$ZE\W%KV&N2\S^TI'+"51N7UT,2D^MTL,SI8DLX^: M$\P2E14SK%DCV432?)@N[B="@`B.E^ZS3_N0@^X8N5E`?KP3=)54E/?D(BTE M3:>9HA?HD1[#YP?O[Y&]"5@$E*=IDP`]5&W02K;S,*:+$KI2X6R[S?]W=VW- M;>-*^J_@8:OF;%4R1Z(E6=HWV4ZRKDUBK^TYI[;F88HF(1D[$JDE)4]T?OWB MP@LH`B1(D6@J+ZG8!AK=S?X:C5MWDD\CIS\DS':I@C)NN0[<%CH``*^AC6L` M;*)'8!#?!PF3W]SH3[QGEP%+[`;^+8[V+@G8:S@2K,4UH69G5KT,!^,@.I7! M&$N+^;3L3NZ#W*/DW"B`Q1HD'*&$I>2NW_!.W,#5?.JR!N*+>H&JQG-UKWP( M/R>]L*/<\BJE;^'&IT8HA-$886TWBWZGCA?S]U_72?YVB2)W"S+-Q'/`;.)V M*NHLKT0OOZIA84I.HDB?:EK1$`9[R>BFL\"$"EY&64($?()K(XPTI7FB MNSRU#00I)\:DP80L_C"LWWQ>.NT`BH;&-WNOT]19"E0,::XY1S[QPKH,$=#7 MT_4F5XV5(_64#-!$ M<:8\R021%H'6"F++^/56)%N^1NA.ZK$6:7\_;%]Q]+#*?G'R&8RZV*Z\6L./ M:"EQRX56.Q55"6Y!D]7: MR7X'4%"U4SE%M>;L.VZYQ%Z5='W#OPGRLE*I)CJ!F0E_L.JSWS!C2.NVY396 MYS]I8-.IXHHZR10=O#OZ71``F_3:"N&8"F%OPE,82W&N.Y45Q*9%1>5JFRZT ML6G3\L"FZP!GD=9`3+I#VW1K(1Q3(:S9M,I8"C9=DA7"IK^[6_RP*LPB=^'6 M):NGMR;O)C=\6A&R"IS%WQB?=LU&R?J!C(#8(2D=!-T?$QF$7^+*14#X4 M^$E,SUJ1J\%3P=V,&N@137N++T"XG>J%5C;ZS34=)=)#05W%JNEJYGL^N MV[H!91E/F.,GB\J:I0ZOB`7D1<9NX@T"A MBA"\MZC@SGA*G*3GS94>(AOI`@*%KK0B7<4??J!@8/$&<*]3W;`A?GZ@8$IT MD-`_9^Z;S\>MW<#P`X4^E*4.%(C"75R&MS@S4&BBX@%YD:P.R+F!0A4A>&]1 MP9VIT8\6HX6!A\A+Z0P_4.A**SQ0R`4?=J!@8/$&<*]3W;`A?GZ@8$ITD-`_ M8^YSKIV%T]8-##]0Z$-9ZD`A5+B+R_`69P8*350,Y$5$!?:O^F2FQ39V,9X/ M;/PF=78URR$K^J.OO:4R-9B,6\K@I#)LP/*PMF=^5L>\1:27#?P$N"LO-M4W=;VQ5X=(Z;7/V>+Q?0ZO='+^\&1LHYV-8&>%` M5@)BP?'TH780KY47MJU-6Z!N:]-_J!@POCLU7215 M1>1:SKWG+:@%\-DR.5(Y=DY'6VG$&@*KC*H`(ZWP8%B@?(3%J**ZWG)-)]OH MT')B'!..TA0XPJ1D@FFPVTMYYD:`Z4;,'#G#@$RM[96P4ZT',!`]80^3=Y86 M5;L(/&UF&RC2V,8E^4:SN0P-B00@%-H*(DT;4;4@5C&@,)V2U9^*#&;GSRYE M(=FJU-=>4S:U;>\GXQO[R<6H$#5Q,MG6,EA5MK-%*E@_IP!N^1IC*EF_2FP( M!#RZ1[Z<>0F7WO\=2(0?H]`_L"-S+$(ZS;>K[V<1&[7,&*<0F\X3H*0DT4N( M$J(HIYJL.Z#*/G4L[T02F.T!N!X_'(S1SCWR7/M$1/4^+PQ%K1?MJ%!O;HQ9 M:Y9<>L>[LL33&TQ_S=+`(K+=1>$[!L\N;VSA,D;--#P4P-+@<7]\I)\ZK<3! MOT<#X]$0`(:PFBMSVQY78YF31YQ^5JZ&CS`D6'>A`U'=C9&,2?I<_!)16VWF M=?"MT"0(CG%$O>F6U=M[?G.I155FX-&UMHE0-0O&B0NF:49XB1`2E(`3]'0A MF=-",FM8JC:U`G`J5`&"$DH+L]"#IY=_=*.'B&_!^ZR@(Z;<-4[^[=?1.%\P?4#.Y,-H/B]'=WR3,`B+LQ7_ MY2`A5K!+/:QR+0)!:><2/[GJL0Q\Z1Y5=;DZDYYVH5;'CJFI+J:+''J,:'I+ MB6_0%Z[\]5KES@"-G8KLR"+C])4.QQ>7.:V%YVJ/'2T"S=1J3X!GI#`8((8> MQG[\F0K*CN4?5HV/U!I0L`I,8[:,K97^+P6H((X8=7ZCA-VUMW>L9@[5?I3@ M%)3`7]WX)-Z%L;LIG*_!@K6Q91=!VTQUX.!ED_H#SX@=?_J!(X_$%3LG=?V@ M@*IBQM@R9XNY$IX\?$VHHHSL`!!YMK0*'.*$$"]EQ24/=^"/X8P-58M`K:J` M<*?V!/H;E)5=[*)-RX?QY=OY;)P!33OCP5VM[$Q&#J]/!I=%P"_?FUCD";:J M500!JR?Z17!%BG_"NH&4TVS'OF#!OR[)+1B&;<5$^ M,)NMO+TDM[!MM\W*;HWFXWG!`51(4AA(R8*![QD]X5UR9?!A M]34,UB\XVMZZ.\+2-K#I[N%U0]:5"1R;4+")`7.VC-.,78]2C&3$V=J?D4>, M/DH&0'P$)`T!=;.V-RV(J_,1"3RRHP)GZ@@#Y"5*X.$2Z-*CA7$7\-E0>3#X MC3'5R!N-X^[P.]Z$/)*K?O1;W<Z>PP+.P!J+$*M3#A"H]A'Q]LEQ676(IVQK%T1E!HPK""_2U*4Y MF633##@"/%LJI[%4%E&B-Z\3=&B4`(.*/0VHL?_)C0(2K..EYQVVAPT+0>[P MBGA$M_]ET-$J7NJX,8Z$)M-Q"AY!$Z5$D405)62A@-2IN(YX4I4+Y^N%LX_>C,>+%!NB)Y3YM^#;D?@6)RLDH",% M/-:G*QO!)W"D5321HF5+,D/:;TV^V5(S`'MNFG]UX4RNBG8-GE/V+%%D4P=- M(*NS&95A@Z>+Y4DL*I<%<@N+9BT-:[SM/UTDZV>1'04V[F\K@&,F@"UK5AB( M;,BG4H+9<(*H+V'HQ_H#;&53VU9],K[QA#Y+;U86D_]P.G#GU&>+E%[_8,DY MAI`$J,J<2J:O$AP:`V;F#VCY#2QD-ATIC;XW#+F\WM(=Z'6^J[;HZ) M:XF7@?^,HW="USLO+">2[@/W,I9-I/4A@'$(,T^?@:9LL'-%P0ABG"")E0S- M_(9CR@W*V&%EXE*&^%%(RA+ZG3,%%=F!*[B\K%'F^,W]WS"2N']*"T4]X[5(I=30ZS6E#.SC&K)K?!UG=C6M]F@I M$*FWXD,7'5@V.DJ''Y[WZE-U3D%UX2I3UVM)71_8[YKI"])AM41>G7MJ\S%@ MG1&KZ!W048[).S#.5UT!%>/N(&ZEFB?C&E?3M.")[#LRVND+2,2I#Z"*22_R M"P=PV&Y=*G&8BP]`['$$$+&.#YLQ9.[AF%)]R,"^[J.Q&APFJ78"M([M92E-`%FFJ"< M<84RMI#$UP#C)EAMEYRDK*S?F,KW(;IU-QZ_'415YGI_?J3M0[:U+AZFHL>( M>&SU]2WTJ>I8NOCBT^,OU&?L81.=6?`*=6ZTRZ\+XEC%$O(+#M>1NWLCGKL1 MSXQT%JYM;].IZ9@PSO,\N4H#,D$*R;0J7UI9<"*=2,==@+%4UA!;9VX%O%4J M`A`MV09,S74P;7/[6"GQT*"PZ+@(E7QC#OJ>6">R.6UDLXP7K<$IX*+6QA#0 M8EY4V:0G((;:U^EUKA;SD0Y.@RIDW+7,HC;Q(28!CN-T2U]$\NQ0LC!3T;'V M$7D]0%1-::SW&M:P M4VEB!:SH]3`<;$B;U[J]Z\\NB7B&8&G_A2+_&]Z_A7ZX"=?'NH6?$F]1^W^VU^\>V9Q&$L3<$?>B8\#_\G=:U'7/*'DKY0XS!G\`IGZUW[I(SK1P)WL">L]E"=F^N4OM%P!SE:[UDKTTD M8ZF\QE7&W<^`MEUC+U(8ATM7U[)/K(F64I>HNG%4YQ%Y[KTQH"N$US/W@?_$ M9/U&NW]TWW'DKL7F$]?0AJSXS096PU[D!`?WD+U"NN0:^_M"%Q\\/I'XS\\1 MQOSU:\VG-&E.S' M%5,821464XH=0V9'^TY4VK&;A4MUHI ME?%-^)'3]^(\Y1,EC**8K>/'#] M5[PH5_R5!/A^C[>Z5(D=$+X$UYEQ:U[K8]&92_R=C8[X\)=V1M1.;]T<`=7J M;?#>K02^3KQ6\9M-4O-/1K&MO)MC)'1GB'%VF.SM7M0IWMA[` M@\S^D-FE,],I__*=VMR;0D_F7\\/OD/!<) M8PDZ5P"T?K.BXOMCN@DXA#0#/2*TD<=KJ_[AN#7AFRF7]U3K`7LBQ]B-'\,- M\8Z-K+*:$KA3JF3/_*ES6DQ'ZW.2]#K,BV0C<7\2(S'6D#Q)=TJ1CA@*_G6` M]T^,3+[>#=3K#@;E8;1G=_U8QLIXSS^!UB043:WBM#R^\2/,JWFVFTZIB`NU M$ATHD)TI$4=1C1CVP*.WI"(Z-$(W,__`#7XPHYZ,KA*39K_YXYFL`[(B'ET= M9"F2*>9NPX"E7L"!1W"L2S?2@D#'YN^'WH$I1/7*NSEW9J8T'CNCJ\GBCRN. MCIP^\K)TY>S-GB%&!OV^IQZ=2YTG:V91<&`(P#4O?:G#T:G!/U0#A M9-ICF[F>EMH#F8]S+I\/N]WF2$.(+>%>\@['7D1V"M?0L+/-.=N((^/+=9/I MK(Q801CEE)%$&FAB[U[L)%TZ%]5=1SC9I?B+[-_0S?+Y,Y4_VH61-DV&M3"@ MD0$7`@-SI8$@D\[*7.ER;JKE#Z(-E[7M;>)/QX3Q8FV2%<],29TDQV34H+:[ M.I%.D1I3*Y,U%-496P$XE6H`Q8ZD!$%AKO!HD5NL,!I%T MG;C<[2),V6(J[UUL:!M@ MA=%-PZO)+#NRD&@@002HR/5YPDAUKF.)TB\(:V6R"@ZE-9704)9_&.9?&P5J M.X#"H6GL,QW/9UI8#"#*ZT0^YU2^%"/_,2R05`=OE:H``\U]'!^P?W>(2+`6 M5POY>7W,__B0)L'!D4=BK'W6UIR0;9`UXLZ\!K27>3[NI(!=_K)D_#WC9!;L:2^1G3)$V\+!'.-_.01!M^ENU!=J3Y/-Q M^QJ>?I3RWRW8=6E0TT7*>.$DI\))=R3ZVS7D\]AWS-COVW*UAL$L5BTAA'\^ M>7[U_<`V_Y+*IP^'?;QW`\;EC1L3;QGX=V1SV&N73RV)6?3T[3@TM;_K\2C9 M+"^]R!0CY161I<$0'XU?2TS&@YDW+.BF\.`2I0\N`Z&;<(5>N2;8S41?4&=5 M=?CB2ZP]PYP-R-GH/-#(4]89.A>H2=3PE1*F/].?Z']8SB;ZP_\#4$L#!!0` M```(`,LPKD1F0/V01Q@``)^.`0`5`!P`;F%N>"TR,#$T,#,S,5]P&UL M550)``,=0'-3'4!S4W5X"P`!!"4.```$.0$``.U=6V_C.I)^'V#^@S<#+':! MS:V[S^QVX_0,G%LCV$X9UWO!7!!&OQZ=GYP=]3!UF$OHY.O1+Z/C_NCR]O;H M[W_[\Y]^_K?CX]YPV+MBE&+/PXO>[P[V,$<^[CVB-T;9;-%[X%A@ZB,?FNM] M)_3Y"0G\7SWYI]N#3[]?#+_W/IR<]WI3WY]_.3U]?7T]X=Q=M7GBL-EI[_AX MU=^O$65?>G\]^0#$)7X9LH"Z7WH?$Y\N.8XZ=H&F+[T/9^>?CL]^.C[[_'AV M]N7\[,M/G_XO69K-%YQ,IG[O/YS_A,)0$FI\[`U/AB<))O^]-V)40.G9'-%% MK^]YO:&L)7I#8)6_8/=DV:BW9+<'D%+Q]2C!X=L3]TX8GYQ"-Q]/5P6/_ORG M7E3XRYL@J0JO'U?%ST]_O_L^%7L6'XZ/O]P_/'\Y$VX1W^3'?[,F8>'>-P+:?CB M+^;XZY$@L[F'CY;?IAR/OQY11-\D\I_./D;U_W+%G&`F9Q%UKZE/_,4M'3,^ M"ZD^ZLEV?QG>ILB'-MA\"J2$\\=?SL936?0TM[73NK0.H>:/$4QX+/L8C&\( ME'$(\AZ8(+*+2P\)0<8$N^5)UVQWETP\((XK#$*)QOTI]HF#O.;9N@7!-L.U MB%\VT3AIETA,;SSV*FZI2SAV_%I4;K=6F^`K(AR/B8#C6_J"A2\[$GW7#4<0 M>?56J'[;#?-!?<8)%J-@-D-\(8=W_:TN&WE--\C%:`IKYD)NKW*'PE2$.#4^ M,&6Z:9T[N1NZ@8<'X[X0P6PNOXE?H-`CNT2>$WBP$"X\Y#Q#02!"#,(2#YPX MH-7<,1=[-XR/?.8\1[^(;QQ1OXJ`-D9IDQB3"07IZT##EX'P0;QQT:?`!FR6 M=`+*(,S8YN=3Y4X;Y/PB$(1B(49X,ELIK4#$-\PF',VG<5>4)K7]Q,8>5XYY?<1O_H4' M$[D\8#NDK6TP[Y$/_0W&@[D\-\D%W20<&:VWS=`-(OQ7Y`4X1E.T,M3Y'1EE M\P&FG5-)8ZC;8=ML)]2Q6WJ%GWQ85W>(/V,?/7GX^E\!G*9&V`DXR"42C'*!&5XU&;VTS'/<,Q["$ M)CC$4M<#!4?X(M85']`BK-7*P--0-3]]FB&H;=AT5.=6YE.YCEN'(5*: MAWC.N.R_92FJT]V2Y7E"\Y0F\!3O4!A35YXUHZ^RVV9,F6'GT#V0DNK1D_9> MQM-P+SL,C;H".R<3]G+J8G(J+>#R'Z$I_/CL?&G2_0M\^M&'KEW9_8V')JOF M//2$O:]'V[^?MD[/9<"EN?`&1@)Y_\"(7U/W"L8K@S1ET7)4;D]2^>7':ECZ M&C$2E+3I79%VQ!/I&T+E(E[-,N: MBYG%VJ=N>2X<+69/S,L@*_W[FI[DIM_G:=H0=U8-P3^W=OSTS>JRQ.D\O`L[ M=J;$6RL+8\YF9?:.%14L8W7W&'?#WZ<-0+!##'YI&=<,K54V*D M/AV0*M`\8ZQ^.F"5L2_%^/SU@(]:JXAA^N\#3#DJ=XS3_QQPRC(#2/#GG8 M\\7JR^9I;_GY1]]Q6$!]\8`6TH*_7/D;1[^"PM7/I?7I'F('DQ=)S3WV]:C/ MK&*(!Q[`!"?HB7CA#6TA`XKR1JA?>^0\(.+>TDLT)S[:M!H4E39"N;SV'F*? M\&A-/GED$KF,W#/JY`^!3E5C/&V:@S=^-$>7XB)`4<@*"1[67D>@2REH M3A4Q06-"88))&P[ZE'EPVA"1AYR"[L)J7>2E8%/0KFZ8M_R]H2,:\#89^NAW M85].D%,H>+++FJ!ZX$\QCY2;0JJSRQJC.CYYJC3UK6(F:'U8F5X*M]&LDH8H MGL.Q\OI-NBUBD&R)@<\7)3HUS7#$YIC[BP>14[[.Y54SP`.=D M1"AVKQ&GH!2*ON,$LS#LRP4]ACA$Q8E&11/\C*:,^X^8SQ)N]PH.,HL:H3G' M\EBP6VE5-<.3I@;7$9VMM):FHY?MT.R?;\N1-OX"^\3:M/_!KOM:?6#RQ7F, MCUT7M?KX*)2Z&!B[;F;+KJ@D$E4N7IDT/^T!$HIC5!(03;.5K5>PI?'*5EIV M=]G:<7CR[Q%CF"JX0;Y@_L2L`6K[`!N#8Y?O8VEHTC;0&!:['!U+PZ)U*(_1 MLLO5L;P@4N%2167N_GY?UHZ=A"K/[AKC9JXZ\.5?U\7( MV>49V01R>@XW\1''3I6](9&7#5D5-=[N72*O=(R;7>%-#4\UQ6UYC%X5Q7^O M9IV602+?N\G64,-J:*G\C6T-.*R,DLHSV-:(PVI`Y2-4Y0#>??%4YDIO^X29 MM0G:::BHBI/^YADC:*?QHISBD.DV8FLH:S6(MKU3;0UEK8:/,J;$UE#6:C#I M.-;8&M1:#;'<8TRE6-8R>D)7`P[33PZ8B&?Q//8J'_6X8?R*!4_^./"V;^0* MHG)*M6$X)@$0'_!P<-QP`WC`/`R%+0Y34-8TS%$4R=L/_"FL@3_BZ:KF9*M& M)SBX%2+0IWY9NA.4JS-R:54Q[V%<U79=1*MWQ;TX@] M04#_0_R":4ZZC&09$^>@E:E[);0OD"!.G[I7Q`M\Y;&TJ)8)3KYQ)L0#9V-E M^&NRA)F<'G(N?@(WK"X(S1<7+<4EAP6 M,L0MW4ID=+_#L'^XQ>&SNZ3`',+KY5]PD%>5-D5.7-TI](=)9)8UE$+D' M[2%-3_YT+JADC(\1\K!8ZA/JC!:91'H%E'@LC-W.ASZ_CADN M0A"+%NI6,2-V[\2H?V/,%>I9DEG4-,UZY!JC%'O0YN0;;,<<>3!#^^Z,T#!Y MO$]>"F2*9F43?/V&R60*BGW_!4B;X/M@]H3Y8!SJ_HE3I=[AH6)C)H_@!7IE MVH=H4QC8;GLM`4Z.;F.[H;4$2H5GR%IXBTI;"E*G*=H-J M*6Q29J7=N3;N`3(%RKOMF6)*8:6K&-J>/Z84:)FVA%JI8VQ;@ENVMVJY8SY' MZ%`\D9>X%N%39-NQ/:=,ROEIK%O&"N-_M6PUUB[G#0-^O9PTW9]# M*KMB2K'(M.?9[IJI@TRV/=QVI\NRMR+P+]G_C^P+P-;55XVNM4/SP7M#5<_/G2( MK^B1:9A37":KN<+1WZ784S1ABD%X3,"B M*I!&M9LU\Y04[$P."?'PZVKJA%'.42HE/T#*A6! MP3B50WV=0%WE0Z=7V9`+56KQW-*-I$AJ9ZJ">MWB)@[%*LU0HFIG>-I(R%2& MI\VJW>!IE;:X##/).MW@8JT#+K6G8E]*W08ZPI_>PU$:%;O!SS(K]"J9:F9V M:&T>M1HSZ6R:H^VGBAAR,\TZ5&4H.05KJD)#W>8WRZ9<0P0NX%$ M$^4H'8S>\.\TX8.LP6*(%XQS*V-1!>$,@KM\P M=XC(R8135,^,Z_]\.:$&X^^,3N2#4(K$U2S>0Q(,_F MI2AL.,'/^MY'/['/=A4C/`3SN1=2A+P51;=TS/@,Z>0ITJQM]!F?%F_#TF^, MZ-AQ;<\LLRNT=2W,U2(C]LF]95>(JZ2T[5$53=U593P\H7';_`[B,$I:A3>\ MVC1N,*IY/.^3#&@:Q;P7(\LX-;UG#%-W-/8[33<-G]YE0S7OZO>,Z]:%M>W/ M>+8`X-9]>E8N1)VHFJ/A>Z3W&P&5`U3HNVOAS8# M9-T;W'HOC+X7&5#.=]3V)TC;Q'3+S[C6NZ3S<(1&/N+^`=+8_;K>V:*AB`M<1%<+9^%!?I4`YANN`I42X#Q_J"LZQM5+WG& MWN[^)6\]5/'`EL9VZEQI5SO:O\O':[4P;.<"S_X';LNA7,:$%6-GISFOH56> MNV'%&-JI8S:$8>[)*<;0SBQI93'4=E:*@;/3)E<6N/H^#&M$/]J9:JVD'UQ6 MAJQ-AXVV\Z+L/M%%/#$2B9;BA[\3>!EY#07.YF1,H'TL!N,K/)J)!1.M7Y]E-% MC-(X1*]W(&DX05XAI*FR1JF60C`4/#*/+G_)B4!75C"].13(D+0>ECE8MB>J MJXK2AEBSW;)9%::E%-U=_KK]@B=#Q-@?QUQ%%(.QDJ:,+`;KC3Q*&5V\G?)6!3C)6_[ M)E0^RAWYZ-TPOOPDRYTK<-LQ$5;AG'3BW36\J;Z-)$;`/-QUZ9(K<8?E6T8* M'%2E#RD=&GB3TN?$\9=3(G<4LLL:217@P&DQD*Z%"N6.*_P6*Y0V(7&>!4:'6U,30.4 MT],^(O8-"OIK%O*LOVWTU$G$E'(B/@-15[KSWJ,9OF(S1,JEG:G9E9FD-;"+ M].=QKI*A?-U0C/K#4>X^5%S/&#>W0@38O0HXG`6C*1GI*V44A0H-&4WZD77. M+\[647=IQ+8K.[U`FCGFIL:A.:7)=O`;UR]33K;I!;/"\NP`9@4PF]!UUR-@ M[Q`T=B)(361-R[7MUY[MH+LCNY/MEZU[-C@*XZOMN?K:&:4R*1-*W1"_=V"K MG'5L3\[7$M)M6&)LS^37S:'(-"/:'O_>SE!4N/&N%A;_WH'.=X^H%A]O$:8U MC+I;VVF^(;1>B/P!ZH+[SFIY60_P;FG`A'K3*$]$>D+#S!-0,1=[H#HDM>I0J0-BNWC/I9I' M-XCP,!(J@0%,J3OL3YG+/#99%"7XWT'/G;PY+,.7M+E)X79%9&@W=8`6LK;'8B0]+,16=5B2;V_\; ML;WHBZ7#+57W1RY;O3E<8;4WSJAE MADQHF*.%^I>!\-D,")=YG\-\I!-,'9GMK#,AH5LO1\F4;;FQ>[E5RJGF`.B; MI.S3V<5,#9`7OR<#0N\:<0H36SQP_$)8(!Y?L?>" M[Z#T=!/TZNTTP\%J(QI0K):L&:6:[?T1BNGTGRS7,`6O3*?_=2DS0?9/_BT% MX1A(";K*[=:?R5U7&4^?4\5(*#.(?'_Q&QR=A_@%TP#?H7\RO@)XRQ%@,QA9 MLW8C*1P7J\8.PY5%EC29(U7?0JMD'C@),)`>6Q&J%YM4W,E=3@ MBIP=*Z-@(^BFV[T/Y,H?C-@D)JK=L!)'8[!*FM5[$A]`K+!Q.0@N1BFF] MRD9?9*]R+L\.RJPQ96P/Q]2U"Z2`34H+V[TG=8T-:=?>(E!MGU8ECT,2/#W- MU/:KY`K`Z9F2;+_)K0%<_IV`[?>I-8#354%LO\^LLVA+W*[8'N97==.H9JZV M/5*OQJ3,-\C:'E=7=1IJVE5MCY9K"+Y M'#)N`FT/2:N`3N*>,$;'3H6W"CK)>]P8'SO5,'U\DGY+,2IVJE-;5PRIT->D MA=]VV9MQG9'$8N-6;G?1J=U$(WW[%Z-AYTFXP6N:])S:UH?>47*_1K$L-FBO MD+56@K6$;&*+6$'XX0!A*0BU#X^[3"QITKG^(A#`M!!+Y*(AINXWS"8T9=:%;XQ%E- M3*57I;*LF4RED>9(DM[>=3ORPAJD21( M28##=&WSPJ'//D MLF\>X=WIL5V2%O?(#Y]#&LQQ9!@6A_5>)8AJ"\5LNC,*[L^:R^+R?:Z:=:J7 M6)((HQMF%D$%2RBWBHE%E`^J/A/=V,YT1B2YN`JX/ZRS+5!6(NNPWFKR<(>1 MI$8B'F*ZB/[47GN%];N3QC1*Z`4ZXFUX%TY>L,R_+B*"5=;<"BWMI>0IG@>V MVWK+0E=IDNW.0M8E49X(:+FE,LY`IN]#_!G[TJ@E?<#]Q0@[`3`DU5#J7F+N M(T(?.9(/H_2%P)TQ3R1X67*R17_^7E"B`1.RL[6Q*D2CV>Y,BI+RI2$H\*:R618&UE MY)BV_\LLOD)<4[8,4`]1+5IRVM7W:/GI0_(^EV*,XF"HJ/,H0D7*]9A>,A4:,"%#UKT7B,?M"TR,#$T,#,S,2YX:QUYK>-1J]5IMSI'[__K2HMX+NETIM&[X"<0!DE`'*)!<]!TO/HW&@JN M0#J*,9^C+F-H8%`*#8@B\H&$S4RILLXBZ$&N3AN.?X^'32&G/C31]K_<7*>= MTOCQ!Y3*=I[&DM$5A"G),8<^Y4IC'A`'PBB_+T&8:M/G;B,;D,RL]O'QL6]K M'>E$>5.,XX7\!*NQE$U4(LS7%.([YTXII4"#B&3A@ MX\$0V3I<10`_253<`Z&6OFG,!R$/I(BD@0M]&;>!,3*A7L#:K`@D?"GRT6@YP9P+;3.)?3XCJ$*I+N0H._'7-:PK3R!U]_E'^QQ@%B3,`J_A/0-G M$F7`6$*RY'H'Y-*RYW%9:<[':]$T!'MM0/4GEQ0$`XK9G5#6F![#2F5Q90@; M`.!K14`Y?_!%0PM%\'S6O>[>]B[0\/>+B]&PYFM?ONXP)%$](YI"[VQ-GD6_ MP.#[4@;1NQ4+?JH9K<3H%4Q#(U+,5U97SLK1&BO#47=T<7-Q"XST+U'_[F+0 M'5WU;X&?SQPG(=4DK+FIQDT/J]DE$X_JBH=4DD`7T[0I5L[8AU+&>MWA[^CR MNO^?FK&*C-T*3=1(+++;HF]57TXQIW]9=WJPW!&,AO:ER\,[QU4G-2[!YU0% M3*A$DA%YTF=,!/<._W]CH^71](N9#"U0)BUC1142$^0V5L?/+O%SBS7T:7_2 MC\T&`-BF*D5``:R]"3-S$<6$*^O:@$#GD+`GE%;#&2Q5S\SF M_1V>6]1VA._;1GE,'*S'A%7E65W(;:X.D%T"9$BGG$YH@+GN)4K#"EO:["RX MAK1,0'K;Z<%V&LO)/]P@?ZD<+;3;7<\5_74L[!0+9&K^#T@LI.G+7;\`5?24 M\_Y^8QF7S?E1ICO]"=#P_HF(J<3QS&RS&4RZ^U_G@V^Q/+B#U;L97OLO$Q:: MRN/@J-)R`;W+U=4[0Z\^YQN9^7LUQBNH*:?[0\G\#[U+5=04?X^)X!91\#HM ME0?*QC;?7+Z=Q8Z?/T0=O2Y7NC]GH MW3G1F-:_J56G-$NAPR2*L)R;G](6946,EHF7$[JQO>>QM M[!*6Q%YNHDDYCI'(6(FT0`L[D374RRQ%J4$HLQ598Q'$+K+F9M4*90;7L;Q= M+%?8(:J6SW965!YAFWN.U;:=ZF3W.@&2[_:XFSW`J[O5X^[T5(J55]%9'C8; MNY4[[%K5(03%YH\YV3X@$V0/K7?,D>W3AJ)1S$@C*\,R,/CRX^Y^+$5,I/G1 MT<_5Y@HVT*OGZVU0KO5?9E6N82;)Y+1A3K9[^1GEKX!H/D4L%]%4FU9Z2SW( M*%(_(\Q8PW^[GJ_26,%Q`!0X?KY0\P_QF^$Q815=!MD"EZ^-AG^(M^O#O(+3 M`"EPVCU?5>3[B>^>KX>WU?/W)^"ZD!KQPNL`SUR50>EMG&L16$4E$//FY3C/ M%'GM`^^PW7Q286;B-A8L>WH["W+56JN]$;/<\W:)@NO M$/F$:;70Y2UU;=_[&]=W*G7".LKTQ+'I_O:'?4QP;AYM:8;@M[M94G9%:P]B M3,FVO+QTX:G4G")<_K*?(077IZI9X@(7;]Y2S?:VK-W)JF1&CC$/>W7$^NVN M2JTO0/9IK_8W[XE5LL"!9<][6;%^[ZR2#0N0??*6<+?][!J:->"T<8;5Y(9$ M8R+3=8?Y8GYU"],/?'JCL1.*"%-^I4ED)K\-A,>P`,"!/FUHF9C/M[DKVH'/ M.A7AR`+#1&:K&DX9,S]IY+(J`3#5=O'P28HD/FVD<`KJBXTU:U;37()9?\SH MU&J^)?H"2PYK606?\@!0E MYB\KWY+Q^17,;L%ESFYFBN-.-7%WT)@]`C[];OZ9([RQ>1]B6+,+&.]G0MS; M`QYW1`9FZC\ECH,5Y3,*@;\X+=TQ)[R^AWU)IY1CMI6;I:`WY.L-_I^0BR$% MDU$83_W)HL!Q\$5)-T8IUV1*Y/?SZU9PR`,P:Z#!@#P0GFSFP>=%WE(ZV>%< MIO5N2]R*RSHO_]OX._'3^1@\_A]02P$"'@,4````"`#+,*Y$AX7,&FHU``#M MJ@$`$0`8```````!````I($`````;F%N>"TR,#$T,#,S,2YX;6Q55`4``QU` M`L``00E#@``!#D!``!02P$"'@,4````"`#+,*Y$$<[DQ@0+``"PD``` M%0`8```````!````I(&U-0``;F%N>"TR,#$T,#,S,5]C86PN>&UL550%``,= M0'-3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`RS"N1`:[.,XC"P``?88` M`!4`&````````0```*2!"$$``&YA;G@M,C`Q-#`S,S%?9&5F+GAM;%54!0`# M'4!S4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,LPKD25*'OXAC```-9P M`@`5`!@```````$```"D@7I,``!N86YX+3(P,30P,S,Q7VQA8BYX;6Q55`4` M`QU``L``00E#@``!#D!``!02P$"'@,4````"`#+,*Y$9D#]D$<8``"? MC@$`%0`8```````!````I(%/?0``;F%N>"TR,#$T,#,S,5]P&UL550% M``,=0'-3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`RS"N1-,?6_7,"``` MED0``!$`&````````0```*2!Y94``&YA;G@M,C`Q-#`S,S$N>'-D550%``,= H0'-3=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``/R>```````` ` end EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!!5_NWL@$``,4/```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,EUU/@S`4AN]-_`^DMP9* M4>*0DI68$EH^'EQ6"RTF`#7RUM M2@KG]`.E-BN@YC92&J3?R96IN?.W9DHUSV9\"C2)XQ[-E'0@7>B:'F0X>(*< MSRL7/"_]XS6)@Z*C/N/"E=2+&G$FX4(E_9GK%%J>V5QR"T M4Z'9^5U@4_?F1V-*`<&8&_?*:X]!EQ7]4F;VJ=0L.MRD@U+E>9F!4-F\]A.( MK#;`A2T`7%U%[1K5O)1;[@/Z[6%+VX6=&:1YO[;QB1P)$HYK)!PW2#AND7#T MD'#<(>'H(^&X1\+!8BP@6!R58;%4AL53&19395AR295="VRGZR'JZX%Y$A"84"Q`= MVK0-X<-O````__\#`%!+`P04``8`"````"$`M54P(_4```!,`@``"P`(`E]R M96QS+RYR96QS(*($`BB@``(````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````````(R2ST[#,`S&[TB\ M0^3[ZFY("*&ENTQ(NR%4'L`D[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50? M'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+ MBQJZE/PC8C0=3Q0+\>QRI9$P4P>J M/OH\^;*W-$UO>"_F?6*73HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;',@H@0!**```0`````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````"\E\MJPS`01?>%_H/1OI%'>9KS9?;5-\J&LJXW.&$Q2EBB=FZ+69<;> M#L\/*Y8X+W4A&Z-5QL[*L=WV_F[SHAKIPTNNJCN7A"S:9:SROGODW.65:J6; MF$[IL',TMI4^+&W).YF?9*FX2-,%M[]SL.U5SF1?9,SNBW#^X=R%D__/;8[' M.E=/)G]OE?8WCN"?QIY[ZPF03'CM\7`E%@-3%$YU'`` MI4,-!V4C@+A4`K!2+8G5+#$Q((C5@$#E4,,!E(Z8CTG'5=*JXM7;X*@N)+[8 MSE48@T-=*KQ2BS'11.L=L,30Q8UA@;()7RO2CX-(,3G4CH,:#G6ET$(!.1J4 MC9B-V3?.GYLP%0U7NU]CC3*JP<0K,RB(HXO3`K_X/M]\```#__P,`4$L#!!0`!@`(````(0#TURWHY0(``*4'```/ M````>&PO=V]R:V)O;VLN>&ULC)7=3N,P$(7O5]IWB'*_-#_``J)%;0E+);:M M-@$N+9.XC45B1[9#Z=OO.*7925/07J5V.LR\)Y8TIS*8:N?^*Y M#A.IS+A8#]W'Y.['A>MH0T5&"RG8T-TR[=Z,OG^[WDCU^B+EJP,"0@_=W)CJ M:C#0:TJ;\7KE-0;:*,&Y8- MW3-8R@WK;*BZFM2\@+>7H1>Z@U%;Y%(Y&5O1NC`)E+=7![^"TR`XM_^T5CQQ MMM'_@NS2>7_F(I,;^U>P=MNN0DA@T[QZYIG)X;WG>>W>/>/KW.PW07Z`]!L' MX9SFZ8BFO+TC!#I%(F&XV9*9V+G/);30NCZ#RGS745< M3R,2WT=1$J.H($1AP==A9$D5]"9GAJ<47&^/#DZ12&,O/CM.QDGT.YHG,5G< MD<4R^C-.9HMY3!X%K3,D@U5.#U/IJDS'\3VY>U@\]U7`ZM:'LT.5"=5<$[DB M2\4TU-+@A5((<'33?ES)+=.IXI5%TFI,:LT%TQK'GZ/3?QZ>?L<%%2FG!710 M&]60WHG^B:(O#J-GX@VHMK>C$P/7N*WW\EB,,%)QN-RH7YB8&F)\ M_1YYGYAZ1`"MG5HAOCE!#^+] M[3X.'Q8*,'VPL%.].05&.0S*%+XQ]F&'=)/N8/^%'?T%``#__P,`4$L#!!0` M!@`(````(0`_?MN#'`0``-<.```8````>&PO=V]R:W-H965T&ULE%?;CJ,X$'T?:?\!\=X!DX1+E&0TT.K=D6:EU6AF]IF`DZ`&C+#3Z?[[ M+5^XV$RRY*4[21T7ITZ5C_'V\WM56F^XI06I=S9:N+:%ZXSD17W:V3]_O#R% MMD596N=I26J\LS\PM3_O__BTO9+VE9XQ9A9DJ.G./C/6;!R'9F=EXKNL[55K4MLRP:>?D(,=CD>%GDETJ7#.9I,5E MRH`_/1<-[;)5V9QT5=J^7IJGC%0-I#@49<$^1%+;JK+-UU--VO100MWO:)5F M76[Q99*^*K*64')D"TCG2*+3FB,G?+7HFUS_;(O]6U!C4AC[Q#AP(>>70KSG_"18[D]4OH@/_M%:.C^FE M9-_)]2]>1>2"(BBTYVWOAUOG M#13-%"26$-@0/03IB*1#\$8`NYXBU&U27$('?Z]]QX@OTAFM`_UY\13BZ8AD MBO"C'J)Q!.G&'.]SX^"=O1I)$;A]6B%H+"$P&[U:*QV1W$-HU.`Y\ZEQ,`SG MZ+F!T:980B+196\=^`8O+1R-PAHIJ&P^*0XV2!F=BB5D+4@-+1):)N/8LF>K MT?$?H@WKO__EBI6 M&?0,56*%4:)%1CC1PI$_N)ZNFN'X]\<+29?6/&NH6^Y'A9&TGE;>1#:9HXN' M-R8,<=.=/?<"K>L5#A4K8IV-\S/SR7"U1&50M`;2NEH/&3R:.GQH.KS"W'.* M'B+.^M[>=&+<>.>K)6UZW,;0T"/FKURP:[LVC<9;^JH1#P<'U(D]9/=HZO>C M^5!ME)BQ8FNCU8G*"SV6-\/T#FCI7W"_G^7>'VA!-(FTD? M@&M%DY[PWVE[*FIJE?@(2]U%`'/5RHN)_,)((]Y_#X3!A4)\/,,%$L/KNKL` M\)$0UGWA;]S]E73_'P```/__`P!02P,$%``&``@````A`!A$.O;0!@``"2D` M`!D```!X;"]W;W)K&ULG)I;DZ(Z%(7?3]7Y#Y;O MHT)[:ZOMJ5%$P;MU+L^T8DN-B@7T],R_GQUB;+.Q63@^*&Z^K(1DD820IZ\_ M#_O2#S^*@_#8+1N56KGD']?A)CB^=LO__F-_:9=+<>(=-]X^//K=\B\_+G]] M_ONOI_N]MTD2'?=6LU9K5@Q<R^A\L>[X!0K MM<.ZB-S!B[Z_G;ZLP\.))%Z"?9#\2D7+I<.ZX[P>P\A[V=-U_S3JWEIIIW\R M\H=@'85QN$TJ)%>5!\V/UL4I*ST^;@*Y`5'LI\K?=\C>CLS+JY>KS4UI! M_P7^>WQU7(IWX?LP"C:3X.A3;5,[B19X" MVSY9A>\C/WC=)=3<#;HB<6&=S2_+C]=4HR13,1M":1WNJ0#T73H$PAI4(][/ M]/<]V"2[;OFA66FT:@\&X:47/T[L0$B62^NW.`D/_TO(.$M)$?,L0K]G$:-1 MJ9N-5OL>E8>S"OTJ%;-BMAM&HWE'6>KJ@JC(9QFS?O<5&>J21%TJF6;%J-?N M*8O15(6A@[/*'U2OT5(R=*"JYK'2;C3JS7:K>#,9=-/+QJ:##YV"K5V5SDF- M:'F)]_P4A>\ENKNIHN.3)_H*HR.R4!:4AKF8\C-/DAF%RCK);3#?2 MCV?3,)ZJ/\C\ZS/3DPQ]7QA&]!4AG"YD+1X8\(`M`]<9,]&A(I3HB&LX/."J M))^6=*P()3KA&E,>F*DDGXK.%:%$%SRPY*(K%;@E6J4FOK0SW1):.]_N8E1S M"EHTIRI)3P8HMTO;F7KK]E62*Z*E(Q84&62)YJ,N8F<15I)AEN`BHRS"1)PL MP47<+,)$QEF"BTRR"!.99@DN,LLB3&2>);C((HLPD24D5GF$9D<:)NZPHZ`U M.\J`9D>#E;;/$UFW$CWH[AH48.P"S+``,[K%-/3R.`48MP`S+L!,;C%-O3S3 M`LRL`#,OP"QN,:Q+619@5OF,9DN:?]QA2T%KMI0!.;T2XU>?$Q8G!CQ@J\!5 M/VK4]588%F!&BE%=N,,#K@KDY#0NP$P4HW*:\L!,!7)RFA=@%HI1.2U5X%JX MK5?6ZA;S,:AHS4^SL3N:7]#=,LE_C(EF3<^\)QGZOC"L+?N0L"`Q@(0-B2$D M1I!P(.%"8@R)"22FD)A!8@Z)!226D%CE$9HUZ1GD#FL*FAX&KVQGFFQ>W)-, M(YVLLV&PK\Y]:EL+$@-(V)`80F($"0<2+B3&D)A`8@J)&23FD%A`8@F)51ZA MF9*>:.\PI:"Y*=FDK2<9NBL^[2\A84%B``G[3!CIW5&KL#%ER$ZW/L:3]+EU M!#-P(.&R/&IL*C;6SKM"MQA3T%S>[)^L2>9Q]05AO$@JEP?\/O71(.64]EYZ_I\JUW/`(-K MH$VK.US!ED#.+3*$Q.@Z$Z.>+85S#9@U(U,*%^8QAL3D.I,;5SJ]/M]J9\HP M@SG,(;&`Q!(2JSQ",^0C,Z18;#,-6C;.7XT1R;@SV32R)YD<5_0A84%B``D; M$D-(C"#A0,*%Q!@2$TA,(3&#Q!P2BRQAFJQC7689YI!5'J&Y5!A2ZS>%31^@ M2]-DW*9LT.J=H3R?8L3"R``C-D:&&!EAQ,&(BY$Q1B88F6)DAI$Y1A8869Z1 MEAQ.J7_/=/&K7!7=M6(IG+_)*.!:N8*N/RJQ5::>(:%E_&XJ[1H3TLV?C,Z-"NDVR\;W;H92;%JQ]!L>XM/>W5+1:16QIBN16-ODG"4_I-J.7,*$M:.GACK8<^O1^M%8A M>!N&B?HC,KAL8GS^#0``__\#`%!+`P04``8`"````"$`8M7K(O\"``")"``` M&0```'AL+W=OZS)Q)[$7S<@D`+FS84K?<[1TG6RGM*A_&U%PL#(F MX<%D`O2']^%[37P#U,5W1S5=+:78.]`SL*5J*79@L`!C#&P*2`:C#_5?D4*( M:'*++HD+S0[+%53G>162R=)_AI1F!\WZ7!.,%>E1@94`O)X1`A\R_CWI1Q04 M(PH6`=G6Y@%XG]BL?<\5\;R7C$@@0T,2S%8,S729"!=!5H<`9-K[&TBC@<3W MD)8BO:08,<)&-N/D3496N/F[<3B M(@LXL&J[-IJ`=,U)O*G=F=;[R6DZ&3XS^LUHK)G9&B[8;R!NA MX0SH+DLX\AE,,>*!N!!"'V]P1O9_(E9_````__\#`%!+`P04``8`"````"$` M\,,,RZ,$```)$P``&0```'AL+W=OE;=5-4NZ3 MG)5T8W_0VOZZ_?67]955K_6)TL8"AK+>V*>F.:\QR\/U._"3MN-L/ M`_HB2RM6LT,S`3J'"QUZ#IS``:;M>I^!`XS=JNAA8W\CJ]AS;6>[;@/ZF=%K M+;VWZA.[_E9E^S^RDD+:L$ZX`CO&7A'Z?8]?P61G,/NE78&_*FM/#\DE;_YF MU]]I=CPUL-PS<(3&5ON/F-8I)`HT$V^&3"G+00#\MXH,2P,22=[;UVNV;TX; M>SJ?S!;NE`#=^-YLL?P,RU2P MP*M@(=ZGI?B"!%Y[$F\Y([/YN"&'A]-F'2=-LEU7[&I!`8/]^IS@=B`K8.Y" MYI'<8G^4.L2-)-^0I>6"0&LHE;"HB&B+F@0J)AQ"O_QW%!I2# M;L-_6."=#9RTL6&I^A@#HDH(.0:H;AA?142CB-B$4%R`%-F%>1$0#!M14D8" M+>.08X*VC/0EBN3!0?1\\+YO13-`9,U8]>/)XR1=^U3-->286:O=)]H6B+K1 MA^L2FQ"*@_G_<8"3=`=:980<`SINM4."F>HR&F(TEMB$4'PLAC[&MS).TGRX M[&^A3ZV8I^O-K0SL]Q_3A)TQ_H^CF&5Y)>1WQL MP0]:%_Y4[W$W=U1]H*HW[UT$ZZK[DZT]L4..XE/QSUQ2$-TJ(2&JW`RNF;MJ&'`D>@]O8"%&M8/>3K(P4$>^5N MGV(-:`46D6ZPSZ!OMJ*&3!!5._:^Y[7S3BEK]US]>I28VJF(?Q02&UE4"]@" M)0M/5A)OG".59.JNPLHH)"8FB&(%G@\H5LR5U*+5?3VH)(&YWZ)O@X\KR0CA MVOD3"7Z77-#J2".:Y[65L@L^;2!PU77[EC\)"8*H[6<`&K?BC#/ZA8>?VGG3'&G@$T;X]P2,G"G>_[@3`!\::[@/^ MP.TAUO8_````__\#`%!+`P04``8`"````"$`Z6UK8?4"``!O"```&0```'AL M+W=O62H>$V'MD"_?MY=9?_RPVG-Q+SM"E`<,@RQ0 MI]28!X&L.L*P]/E(!H@T7#"LX%6T@1P%P;5)8GT0A^$\8)@.R#+DXA(.WC2T M(K>\VC$R*$LB2(\5Z)<='>4S&ZLNH6-8W._&JXJS$2BVM*?JR9`BCU7YEW;@ M`F][J/LQFN'JF=N\O*!GM!)<\D;Y0!=8H2]K7@;+`)C6JYI"!=IV3Y"F0#=1 M7F8H6*^,/[\IV3!N]Z]8/O/Q/:=@JZG4)!NJZ\?KHEL@)#@<:/4\U4\1X$P%^/47TRP!#\ M:)Y[6JNN0,G<3Q=A$@'>!)(K?39(< M2.!Y(HFS-$KG_Y<2V+*,2[=8X?5*\+T')P^$RQ'K#;^T7J)%=D M/'<5;"S$G#Y36'FVX`@`9\X%O.V.!A=H=E9YE,PF.UL,G*"C.Q-$^1;"T08; M7:Y-@Z'#9_M&LW"BS6*6MJ_S2;1THLFIIXXF*.QR31H\U73B-8W96$QJ-&5Q MXBHNG>CRU&5'T_P]FC1XHBG+W%TW%F,U+;.I)AM=6!?#^)3LB%JXHB[[_'32 M1-QLLOW&8JRXJW1B9_FOJ*--WX!GH^'M0Z_!$TW9E[Z55\IX=W##8?5^V]LHER^+YAH$_62[AOS'IP#,"\ M'W%+OF'1TD%Z/6F`,O07<*R$O3'LB^*C&2A;KF#2FY\=7.P$1F+H`[CA7#V_ MZ#OI^*_"^B\```#__P,`4$L#!!0`!@`(````(0"H8JQ2B@(``'T&```9```` M>&PO=V]R:W-H965T[MDM$0L=X"7%\[O&YY]YKY@\'6:,=UT:H M)L-Q-,*(-TSEHBDS_.OG^N8>(V-ID]-:-3S#;]S@A\7G3_.]TJ^FXMPB8&A, MABMKVQDAAE5<4A.IEC>P4R@MJ86E+HEI-:>Y#Y(U24:C"9%4-#@PS/0U'*HH M!.-/BFTE;VP@T;RF%O2;2K3FR";9-722ZM=M>\.4;(%B(VIAWSPI1I+-GLM& M:;JI(>]#?$O9D=LOSNBE8%H95=@(Z$@0>I[SE$P),"WFN8`,G.U(\R+#C_%L M-<9D,??^_!9\;T[>D:G4_HL6^3?1<#`;RN0*L%'JU4&?<_<)@LE9]-H7X+M& M.2_HMK8_U/XK%V5EH=IC2,CE-3:TE($.3S M>Z*6+N9:[1'T#!QI6NHZ,)X!\3&Q(*-+]5^9@CI'\NA8/!W??I14D MA6L@C(GDNN0K7M<&,;5U(QX#9?N[=*,LS+U_K>":YS!5HPC`A5+VN'!ST?UQ+/X"``#__P,` M4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q M+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE] M&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_ MW^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$CO MVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T M0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I M@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$N MCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+ MKS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX M.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-Z MAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@ MK,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D) MQW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)Q MTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2 M(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-% M[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@ MA_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/ MR"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR M@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NM MK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1 M?F#R`Y+<,_3=6_/IH78U6)8LM?66[@VU/U MS8[4[V]_^YN;*'YS[4_/MATK(,*/INIS'&^N>[UH^6Q[5G09;&P?/ED'H6?% M\#9\ZD6;T+96$3;RW)[6[U_U/,OQU43"M;<4$>)9X(W M)DM5O.7UAR<_"*V%"U!?!X:US&2S-WOB/6<9!E&PCB]!7"]8KYVEO8]RTIOT M0-+MC;_U3"^.E&6P]>.IJN67E.23#ZNI>J4JBWW_WC)WOUSY^_V?_LYV_57J:&R`0.ZF5>]FO%PL>)Y%YJP>W-.O`+ M0W0-W(3>NG[Q@R^^B9]!,(!Y^+7;F^@7Y;/EPI4!PEL&;A`J,;`,]K$KON79 MR3?FENLL0@>_MK8\QWU++FMX@05&^CW/`9KP8B_1<%X]"T23V31&&)Q-.EZA M-GE@DH47ZVVR_EUB$Z=KV*SK&/]QNI@5]79UIFL_+O9\>(RNG"NB)WQ:3%73 MA!HRZ/?1K92P$RF;S/N@[VS*KH9GLTPW=7/4J65<+.[SA@IULTM7-B@TWX_N MSN;.[I5569>6X7-E`"9.M>>NX?#/PZ][3.DRVM8V>ENC#E9'&8%N310GG@Q,RL4?FB:LAD907!W7S2>,NH%3*KAR>P-SU]@.?1/>*.GKQ[<- M3*A\F&8CH[WD>PW??@JMMX'&IA5B#:+`=5:(XFG.IG$IB_.K>W-^S_029*(H M*H2:YGQT`J'WL\F\>Z3SR:1KH9H)/QT+?3_$GXZ%FO#?O#.?IHED=`4REZ?$ M#BZ[]"]'D\ED/+@:C\<30Q\8!G/R(HUHQU_9KS:NQ'3FIGT$0T`PT<>3*PV` M](TQ4W56!#H`&`V'X^%@HAGP/ZMDIT?0M4^'JFQ6"0))K!($DEAE,_]>!Y4_ MS118!)68J;"Y(SE6"0!*K M!($D5CL;?*85>"*=58)`$JL$P;E9S:95\_M[DZU>[H_,JL?';"8'<\=%$*Y@ M9S;;;ASH,&]+KMW>N/8ZAEEBZ#P]X^\XV,"_BR".81_S]F;E6$^!;[GPLI>U MR'[7M(2=7MC4G:KQL[-\`67<`DF"-U%Q*@UY)3)PA&^,C/[(&&I7R22J(]6> MO7*VWKYUN>[26`$WHF^;#2<^]',E:3@4B]D]9"&E3[`%HYHQ+=@`8B(+"<$6 M7=A8;.R(VDA:B-E(&@C:2%J(V@BI4Y9P2;)KC?C]90Q?54R^0 M`"^)F'(0I,V^/QN;E'BTL4U;6Z&^[.7&3,,?-F(ML;2AQ;Z=#0U*K&QH(6HC M'S<9NYSP?#D!RW,)DAU_':*8%J?<+\EV=T3+G?EYC:*)U:# MA';=56;#CIOV;6A6DG:.T-XMV,C0J* M]^]=Y\GW;+8RIB9B?@R#V%[&[$@7VXJHPJ-7X!FD@D3P'*/?J-`/?A+VQS'Z M8>6EE`_PBU3]$%S"^KN,!SR\E@8U4$"#N@Y/EPA@?ITA`!)D(,##=JD/(#QE M((!Y2X8``K1``'!JHN*8/!B0:@8Q4*@$_:=2"34FLY)3>4(KJ\HOZ*^QTN3* M[U%N)O46`KUP,[RI`7"4RJH2*ZO$$-HATPH7P)L:%YC0ZW;3Y0VJ:KXTAY"B M"Q@*CT`9J/-(=U%):B[H+`#4>V36X3B$!`66(MD0`(X4"(2(@:3^=T`Q2.J! M:31(ZH(I!*X//F-.4":X'E(2!L`C)2N*<<*`ZS'.Z`8"05:%)-&@R2J1%(.L M&EE0H'K9\JK^O&A=1!U:0)>,^:)[.G9.8( M7+"Y%)E*X^V-5K9VJCP'H?,+3#+Q-LF>ME\TNTQ5B<8S\,FN&];S(P7'-2]L[OJWT9N$Y6(-7E4:W$>7B7A/T MSQ%8$%:Z%`@ON43B@ZS2$8V6TX`15E<>+X>#P&6IQFV-'>Z[QG#*$.@HN;'F MR'83=._2,5"JH*L72Q'!;&U,&*HV- M"Q2\;P,7^2M&5B3O2?PUP18#^C4Y[6O"0@ED1VQ:#N5(KC81!?TJ4I^.V5/: M:E*W?1UH,0'H,EA/"O0`4K2N9TYM`K92.3Q99F=\R5?<6;K9E$5(9..^.14CZ]'JZ.B%H\*N=MFB8V%_; MG&D_"F7$75.=%1M+MBWZ[.C5_JI"`YB*0BL&47ZNEB"`L5YO;SF5E#!2(!I\ MLDT%0XY#L'.6C#`3;IX.=.7*?`W^70[Z/I^"CPN#1 MIOW?*Q?*^R46QGQJAJ.FQ=9QX79AW*##/=;E-H*[XF;)Q73MIDY6[FD]T-!WQME/++S0P4N-%D$%Y55\`B>(S;J8');606/0!R5!2:WE57P"`B) M+`.4M)55\`@L4%D0;FUEY3P:6',+WP\%?7]5RB,?J[C9+X*+RBIXY&-5%XQ5 M*JO@D8]5-+DMKH)'D$K\9<`';645//)UPA"L$]3&@D?>]W#400C7;D7E(UX3 MC/A$2L$=O"(^PD&?B(\2*05K?)3K@E&>2"GXXN/;$(SO1$K!%,@C%AGP@;A% M.48"/-F>'67!]DQB$1Q>%)#W; MRQ=E#OO&M7PK#L(W!0^PY.)XTH>"XOX4!+F/>`DXR!(! M]`,\"!Z>,:^`7Q(/\3&,IT#:B,ES@7U"[&_=GXPM#MX<5D.+N[&!KS MV=V=.>EK_?G_P&7X=R6NX0\3'/%W&]C?EX!#>@/C.G+AKSN$J;$I^$_%M:E* MWB3PV=,(`#8L365&]*+\[U[<_A\``/__`P!02P,$%``&``@````A`)5:3'S! M'```\5L``!0```!X;"]S:&%R9613=')I;F=S+GAM;.RKF%HL*Y_R$/.E@1D@SY)' MR9/,[YQ[:V$5*2ON)(U9@D['KN7><\_Z/TOQLS]_F$?FO4VS,(D_W]C?W=LP M-AXEXS">?K[QU*/CQ]GHYF=!]ENLK`Q=R9).@]R_II.'V>+U`;C;&9M/H\>'^SM/7L\#\)X MPXR2(LX_WSC:V]\P11Q^5]@3=^7@\.G&B\^R\,5G^8O39%3,;9P;R#!G<1[F M=^9U[-:'[,\>YR\^>RR/NL^V>H$O M]]MKWJ2!*)09W,V'2=2^^^BB?_&O[8M>S-=V&@K'$?Y%,.\<2UZ]O/JB/S@S M-VM9][M,<_ MQ\>'^WM'[5LG19J*.C9YN8[QCW9V]@]V#CLL\><[#R.;FA,D-DW2+@V#>1#) M`]=VD:2YL/`DF2^"N/.D7XZ[\R0V@SP9O>N9P2Q(;68NBUPMF-?;)WG9?]._ M.#DS@R_.SFX&9NNKP:G9W&X_]3HV-[.DR#"_K(>91C;+3)+/;'H;9M9D"SL* M)V'7U$[MJ#*UP_:B)1.#++-Y]L?.[2";J;V/Y`_VNR)\'T0PO:.OK^/W-LO% M;#JW1.VL"4;J9#*3VI%EE6%D>T:/`&^3VR`>68,O,>.D&.:3(JI?2"9F\YF! MG_B,T:QR&DH69[/S(:+QKJ1SODOA3V//#G5">)PG:6AA:FSS-@>N4KL(PK&Q M'_"G&7(4[Z=<-R.O@(YW[1=ODAS%OO^9,QBZJ'QJ9(/,SI)H;,+Y(DW>6V7G M2JK$>3.1<3%/D,3?Z>DXB6QDEY(\PR8;BJ[GHW].BG M'W_ZLLR66]F)>RK7U*&,?\F;; MT5\1&IP+B<$SABW&\*]JR13 M1MZ#K/Y.+][F84>S*Z7^Z),=97_H&T[Y'OITLMY0EFUB+>7+CWV4[)6/KZ9Y MY:/W$#RXZ=^+VV1,_"KG!< MR;@8B=O4^VV>EU%YY4UG7NO>7-B4J`,$\P&YL_5)0DI$N%JSP*LT`3817B== M%W!M,P`Y&$,J'-OE>D\!)!QV&V2#*4$+X)4E?5;3\\$!PA3!0TZ];WRMU^\F06Q%/P M+HL[&*F$-!`-)W8!E6/6*MRQQ[6!H[VAQ[0E>*SSA/:##OG6U'JVOQL*B MKQ^53WL7E^R($[I'AMC2R-JQM_$'":<_0FP^$C>%Z#B_,CMHDW85W&EXY_4J MX_(P'$EJ-C)6-P#J,(L"9T?.L:0QOV"S#O-"S0*7&=.FT*..CS$/8L.%`CL] M$)EN!>Y^SY%J_5O#HK%(E+\Z9EN%'D'6;4J6UHN3>$?7;$@?8E:QL;-+.U7\]77T)=$'Y9D87$,&V%[I M0CT9POVK)"([P.^M+S)N[6^;!RU[@XV)%6JM2!8O2K3%.8GLX;SD$F*A..2@ MN5)[$<3)0FWSQHYF<1(E4R'J)$E)=9W?WOKYA_^L'OOYA_\R5$_$JKE\XK;D M8D\X&@'QV)T;MU:O\:>D2/T[_*7(^/,V#GT265`;%1E03!W=MHAL<%%A%YR, MI:0<\;2X$UFX\>RVN9V%HYELJ\0D"["0JQ_,@YC@+MZI9\A["(TC*EA!>J?^ M*#"3($S!*K641&J0V>`1\-=4T?V M]DOY++764+>3FC761+C6@M-//Y9E:D=UDE>4A]$=YQR3O"G2@USA?[EP/L.L MY\$=IJWX;200IR3Q3BJ_["+L*XM8]4Z[;8-#DW`VWJ26E26C)DC)B$VDN"]\ M1UK?%C'`!;[?AOE,F>AA_NHUA)UQDJ-@'(!21]*A$]([9!Z6RN60C9R]4KR_ M9:8?QP6DNJ*IN.]S],90L/1.<4CFF8.OM`_`*ER+YS M4B5.W&'=J2PS9AT)>6Z_>!M70CV:9#HZ3Q(WTF16,)3IE67D=AQ[6"R(H:!%F0I%CZ: MD5?*\3CK*,%$XBG7L1=0L_"JO&B:[.+%88K+)J9@1]`A/8=`ZSP4F'MF$07X MH1%\KJ_-K9A@!/W!-";[XW8/;MAT>N?$T3QD5J0P76TIS&9RK"9#S=8"_Z_7 MMY?H4D[G03H%+WH^B*FILS.W%O.+0A)&7(U`0J$F2TAV.$?&\^H#)K34QC!> M]A2W1EHF.7*F2]\F*;",U!'9R(_SVW(1@*D4,BGY(`PH&8[97ELA$7%./0LNKK(3Y4I$5\O M]V0)/#+5!!$GQX3M)+KEKEG'4=W4_M/!IS^P_/WZ.X;#IT([HS^&43LG-;L4ZRS4D&+!(^2+O/#\B'$*DN"1N M.I`,]\:$`?XN[O;RYN3+EYY-6!XJ@PI;!S,R[2(:Z1IVCO+U3/)@K^"&G)0E MV089B;ZRL'#Q=F8C*B7B5[ZE:NU\D..:UH54+KA4EUI/8^K:,%1O^;H)*U%D MX!6`A+N4AU+:2(S\=Y=VF=A'G:-5`5Q27@W'/#I.I4HC1-5U^VF:W$K<=`%] MZ$/&KD0PGD0$`O[AD2@.#BD36\L*1%W2A_@$8RF!_IJ@+00@!ZRKL.S@$0F. M`A$B]9P6&,&* ME*DE6,8D'?XQI]-BP-K0U/B31%&`9\.`1;#@)U79L;O<.<]Y5;Y^'6/UA7;+ MVF']7$#EOTBSQ)PV#G8/N#_<;A3&UZZFIY%.(&J&-E+* M`"\3_F,$M)_W!R\5;Z]\[D19+9`2!9/'^X,3??H&+#TRQP=[O;)+`Q'RORO^ M+WS,W,7WTA9B?&1O@[^-R!GP0-/AYQOGY])%W]/+Z3D(USUW$D3A,`WE88\U M]/4#N:!3)-8]AY$FJ5Q\K%OE+QI,?8LAH"K*>_5`#2X[632(_-T(Q'5(%D(( M0@?%-X@6^)89Y52:DL1XKI-TI/A+#;Z"BN9Z&O%)S3?$L3JG#IIK*%$PI/S8 M>-*_[IBAWJ=YL][)AUT%VV3C.G3@:WMB!FNJ;2!#_)HF*9&4I@EK%"``%`OO MK'FOF+L:A]D*XP7]BVW!>6JT&#C>6]34+\]I&[6\7?-&UC0T%Z4$+"%`GIU+ M+9TR'ZTN_+GCCE94FNS!CXL[]"L--&4QKS0Q*::@\2UB8N@9&,%M>[KIZ"]^E6$1L7RX*8")8GEYK1;;EI-BX) M\6I:;CF[^NK2[PKP"2<3+G-6]=(P$NT#*J=WHEFJAMWH[VJ*SHY.[3`G?6*. M"'Q&7&QD/?9UP.M/UPQ35Y4,"G$((%[FUP"01 M0T69HR-HZYB9&))R"6VJ77,9'),;FX=[`M?M>(H&HA[X(RD72S8@IN8"/8^* M$(@UI`0:D7D2/1?(-$Y!,$`Q258H''3\OYQ()C?N&I[]OJK-4\4..86<;6]QVN1O^^9U(,C6Q^[VS+"Q MF2;)N)/+]I71'1O_,6$3*W:14]!Z*5>M7C'[)`@.^)DH%,<9 MQ()#,<],]<')#]?J?%@38HM3TBRW\?;*#1H=I:6:O?J3IT?J*S:?/===Q3(; M-3M?,U];NL/+,%)YV!-?(^`?T!_=K0P\??5KM1GKB&I//`&^4!(SLM\T^4"Z MF4NROOED?T\]A^8`1-_BVQA9`AU2W'4*I"U(:( M]YJ!B?MLLD@*(S'9]XT4'74KA-64P5"2IUIVY%^@'X`;";A$I5O?@]TI>["N M=BH'.]@]U,R@&[,&VDR\])A#'+F[\DI([7BE4RIW[-22VQJ!T=1F>DG7]WT; M%XO*MLZXIPDECLC#&]]LT\##N8"VY1C4_M)\$@_`XSKA]1-)M,(R<8L2?-R& M<,]UD`!]->69I->>-QB+J%29%BZIX]IC/7UV[,:ENFH'_T(9>U0X?2FCV%5;>]K&0KH*-&5 M)JH("H&/'S#W\3:T]`GX*H<()` M(K5A<,U62OPKOCQS:-E)[)Y M+,AX":4Y`V]K:W_5"509QTP*QU1NM##(@#C>VHNK`7&]S5`!;M1B-0BP;CUU MU@&\H@D5%J7L*SE9&$6%*WFZC$W*^5*I;2:#90Y(57JD,Y#*GI?4\][M#$8, M.PJ2=PT221/%25/O(1L4^2X;>,L*A,UK8W`'+9=S/E6,H1SX;FI M:G4V`^Y>1G)`-`]:>01Z/K3UA]HG1??[%2BKIE+/D7"(;-?+?!T MO/>'GGGV!V?]_+$)SGKB)L2KYXJLRM)JZ4`;>K?&B=(AT&QTV3VO*`VL2H@5 MBBI>D?-(';E]*LV-6UCPZ/A)SVSN/WFB)]I\BH=I'DFZ(XT"]NIUUW/KZ#DL M.G+<>OHKMH^,VMV[$C M(12(\I7%?R5-IPR$%CRW!D_7!JI+0\C.C:1WG#>UXKK'I%N3E^.[I?F0R7@. MT7.**W1@7SN`+_N#>)#+DHY&.N`.NKES.B!^+T7D#2%!$#7AY;:%TA@ MD?X`O72MC#H65(TU=D=/.5Y9QZ%_K7!%.%XVG+6;^M@S69HZ(@_?Y)%B=35T M6-6]-.F7,.C4HB)3_;V.6'##5QRID"V"D92[LF(B$_I20./VG*\5Q0*KEX$R M.L`KS5/9EI[W6#,?IPAT`JB13:=6 MYW:"IEC0\3BCY&@4VIJM4G@2$6JAJ,10#J=!\-"%F>U2Y.*9$J[>,2[DK%H.('A?AR MXDEPI7X,IDV?[VWJQA=D1:GR(A&I]RNE(*4MLI)W.65-O<-0Q01 M:H*]I&9KR.%0VH"9UM'(\DV?@\!Z23K6U%U)ZTGW4$.,2(X6H*!4G'48,:BJ MF\SC2D1@H4W2?[^'ZZ?>)T1M9SYNRT'CR!( ML_"FEN:*X2$B6P`VB&&1S$W.X5[U) MBYCY%M*7Y@O,=DK;M3J*SQ[P.`#@1":H\7C%`B"E+0U&(VCWL\U#2>I)?=OK M.-S1`Z+^&E/$NLJ"545`R^^7%5]CCVB(!G$\33EN0+23L7#G,46?FLZZHTXZ.T$( M))(3)D#/0X*+9IK.^*AJ\#$MI;WD+HA0F:K\ZI-Z1%U"`Y6TC];41<1DZUFD M.L;_RPB8TF8'5Z_B;M*0"ZGE(.XCTDUUKO/8?)EG%8^#WM(X76: MQ)F#`A))R-FG`B"Q#$CB!>:"F?5IX8(H<#TW6ED=^VO9TP]"EG/M\$MME+(' MO!OJ/%3-CV;)3X6\ M?KPMA14&X22HZF%%=ZL04.M;J0^[I'G$+;@L"0*&T'1L=66(CCHW.FRL0<81HP(S" M=U)I;R%4GQ?03];I13GN.RL#8,%$(OP8RR)EL/-%E-Q93C9F!@3:Y3.=A)E( MEJ-(+!\_:VMBR4/+6O6+`BD"PQ"I&^R3LA[&Z)11GH1HU0S9DTZHTYJA5"$% MQPJH7E)Y.P<-A:-WM!_,*XS7A17E.$WCD:)J.5/-"S7%N90MM;C$TEK[$4%0 MZ/1*KJ-TV3O0#G*HB9]6.Y""3^=2\Z]3-=U"H(!RW-%/W*#\[!*@`MZ<2]"- M!&P(37Q?G$^D'8Y!E(HN`)P](:=TFR+JRFVBEHV>OU1Z]`<,7!>_`H\^3995 M@O<)`5"221FUZEBEJ+D.Z@[9U#M$P?NU>B`LXAF0OW09I5HV1L$``6!TTHR% MVDL#0JYL"KWT,V#TXG5DP>%&X=@KFP`O%C@QL`FA&'J'.OC9+K_X-\6=^?KE M/5688SXQ^/NW7*HV:(W-U7RAM(03C0+&&"R[7^7B->Q_P&`\?)!J=3M_IQ%= M08[2_8NC]V$(D:%X1;>U?XE5-7)LL3@='0P(0/&4Q+-2KLR)0VU`U-*#9!WE MBU!]-,0[1PR%TI<*VP]DBI9^%6MG8R!>L]O@$MT'^L.NQB"8V2J_$>G\1,=Y M/6WV\<&HLJ$N&%%^P^>/&6;';_LL4&2;OK<;_[#Y,M,!?^O&RV#A')+W93JL M,5EVP_AE9BXHNEPS&A_+W>:$F3[^6PR3_0KDX&O_?W3L?_CHV*`QH+(\5=&T MN89YG?_RR1#586::7,ZZR@A./G6\15]<+_L_,@SCGQ.RB!4SAJOH]--\9L>L%L&#Z'13A`S]9UF/X3!&Z>_;BJ+5 MFJ>:AKLDWT_FHEO1C58MK=BO1X,DL6T^YSV>Z4LSWOSUC61!4O_).K^6UWQ+ M,%9[X*O-!??+'+_YB%-[VT['U,_?R$ M';A!)W/HBMR9V3_F)W;N.IU41/&+)HC:&SDS;+5Y[W^((KR;PEG]V(K1&3_A M8O[Z5C\5ZDA?P:I.(SN,+J4H7\-I[W&-/_#SN8[T=6M>-5HJJET,>N/SSRT;7R,?:+KO/NG26\NW+WS:DO"1 MXGI/V%']=2,3;8DM3TRT[W:6K4RD.QG1?O?1D3.2]O7U:S*@P,@!&1RUC7HP MXJ/O3ZJ/-DK]_)C!/&QL`07[Q)AVXKNL;=++Z_S(([YVK<+K>,2ZN_4:-[?) MVC4:3VE6OFXUK3JON_DV8'BUF*_=Y"TCH??=]U6%'GT(/MPS)4WWAIJ+ZB=] M]&N_J@K;<:U+)8L\6:Q_LM_]QJ,MF,'#&NOMUQ[=4!FH^Y1_7]]V^,V'O;W] MDV]\'W6ZGFL?_4&GU"V?(A'ON`7`4X9 M[:"*/:*$JG7#RH/US.J?S+WWI?:)RT6U=7;V@7Z'=)L?Y-V67EU99ZTW>\Q/ M=K_X;P$```#__P,`4$L#!!0`!@`(````(0#+B`4<10,```(+```8````>&PO M=V]R:W-H965T&ULE)9=;YLP%(;O)^T_(.[+5T)"HB15H>HV M:9.F:1_7#IA@%3"RG:;]]SNV*8W=AI9>E&"_?GE\CC_.YOJQJ9T'S#BA[=8- MO??ZT.5%VSRN,A0,.+=^Z ME1#=VO=Y7N$&<8]VN(6>DK(&"7AE!Y]W#*-"#6IJ/PJ"A=\@TKK:8OC!2?"2^FW0C;!8/_5 MZ#N5@9_,*7")CK7X14]?,3E4`M(=PXSDQ-;%TRWF.404;+PHEDXYK0$`_CL- MD4L#(H(>U?-$"E%MW=G"BY?!+`2YL\= M)(PFF\QZ$WB^F$1)',:+]U%\/2T5I5LDT&[#Z,F!I0?@O$-R(8=K<);AF4&0 MWPX/Q$6.N9&#U%!0<\CIPRY>;/P'2$/>2U(M@5TT2")3D;VA6`X2'_`&1@C; M=$8YR&)\L5?32+4D4:F2\\K.&@P`",QT`#EHZ\[/(A`GP_PT@);`.AJ"-#<5 MV9C"0(3O3$>4@R#?9]^/5R9`JB4KE60KQ]G;?086S.T<:WQ92;&)LP@L'"T) M`\43>$%H]F>7^PVLQ10L*;:PK,^F6K)45-$\2*Q$9Y?[#:SE%"PIMK"L+99J M"<1D6%^Q%=!L5&+`R1OQ[*083Z446W`S,U6IEHS"C4H,N-44."FVX*Q]EVK) MY75VN=_``H,)05-J"RRVHM9K]%*;Q8'Z,S79N,8$M,[_\:R&^LP^/S`6UJ&0 M]II^+R3S))RO+$TVKC$!K< MX;KF3DZ/LIR(X"P86G6IDX9KN'*@Q+#:,RB!5+L_=$`%TJ$#_H'8@;3"`N*17/+[)*&JK7W7\```#_ M_P,`4$L#!!0`!@`(````(0#==5>L,P4``"$5```8````>&PO=V]R:W-H965T M&ULG%C;CJ,X$'U?:?\!\=X!FTM"E&0TT.K=D7:DU6IWYIDF M3H(:<`1TI_OOMTPY@.TFEWE)`G5%M8;JYN<5VN;S%S;8E7& MMWFU7]O__?OTL+"MIDVK;5KPBJWM#];87S:__[8Z\?JE.3#66N"A:M;VH6V/ M2\=IL@,KTV;&CZP"RX[79=K"8[UWFF/-TFTWJ"P\%T[`W<.$C77'#F1`YXVJVT.*Q!A MMVJV6]M?R3*AD>UL5EV`?N3LU(Q^6\V!G_ZH\^U?><4@VK!/8@>>.7\1T&]; M\0H&.\;HIVX'_JZM+=NEKT7[#S_]R?+]H87M#F!%8F'+[<_!"5T$)`BO4W%P65V4'M,VW:QJ?K(@]8!X/X\+!`/@?TJP-T06'$#>_FVH<'*>8/P9Q(2(P2J9X"HB.03Q+R'.$"K MYP;A&G,36^=!`ESF*`9I',/>?;>,&"&+;HO$NI+1"X4`!&1,X/+$`KRV_?'* M%]K$"(&\Z8/CJXCD$D*A!O/<3DV`(7:C>6FD3APC),)-);[&/!F;/3H?(JJ0 M@I7=3DJ`55*>JY%"2-"1THW)A%$A%*J$1`:%5S-(#-*($8T80N8=,4(,:FA& MW@'MQRK4YBJUR[DEP!JEP2TF-4(@*).Y=4:(NAT6I)`27>]F-1!@C937KQ5) M(00#$7G#I)TU4:Q3.16IE&X3`3%(HZ956HP0I$8#+?,2Q>H.L5:B12"5;@]7 MA]9(&>HI/*YM3"S?7VA5FD@?TAYX$\))-%6_+6C=*(W@4.BXH1*#!*A'#(*H M[M+NAT/4UF_ON#)LD"&,L[#;0=3Z0+&4HZ1>NN!D#,#N`/CB4MQ&`)$-<3)Q!Z5U_HT-IV:KD?2PQ.[4>106W<-P(OG"+V M2XT!+IR,?-,2*I88_$?\R=E-L7]R=L,;*;QK*5F]9PDKBL;*^*NX;:+PU[%_ MBS=A,5G&5-Q):.\3<4,FWCN]`2ZHCNF>?4_K?5XU5L%VX-*=B4*K\8H+'UI^ M[*Y"GGD+5U/=SP-<13*X\W!G`-YQWIX?Q`3]Y>;F?P```/__`P!02P,$%``& M``@````A`)B1GXV,`P``&0P``!@```!X;"]W;W)K.5*"UDEA`XB$O`JD[FH-@GY_M_3S1T) MM&%5S@I9\82\Z"RE(Q(NYDV"?@B^UYWK M0&_E_B\E\G]$Q2';L$Z&K?[E!<\,SV'E2(`KLI+R!8<^PZ,(@NA&@$'T_\

MCR*=FV;ZJ(.=KMBO,-[G_FXO-UD"D6T@#9F.6OS]RG<$R0*Q! M?(NNF2S``GZ#4N!^@C2RMX3$0"=RLTW(<#RXG41#"O)@Q;5Y$FA)@FRGC2Q_ M6A$]6%F3X<$$_@\F-!K0433^O4=H>9JI/C+#%G,E]P%L-(BH:X;;EL[`]_)\ M8"*H?4!Q0J`0`%5#4E\7T3Q\A;1E!\72*N"W55!7D1X5F'E@:$$@,_U!4(P@ MF&@D6]H'W;BQ%]1JT@_4CB$$*9+^#$9BF$&G;BW;MRE573)QJXB/5>)P.*/3:O`)=6XK!Y59*>2ZZP33_#AF*/[61K MR]-*'#:O3M)SRX&I M/;>[)PGURG%YT#A\?FE&)W3]_ MJ';7-_8KA%J-P^>7R`7--3[O0]%S'YY_,>)3`%LMT)WA7+J(1J`>"VE.=Y@9](V M]8M?````__\#`%!+`P04``8`"````"$`/2F1CX`"```<6`4-K@WM>C,@4VRC]!)JM>;[H8IV0'%2C3"OGI2C"3+GJI6:;IJH.^7 M9$C9@=LO+NBE8%H95=H(Z$@0>MGSE$P),,UGA8`.G.U(\S+']TFV&&(RGWE_ M?@N^,T?_D:G5[HL6Q3?1$DWC?VA M=E^YJ&H+:8^@(==75KP^)``'*VXL4OA*#%B&V.5_!-`R9XJD*1[$GCN29+T:I+!G@2>_TC2R2@9 MC?\OA82VO$N/U-+Y3*L=@I,'PDU'W3E.,F!V]@S`Y+?M`5]0-SV$`+Z>I'@V_4B7=&IR'3.9!,1F<*`@9.4N_2F8^+]Q`G&N%#QQK?3]"! M(>FC[R:3$ND/Y>G_\%``#__P,`4$L#!!0`!@`(````(0#4 M$10VC@8``&L:```9````>&PO=V]R:W-H965T)]0H!<"$HRZG!'N])J-;O[3!.2H`XA`KI[YN^WC&VP772ZIS4O MP^10/N4ZKK(+]^;K]_(R>%G?=*;6YVGAVY0>='-V6RIEVEQU2B#4W^$HSH>BRSWJNRYS*\M):GS M2]K"_)MS<6LX6YE]A*Y,ZZ?GVY>L*F]`\5AJ3A\O$/=W M8YYFG+O[@>C+(JNKICJV4Z#3Z41QS&M]K0/3;G,H(`(B^Z3.CUOMP7`28Z7I MNTTGT+]%_MH(_Y\TY^HUK(O#'\4U![5AG<@*/%;5$S&-#P2"P3H:'70K\%<] M.>3']/G2_EV]1GEQ.K>PW`N(B`3F''YX>9.!HD`S-1>$*:LN,`'X=U(6)#5` MD?1[]WPM#NUYJYGVU%XLYDM[!32/>=,&!>'4)MESTU;E?]3*8%R4Q60L\&0L MUF)JS&=+\/E1#HMQP)-Q&#\_D3DC@2V% ML>@BN#-PR0;"DSO\<,10@YU3>+*Q$/L=7VMF#T]FO_I0<`9D%5UDDEYLE=^; MI4X3I<73B?0Z^E8*0>X3E@=!L-0@= MDJN!NGG9&?9LH[]`KF?,9C]B(UNXW((D-J'U5,!7@4`%0A6(5"!6@40`=)"E MUP;R_U=H0VB(-CRJ/0<&L4Q%"&[!AW@JX*M`H`*A"D0J$*M`(@"2$)#(OT(( M0K/5H)B')+'F:RE+(_;&_%A'D)\A`0("1$2(21&2"(B4NPP:2EVNM=.R6%V M7P8R4):!(E;7BG1;I8L0#R$^0@*$A`B)$!(C)!$1*>:5$O/]0(FU'"A#S'[W M=!'B(<1'2("0$"$10F*$)"(B!4I:@Y^9(B)"H'R52KV7JN#?B1(E()"D$C8ZDD)#^[;G( MGO85A`!G\8AR%K04M-$@)+)P%!&%0XC'$$+SLC-GAG*D^/U['D6`.$*$1/TH MQFHIVO3O.6LB7#Y3+&"T+HQ\V0Y_3D]1XV=FF MDH(!)X;]>7"/UP`11WS@X"M6?*V54S?A0][R)0M.>DU1\'<2GK:FDK(4,I>] MV*[10W>B];C5<'CZ&`HX--"'&(HX-'#%&$HXU''),I!V\B=D(.9*W5/('+XO M7-(\@I4I;07JHGO<:B@\GT.TI-8VRB9&#(][V=2[YU40<>+!5\P@:T9WCYFI M'%H)'_.6,UE'TG"*.GZN?FG;"I[YS/<&A93Z581QF15<#=T1QN-60TWYG!Y: MP$'1N7(\!7R@5%GSA7S$S[P+8^R^*3C%<5_IY9I@RRI M3"&IEGM(4`8G,;,:8O;)?1G)_@$*."36@<9U:LZBWE?6"P]V\58M>8A=QJW==.Q*&[ M[F-NQ=ROT+'RCGLY%4E_+J:BN@;?JAN(.]IDBOT5:_/%C8!"4HKVD"`O3E%J MM>AN?CNM?+)/P!H+4,`@@3[$4(0'QA@B-]1=!0@I2F^GW,TOEV:2 M5<_D-AD&[#8]3*^Z]TL'ONJ@.!0\LAUH^D?PM1-W:Z_8)[8#;2^VAZOTAVY; M4NSWY(I]Q'YO.G`_A7GVE@-W,AA_F#L/$!=^L9\[<#TQ@B\<^'0?P6UG/Q:` M:SON&.[9#GQP81YO[.*W`@``K@<``!@```!X;"]W;W)K M=>^[*\?5$U>1;&2MVD-`I"2D23 MZ5PV94I__7RXNJ'$.M[DO-:-2.FKL/1V]?'#^&Y*+@V]K] MT+LO0I:5@W9?@R,TEN2O]\)F4%&@">)K9,IT#0G`E2B)6P,JPE^Z^T[FKDKI M)`RB:3@#--D(ZQXD,E*2;:W3ZH_'1'LFSQ'O.>!^X)@%U_-P$ITG83Z?SMX] M=WRU-'I'8,^`I&TY[L`H`>+3?L`(8M<(3BGL:5U$\6[)G*%RVQ]QY M#%S_87H$`]%>&=0N5T8P*F-E,94['SB6B4_+3-XC@^"43H^3C^<]KU?V&&A; M;W#:(P8&@>9R@PB&'@!Y3SNNK0==(`V0RZ41W$GWQ?61;A\/',W>0XO@(>T^ M,BSOS>GBS=\CA>"AE(^,'>`\/MKNW3%>G-WWN&K(OX\M+(::_S]B M"!Y*^$!GXFX1L_?CKZ\:&$*<4G4=>69'J+ MDR^&@=!'^ZF\CO',OHU/D[6?UJS_`M.RY:7XQDTI&TMJ40!G&,PA)>/GK7]Q MNH5$86AJ!X.R>ZS@ORA@*(0!@`NMW>$%E%G_IUW]!0``__\#`%!+`P04``8` M"````"$`I&23GPH#``!8"0``&````'AL+W=OTT[=_OC$UH M2-(V>4G"Y/@+Q)92::(B%_?M]?S8FG#6LR M5LF&)^2%:W*S_/QIL97J49><&P\8&IV0TI@VIE2G):^9]F7+&_@GEZIF!AY5 M076K.,OLHKJBX6@TI343#7$,L3J'0^:Y2/F=3#K[VT%?BHOXSG;5.:7W'[CHB@-E'L"CM!8 MG+W<<9U"1H'&#R?(E,H*-@"?7BVP-2`C[-E^;T5FRH2$,W\^F433^0QHUER; M>X&EAE?(H/@A$3[FP^F/:]3=AC(>&\PZA$#@T!S MOD$$0PV`O*<]SJT#G2$-D/.E$6RE^^2ZB.WD@:/I);0('M)VD4%ZP^!T\F:7 M2"%X*.4BQPYP(N^U.Q[D\63FXRE\O_5QX5"BB\#*O8J]T8370]GWI1`\E'*1 M8S4V(6&=L:GBQ/@(=]+X_M^+/I`S4V)$XX.IH*=M.$< MQ^H'!0JZB3!^G1&[T-#3&Z<5C]X%GMP4@$7]H;$$"3GAZ6`0H*>SJM3/A%>- M+C1T-#FHDKO'W)BON2KX%UY5VDOE!N^H$`9W'^WOSU6(3@[C4;QR]RKM_X%[ MK64%_\%4(1KM53P'SI$]02-'"AV9\EO,%P&-XC[-!<2K-[ M`&7:OQ,M_P,``/__`P!02P,$%``&``@````A`)NM8-N6`@``J@8``!@```!X M;"]W;W)K[?=XP)3391-WWA,AR?,V?&8Q;W+[)&>ZZ-4$V& MHR#$B#=,Y:(I,_SSQ_INAI&QM,EIK1J>X5=N\/WRXX?%0>FMJ3BW"!@:D^'* MVC8EQ+"*2VH"U?(&OA1*2VKA59?$M)K3O%LD:Q*'X91(*AKL&5)]"X.%"/)TJ>R49IN M:O#]$HTI.W)W+Q?T4C"MC"IL`'3$)WKI>4[F!)B6BUR``U=VI'F1X564/B28 M+!==?7X)?C`GS\A4ZO!9B_RK:#@4&]KD&K!1:NN@3[D+P6)RL7K=->";1CDO MZ*ZVW]7A"Q=E9:';$S#D?*7YZR,W#`H*-$$\<4Q,U9``7)$4;F=`0>A+=S^( MW%89CI-@-IF,I[,$:#;>930-)DDXBD#T M'1+B,^H,/E)+EPNM#@@V#4B:EKHM&*5`?-T16''8E0-GUY&J@"_ME%$T6 M9`^E8SWFP6/@^AGR8? M30=>K^PQ4/'!X'A`G!D$FML-.C#T`,@'VLO:>M`-T@"Y7=J!.^FAN'WDM+I1 ME%QW.3V7ZD8CF;LY>&2*;!@';IS^O8?=PG/9/G(N M.W\CZ\\&/SJ2ZY)_XG5M$%,[-_SVZ]OX.%UU1Q49/L!1T=*2 M/U-=BL:@FA=`&79>M#]L_(M5+60.HZXLG!'=8P7_!`[S$`9@O%#*'E]`F`Q_ MF>4?````__\#`%!+`P04``8`"````"$`=S2"EF$%``#7%@``&````'AL+W=O M;L- M*R:^ZZASDN_2\V'C_OW7X]V]ZY15?-[%I_RL-NZ[*MUOVY]_6E_SXKD\*E4Y MD.%<;MQC55U6GE>2E4O*L792=/^O[$I/:?5>)W6=+%G].)SS(GXZP;[?Q#1.FMSUAU[Z+$V*O,SWU032>4BTO^>E MM_0@TW:]2V$'6G:G4/N-^UVLHD"ZWG9="_1/JJYEYV^G/.;77XIT]UMZ5J`V MU$E7X"G/GS7TQT[_"Q9[O=6/=07^*)R=VLRBK/_D60,*DPB31)`F!OXG)L$@\)U?M[B*MXNR[RJP--`X\L+[%N M0;&"Q,W&D$:[U<]V"EO42;[K+'4NV$0)Y7G=WB_6WBLHFAA(B!`X$"U$4$34 M('0A@%U+$?;-*090P8^U;QCI1921G-/GA1]`*"+J(^;+%D(X@G1=CL/<-'CC M3CM2W-^W:6M!0X1`;[1J32DB&D(0:O"<\=0T&)JS\]Q[]N`0('B)D2+E3PL6(F16 MZR;X\8BZ4=EI54)I<0LE#6:4V(D+$3*D5H/01_K.'B#"2@^YCH4,"Z7!C)5D M0B$$A9HQ&XFZP84-$D)+2FA<<^E%M+F6`2.&D"&YAA"$H@`#&R]:C6:J\6-I M,`L\E\)?,$N)#`!UO9.^E9TR8Q-AN)P"3;MK&,L9D\U@3.?38$2"TBZEG-@( M^((3VC;A9%L7_54@!CE-[6/1PTA4B$_:3&@+'MWX-9K5T"8VK'3&C6M*-.U5 MD(2%L.9'U;K)\47?\J?<)PP&>9,S$B_GUDQ/Z_B33XO/C!Z5J;08-J3.&>`R`":,G=&*%7L)KL7:-50S?:5 M86D;Q"C6V+G%V&J9UA^"4'HW^;[H&[_P^8@T("AO^X`L*>:,OM?`T"@ M>7=;3OB]D]`X?#T0`[:!R.1H*]N:'>$GF?GK`36%30_;6KV*&HCHF#A6V(`, M`;3%271SVF]L$H4&9'3C%D>C@=TN])LAL/YITB4`W9F/C"?M'YH9O;V22$;1S#K!D/%F3E M,?(-00@__85X_*FHT>Q4"/[*9$#878Q\1(+VQ%!.;#2,JVJ`(X)J9[T`M3.@ M(2\9A%">;%1HGE^/6+A"[#F+8`4,#0@O0'AOZEM(G0*C7$2\7\3[MTP5!Q6I MTZETDOQ%WQT*^.K6_A?O-4.XUZPO`;TV`->*E_B@?H^+0WHNG9/:PU)_L@#= M"KR8Q`]5?JGOOY[R"BX4ZS^/<(&LX+K.GP!XG^=5\T'?N+57TMO_````__\# M`%!+`P04``8`"````"$`*NKA<08%``!%$@``&0```'AL+W=OC;DD*VVD*,KEF<%M&XVA M+6!N?Y\J&NB;@V>D[,,R/JXZ7:>JZ.KVYMM[=3%>2=.6M-Z:KN68!JD+>BCK MT];\Z\_L864:;9?7A_Q":[(U/TAK?MO]_-/FC3;/[9F0S@"&NMV:YZZ[1K;= M%F=2Y:U%KZ2&;XZTJ?(./C8GN[TV)#_T3M7%]APGM*N\K$W&$#6?X:#'8UF0 MA!8O%:D[1M*02]Y!_.VYO+8C6U5\AJ[*F^>7ZT-!JRM0/)67LOOH24VC*J+O MIYHV^=,%=+^[05Z,W/T'C;XJBX:V]-A90&>S0'7-:WMM`]-N:&IKW;]`GZNR1OK?"WT9[IVR]->?A1U@2R#77""CQ1^HRFWP\(@;.M M>6=]!7YOC`,YYB^7[@_Z]BLI3^<.RKT`12@L.GPDI"T@HT!C>0MD*N@%`H#_ MC:K$UH",Y.];TX.%RT-WWII^:"V6CN^"N?%$VBXKD=(TBI>VH]4_S,@=J!B) M/Y#`(OEJE]\QA-X^ZCA.7G.+A4.#O"<'&:7 MLEF>^K0G>9?O-@U],Z"7(1/M-<*#UUJ,#U]Q;V&! M^1?3CSQRZ`P)X,$+L@CE@L23T:@OT9!40S(1D=0L937SV49C.62&B-G6D$1# M4@W)1$2*#T\BVH9J+2'=\Z&BGQPJ0X(U;PP-230DU9!,1*10UW*H\_&AL1P? M0]@4QNTZ5H%$!5(5R`1`"LV%C4Y,XWQLO;4:0T*Z^LCDF(Q=DC3>U MOY*;.N5<8U=G]QQE?3BX;K=)=RZ+YSV%Q<'FAFX?YNLP==GT@PUQ#&+O,DB2 MK4'):+7J1[7GN,KVGXX&?%/*1FCRX1NOK`S'F:+L_MARV1"4I##(AQ;AA5@H MY8H'1P_ZA5OI165<@<,$6XZ;/BB3.^5,8S:S`1K<7,OW1#=9-LX^0?:-PL'Q M<:H*3B:N_XR7IQ'`IZ M<:I\HLQLB$JZA[DJE3ETY&ACEUG=*S.S"J#:7'GHREPIY^+2[SC*TG'2?ETZ M>BE[%(,@[4*T2EO&>$ZZ7W)F%.#>\+ISK/7"5<9P.O%PT:J3YX5KX1]GD.7C M:/ZZ?#;0IGLFZ-"SE"BIW^W-2PGP'8AXY> M^\'X1#NXOO=_GN'G&@+G#P?/M$=*N_$#+C#]`+3[%P``__\#`%!+`P04``8` M"````"$`E@@X='`"``#Q!0``&````'AL+W=O#P5C3K1280?;X4ANKN#NBU$M8X4_L$="PF M>ECS.3MG8%HM*X4*@NW$RKJDZZRX7%"V6H[^_%9RY_;>B6O-[HM5U3?52YB- M-H4&;(RY"]";*H1PF1W/@W_TJ M3Y?L'C6+)\AEA.`Y0;()P:`Y"4/L>.$`#L+!E)#)90SLR\S>ELE?R@3/.GR+[)6?X?FQ-#M=>BCY%T-_)@"S/7SD;5RS.L9:VD9]E MUSDBS#:LSPR3.46GS5[/PO2\CL^+];CQ;/J`C1MX(V^Y;53O2"=K4*;)&6JQ M<6?CP9L!F6/OC,>NC:\M?JT2TYF&PFMC_/,!PFSZ6:_^`@``__\#`%!+`P04 M``8`"````"$`+/*,L&D'``#>(```&0```'AL+W=OQ>8CCCS/#NOI./J2E55>G->..YXZH^R<%KO\_+IV M_OI3?EHXHZI.SKOD6)RSM?,MJYS/FQ]_>/HHRK?JD&7U""R34Y*?'65A5=YCH]CO M\S2+B_3]E)UK9:3,CDD-_E>'_%*UUD[I/>9.2?GV?OF4%J<+F'C)CWG]K3'J MC$[IZI?7(^ZL;)&EKN_G"S)_RM"RJ8E^/P=Q$.=KE M$`&F?51F^[7S[*ZD'SB3S5.3H+_S[*,R_AY5A^+CIS+?_9J?,\@VU`DK\%(4 M;RCZRPXA4)XP;=E4X/=RM,OVR?NQ_J/X^#G+7P\UE#N$B#"PU>Y;G%4I9!3, MC+T0+:7%$1R`WZ-3CJT!&4F^KAT/)LYW]6'M^+-Q.)_Z+HB/7K*JECF:=$;I M>U47IW^4D*M-*2.^-@*?K9&QMPC=<(9&KB@&6A$^M:(['P=>.%\TTU_1!+N- MW_#9:5Z=:J85X+-3N#K51&6J27R**`B42?2Q<$0P1!I(B04F,H.!=?U@UV&5J!/ M818C.+O-E-#5X#J1+CB&"(9($R'!02!F<-?K@\)-#.W<6X6H;;5I^X@A,4,$ M0Z2)$/]@6=_O'PI3_Q02@'DCZPNK7SJA-JR8(8(ATD2(R_-'7$9AZK)"S)0R M)&:(8(@T$>(?'CBL7=-?("<]VM)HB/JND`!28Z1[::6[$^K2S1#!$&DB))PE M#>=Z!Z,P=5DA9KH9$C-$,$2:"/'/A6WO^^2[L42]UQ#->#BU,MY+=2GGD."0 M)!"-"LG+Z*+K:7<5U<'NUSJPU9"9>`[%'!(^F8C/BIH("6$U] M2X>NG>!.JHTO=ADD."0)1#U'/KK?<\5>Q'.3T-3>C.P#[6_D/.:0X)`D$'43 MF<5P$\]@,W\\?WPW<15'P51M#K<:LKK;/K7T4JUBS"'!(4D@&A7RD1'5C>Y& M:6M=*LC(=(1G!COY#!)<2A*(NHD<=+^;BK%(@C6)T>[V[>[NI/H$,TBX#)($ MHIXC.]WON>(RXKF"2((9%+L,$AR2!*)N(NL8;F)WS^&I[&&J=!5]D0@Z1C-W M%OLLJQ5A"?2Y[Q1;2'`I22`:%%*5$=2-YE;$1CPWN4[O+`R*708)#DD"$3<] MBS>ON]E(TS6HH:!_!(HX%'-(<$@2B+KY$!%ZG`@U9'8RAV(."0Y)`E$WD8[N M+KJGR,LLNH:LO3BTMHI>JNW-F$."0Y)`U/.'B-#C1*@ADF!.A%Q*<$@2B+HY M0(1>^#^V"H_SH(:LW%L/CU$OU>=>V3)V#\&E)(%H4$A0]W>-HC/2-8SA(GS0 ML'B00X)#DD#43:0>PTUU$=0<0F[L&HJSB,>:QI;=AAMY#(HY)#@D"40]1F(R M/+[AIJ(QXJ:"U$4BWC=%GHW$#!$,D29"/;2H[X:'G-\\!9%EUT$&Y?G6#4^L M%9'`^B.W;SVT"VY>WE*D\2$]&14P>J8^Y.G;MH#)8;<>B-N'2\*&]IX]Q7&D M,(SV(BUE9")NH45SW^A-78OW12O07%@WD\D6ZG3Z4KN!2:KFCGW/5*-A M/T3$/B=B#0$U]'&$5MM%6@CVL%Z(!ZN,!_#12X76/8CH3/71WM"C\5J,C@V, MZ1IH6-@YVX[U.;-KB)9Y9M\A:*E;95;F`_CH(Y]9C\NBM]6'?D.1AFX=">X, MG1\-?'T.(-Y:;1EIH1LE5Y8"W!N^;*;C9>A:_"PZ.WW0MI+GS9;&3V^!AC]P MU+BC\OQ<`3M20\5D@<_Z;46=[;74KL,(##I9'1CL$D(%!PL(]6O*-^D4X.WR)7G-?DO*U_Q< MC8[9'A;-M#D6E^K]M/I2%Y?FJ/-2U/!>N?GS`/]'D,&I&PO M=V]R:W-H965TC>9,<=G1P)";!E!(E\J]UIPW?M)C[ M(9URL><>!B?T2@JCK:Y<@G0L&#W-O&`+ADRK92DQ@2\[,5`5=)WFUQEEJ^50 MGS\2=O;@G=A&[SX;67Z3'6"QL4V^`1NM[SST:^FG<#$[67T[-."'(254?-NZ MGWKW!63=..SV#`/Y7'GY>`-68$&1)AG//)/0+1K`)U'2[PPL"'\HZ!B%9>F: M@D[FR2P;35*$DPU8=RL])25B:YU6?P,H'4P%KL':#7=\M31Z1[#=B+8]]YLG MS9'X=2]HPF/7'EQ0W(XH8[%^]ZLTFRW9/8863YCK@,'G,R8B&(I&950[7]F# MO;*OBK=R'28.9<:ORTS^1\:#"SH]-#_.(F]0#ABL>`PXC8BC@$AS&'#?[M"< MN`'>J[EGP>:@:M1+LWE4#)X"Z`Q/"#GQM'BW[W[5X"&6_VD&5QZX>J[441WF MQYIO;S$//HE[^2)N`)T1-SN6'EHPP75O>_"KCN.&F4/!-%M$4R%M./?A<"DP M-7R"MK5$Z*T_TQ,\+G$V7C?KL=_1+^>G^7HX_R_GY_EZN)Y8_(#70\]K^,Y- M+3M+6JA0:I1DZ-2$"R8,G.XQ$%X2VN'%,+PV^!\`/$FC!,&5UFX_0$,L_EE6 M_P```/__`P!02P,$%``&``@````A`"EM/OB/`@``@@8``!D```!X;"]W;W)K M&ULE%5=;YLP%'V?M/]@^;T82!I6%%*EJ[I-VJ1I MVL>S8RY@%6-D.TW[[W>-$T::5LU>$#;'YYQ[KFV6UX^J)0]@K-1=09,HI@0Z MH4O9U07]]?/NX@,EUO&NY*WNH*!/8.GUZOV[Y4Z;>]L`.((,G2UHXUR?,V9% M`XK;2/?0X9=*&\4=#DW-;&^`E\,BU;(TCA=,<=G1P)";!E!(E\B]UIPW?M%CW8S+G MXL`]#$[HE11&6UVY".E8,'I:\Q6[8LBT6I82*_"Q$P-50==)?I-1MEH.^?R6 ML+.3=V(;O?MD9/E5=H!A8YM\`S9:WWOHE])/X6)VLOIN:,!W0TJH^+9U/_3N M,\BZ<=CM2RS(UY673[=@!0:*-%%ZZ9F$;M$`/HF2?F=@(/RQH"D*R](U!9TM MHLLLGB4()QNP[DYZ2DK$UCJM_@10,I@*7(.U6^[X:FGTCF"[$6U[[C=/DB/Q MP5-@&%V^9A+=>9*U9RDH[E/4MQCLPRK)XB5[P#3$'G,3,/C\AQD1#-V,EM#& MU-++\1R4/=@K^[B\E9LP,95)7Y:9_8^,!Q=T/C6?)2-O4`X8;,58X'Q$'!6( M-.<7Z,'8'"0?:4^S#:`SI!$RE?;M3A=^N[VR"P\Q^W6#BS'G_K% MJ>IB'KTIZI<=B^YGL,>3,&8OIYR=BLZNWJK3+SJ6W,\<2SYO;#CSX6`I,#5\ MA+:U1.BM/\\IGHAQ=KQJUJG?M,_GY_EZN(+8^`&O@)[7\(V;6G:6M%`A91QE M&)\)ET@8.-VC<[P(M,/#/[PV>-<#'HK89UUI[0X#%&;CWV/U%P``__\#`%!+ M`P04``8`"````"$`N/PN!_;@$^@.*.8,]J55JL]7!.,;11C+"#) MS-M/-=T%=)?M.*.Y&<8?U=743U5WT7GX^JTXCMZRJL[+TUK3QU-ME)W2JT=FN9L M3R9U>LB*I!Z7Y^P$=W9E520-_*SVD_I<9[NL=' MN=OE:>:6Z6N1G1KNI,J.20//7Q_RBO0>=T52O;R>OZ1E<087S_DQ;[ZW M3K51D=K1_E16R?,1XOZFSY(4?;<_B/LB3ZNR+G?-&-Q-^(/2F*V)-0%/CP_; M'")@LH^J;+?6GG0[UI?:Y/&A%>B_/'NO!_\?U8?R/:CR[1_Y*0.UX3VQ-_!< MEB_,--HR!(,G9+3?OH&_JM$VVR6OQ^;O\CW,\OVA@=<]AXA88/;VNYO5*2@* M;L;&G'E*RR,\`/P[*G*6&J!(\JV]ON?;YK#6C-5X-9_/%JLEN'G.ZL;/F4]M ME+[635G\SZUTX8M[,807N`HOYGRLSZ8+F/->'Z;P`5?A0__\@\R$$[AB...E M/K5,%LR-`.!N*P-[@*^^5=P>F05?PEL_02;_FCIYSP1&GSSDV:Y/&A*M]'4,R0"?4Y84N#;C// MF''\P;L(-538;*A)KILX:`%RVOF MU56!IP)?!8$*0A5$*H@'8`*J=-)`^O\*:9@;)@U&M4'0:V4H0J`%#G%5X*G` M5T&@@E`%D0KB`9"$@#S^%4(P-VL-:KG+$=V(3XA`2$A(1$A\9!(@4(#\XE`F;4<*"BWF1I6L=K[6A=A2YB)BKMT=CJBM;JM<;8"P^ MHOZM!!2%B#K/IB)2;X">8T2M9UDFUHG=7S(Z;]Q@KT3?&T3P)OJDF$WEAW*$ ME0'C>RM3S:^+5C.E9_70RFBUU1?*7#[>'V[HNCI7@%:]VF&/!@^I3A^AE9C> M5#K)&.]?FU[6GS6`0_U_+DUY&RF]%HX,Z`MZP6?*LSJZ&`B7WDJ5RNVM\*U[ M`L'7*10\`OUWT8E M%@!FKBP`'!F+K@8^C'D4^HMY]0%&(J/<5410C:GW),K!^ M\1,R\/82_&$&;'2.C/XKRT$D+04TF\3`OO`\',A+REJ1;!)#0.9;V22LK.XA M0W3?JU_>P4KRM^C+S!&*G2_W`F;))^3A0RNN9TOP':-7G8HBHGS&Z:\88!UZ;418? MK"3Q/ZAE9J[4,D=2+7=HH`Q-8F'5Q^SI!/F(AK7/4NYQI%4R@)]4,K"2MK5U0W38]G)5D=1W::RG_MX_UK!M2MQ M@%;#ZKYG^@@'BNF7_?<;3R9^,LQ/Z(JLVF=.=CS6H[1\9:>^^@K6B0[S(^G- MPH;O+GA_*E_:\&U">6C9T+I>X/K4CJ`WHW=B"PZ]+]V`T_"GMJC4J=DI^05' M&\.&,R8ZP<:TX5R%\J>9_02"T1N;F0UG#!?XW(;O[PO+O3 M]GNXXJ?^_$=3GN&MP^%NV&PO=V]R:W-H M965TJI(\"VVDJA,:>@$EHN8J ME76>T-^_[J^N*3&6U2DK52T2^BH,O5E__K3:*_UD"B$L`8;:)+2PMEGZON&% MJ)CQ5"-J^)(I73$+2YW[IM&"I>VFJO2C((C]BLF:.H:E'L.ALDQR<:?XKA*U M=21:E,Q"_J:0C3FR57P,7<7TTZZYXJIJ@&(K2VE?6U)**KY\R&NEV;8$WR_A ME/$C=[LXHZ\DU\JHS'I`Y[M$SSTO_(4/3.M5*L$!EIUHD25T$RYOPXCZZU5; MH#]2[$WOG9A"[;]JF7Z7M8!J0Y^P`UNEGA#ZD&((-OMGN^_;#OS0)!49VY7V MI]I_$S(O++1[!H[0V#)]O1.&0T6!QHMFR,15"0G`DU02CP94A+TD-`)AF=HB MH9/8F\V#20APLA7&WDNDI(3OC%757P<*VZ0<5YO:';-LO=)J3Z#?@#8-P],3 M+H'X0,5#`YW483U?^,YCF!\RMP\#S#=,A?!#ME$%MO#*" M41FK@JG&D$M])=<5VD/8,#1_%':!$\I#U$AN6-N_(.I.8?D4+P4,I% MSAW@+.T==_P%H_C:`\/OGWS<-U0X1&!GKV'SRV860]7WI1`\E'*1EB"A%RR=3`5LT#A+ MAX'0%SF$AI86)Y;+=CY62DL%:V#!]=:<$&!3R+)>"ILA>H0+,78BQHT]UEL MF!AN6J=YB$>WQ9:+=[X%/,OS2ZPA<,D#QWM@:B)]7>+?62G%8$>%`QY`)O$]>K`[ M)L_SV[OU$K%93HHTOTA)L28Y)5>T*%Y+?&R-]]D$U*/`OXE'`!N\?_XY^P(` M`/__`P!02P,$%``&``@````A`/MZP\N8`@``Y08``!``"`%D;V-0&UL(*($`2B@``$````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` MG%51;YLP$'Z?M/^`>&])LFJ:*H>*4+)4:IMHT/;1U=J3 M>DVA(%[72)!=#&FMN-GY(^)UKR1.60$A`OLY*S00[^.! M+(#9HJT85]HG6W.YA=1(Y6C^&\LV<9UGIL'2F;I;IC@3!FE9M_;2G(M*&^4_ M2?6B-P!&$P\=VL?FV/7MGOF%/YDT'GCJ>UJ$E@D:^AP3;@K0RWS%E!FBW./< ML&@9MX3V*E+L#1H)@_6B-Z)5F\LN\T,.L^`VN`\C&B^B*(D_X4*1&C;*!@QJ MAT(=D&SA6AIQ$B31772?Q'0YI\M5]"M(;I;W,7T0K,X^$1(&\8+.;Y=/IT)F M3'--94Y7"C0R:AII$/P:=*IX91O-^L]JS07HGI('[G,NF$@Y*[!P*'PS%,.> M-V(+VMBA.6X7V&TXC8.LX@T6$I.`C(:RQ,'4QS.(^5IPG%/L4!K6VL@2MT.C MC!D,'>ZDCBEQY*P17A/DB;L&7MW$/E(KJ=" M.N6E099QJUZC2M/.@U_IDHGKLF1J9_5^?QX,.4:L_>(_A<2X8[-Z..2D?./! MF-/Z]6)Z^^2/#7++Q8M^J!)YS0SL5V3_D31%R'!Y[.T?#V2!VU$5%B3<,+&& M;._SM\$N],?VK^6/+\Y'WT:XJSMOQ/OX/_EO````__\#`%!+`0(M`!0`!@`( M````(0!!5_NWL@$``,4/```3``````````````````````!;0V]N=&5N=%]4 M>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L````````` M````````ZP,``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`,_0W'69`0`` M:`X``!H`````````````````$0<``'AL+U]R96QS+W=OCE`@``I0<```\````````````````` MZ@D``'AL+W=O&PO=V]R:W-H965TLB M_P(``(D(```9`````````````````%48``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`/###,NC!```"1,``!D````````````` M````BQL``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`/MBI6V4!@``IQL``!,`````````````````4B8``'AL+W1H M96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`S7;F['(+```]8P``#0`` M```````````````7+0``>&PO&UL4$L!`BT`%``&``@````A`-01%#:.!@``:QH``!D` M````````````````!&4``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*1DDY\*`P`` M6`D``!@`````````````````MFX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"KJX7$&!0``11(``!D````````````` M````67H``'AL+W=O!@``&0````````````````#&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`+CW*W9_!@``-!H``!D`````````````````;H\` M`'AL+W=O&PO=V]R:W-H965TL/+ MF`(``.4&```0`````````````````):;``!D;V-0&UL4$L% 3!@`````?`!\`2P@``&2?```````` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments
3 Months Ended
Mar. 31, 2014
Investments Debt And Equity Securities [Abstract]  
Investments

(4) Investments

Investments on March 31, 2014 and December 31, 2013 were comprised of certificates of deposit in the amount of $30, pledged as collateral for our rent and restricted as to withdrawal or usage.

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C-&9D830Q,E]B,S`U7S0Y-C%?865C,5\W-#@P M,F0Y-#@T,F,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DEN=F5N=&]R:65S/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP M/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V,T9F1A-#$R7V(S,#5?-#DV,5]A96,Q7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^36%R(#,Q+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U$Q/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6UB;VP\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M'0^)TY!3D]02$%312!414-(3D],3T=)15,@0T]24$]2051)3TX\"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)RTM,3(M,S$\ M'0^)SQS<&%N/CPO M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF5D.R`R."PT.#$L-#DV('-H87)E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XR-"PP.#@\'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'!E;G-E.CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]C-&9D830Q,E]B,S`U7S0Y-C%?865C,5\W-#@P,F0Y-#@T M,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S1F9&$T,3)?8C,P M-5\T.38Q7V%E8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPOF%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#<\'!E;G-E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6UE;G0@;V8@86-C;W5N=',@<&%Y M86)L92!I;F-U'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78^#0H@/'`@ M6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0 M.B`V<'0[(%1%6%0M24Y$14Y4.B`T)2<^#0H@5&AE(&%C8V]M<&%N>6EN9R!U M;F%U9&ET960@:6YT97)I;2!F:6YA;F-I86P@#(P,4,[3F%N M;W!H87-E)B-X,C`Q1#L@;W(@=&AE#0H@)B-X,C`Q0SM#;VUP86YY)B-X,C`Q M1#LL(&EN8VQU9&EN9R`F(W@R,#%#.W=E)B-X,C`Q1#LL#0H@)B-X,C`Q0SMO M=7(F(W@R,#%$.R!O2!F;W(@82!F86ER('!R97-E;G1A=&EO M;B!O9B!O=7(-"B!F:6YA;F-I86P@<&]S:71I;VX@86YD(&]P97)A=&EN9R!R M97-U;'1S(&9O$$P.S,Q+`T*(#(P,30N M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)' M24XM5$]0.B`Q,G!T.R!415A4+4E.1$5.5#H@-"4G/@T*(%1H97-E(&9I;F%N M8VEA;"!S=&%T96UE;G1S('-H;W5L9"!B92!R96%D(&EN(&-O;FIU;F-T:6]N M('=I=&@@;W5R#0H@875D:71E9"!F:6YA;F-I86P@$$P.S,Q+"`R,#$S+"!I;F-L=61E9"!I;B!T:&4@0V]M<&%N>28C>#(P,3D[ M65A$$P.S,Q+"`R,#$S+"!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M=#L@5TA)5$4M4U!!0T4Z(&YO#L@+7=E8FMI M="UT97AT+7-T6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@3F%N;W!H87-E M(&ES(&$@;F%N;VUA=&5R:6%L2!A;F0@82!V87)I971Y(&]F#0H@ M2!S M=')A=&5G:6,@9F]C=7,@:&%S(&)E96X@=&AE($YO#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE M=R!2;VUA;B<[($U!4D=)3BU43U`Z(#$R<'0[($Q%5%1%4BU34$%#24Y'.B!N M;W)M86P[(%1%6%0M24Y$14Y4.B`T)3L@+7=E8FMI="UT97AT+7-T2!W87,@:6YC;W)P;W)A=&5D(&EN M($EL;&EN;VES(&]N($YO=F5M8F5R)B-X03`[,C4L(#$Y.#DL#0H@86YD(&)E M8V%M92!A($1E;&%W87)E(&-O6UB;VP@3D%.6"X\+W`^#0H@/'`@"<^ M#0H@5VAI;&4@<')O9'5C="!S86QE'!E8W1E9"!T;R!D M#(P,4,[;W1H97(@#(P,40[(&EN(&]U6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M=#L@5TA)5$4M4U!!0T4Z(&YO'0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@ M5V4@9F]L;&]W('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@ M0F]A#(P,40[*2!4 M;W!I8R`X,C`L)B-X03`[/&D^1F%IF%T:6]N#0H@;V8@87-S971S(&%N9"!L M:6%B:6QI=&EE6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M6%B;&4@86YD M(&%C8W)U960@97AP96YS97,N(%1H90T*(&9A:7(@=F%L=65S(&]F(&%L;"!F M:6YA;F-I86P@:6YS=')U;65N=',@=V5R92!N;W0@;6%T97)I86QL>0T*(&1I M9F9E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]C-&9D830Q,E]B,S`U7S0Y-C%?865C,5\W-#@P,F0Y-#@T,F,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S1F9&$T,3)?8C,P-5\T.38Q M7V%E8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM5$]0.B`Q.'!T)SX-"B`\8CXH-"D@26YV97-T;65N=',\+V(^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)' M24XM5$]0.B`V<'0[(%1%6%0M24Y$14Y4.B`T)2<^#0H@26YV97-T;65N=',@ M;VX@36%R8V@F(WA!,#LS,2P@,C`Q-"!A;F0@1&5C96UB97(F(WA!,#LS,2P@ M,C`Q,R!W97)E#0H@8V]M<')I'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQD:78^#0H@/'`@6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,G!T.R!-05)'24XM M5$]0.B`P<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1% M3E0Z("TQ96TG/@T*(%)A=R!M871E$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P M.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E M;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*($9I;FES:&5D(&=O;V1S/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C@Y-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T* M(#QT"<^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T&-E6QE/3-$)T9/3E0M4TE:13H@.'!T M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/B@U,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH-3(\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XY,S$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C-&9D830Q,E]B,S`U7S0Y-C%? M865C,5\W-#@P,F0Y-#@T,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8S1F9&$T,3)?8C,P-5\T.38Q7V%E8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@ M8VAA6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@+7=E8FMI="UT97AT+7-T#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE M=R!2;VUA;B<[($U!4D=)3BU43U`Z(#9P=#L@3$545$52+5-004-)3D'0M'!E;G-E(&ES(')E8V]G;FEZ960@;VYL>2!F;W(@'!E8W1E9"!T;R!V97-T+B!792!R96-O M9VYI>F5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E#0H@2X\+W`^#0H@/'`@"<^#0H@07,@;V8@36%R8V@F M(WA!,#LS,2P@,C`Q-"P@=&AE&EM871E;'D@)#0Q,"!O M9B!T;W1A;`T*('5NF5D M(&]V97(@82!R96UA:6YI;F<-"B!W96EG:'1E9"UA=F5R86=E('!E65A6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@+7=E M8FMI="UT97AT+7-T6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@1'5R M:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@F(WA!,#LS,2P@,C`Q M-"P@;F\@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M=#L@5TA)5$4M4U!!0T4Z(&YO#L@+7=E8FMI M="UT97AT+7-T#L@0T],3U(Z(')G8B@P+#`L,"D[ M($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[($U!4D=)3BU43U`Z(#9P M=#L@3$545$52+5-004-)3D'0M65A#(P,3D[#0H@'!E;G-E6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@5TA)5$4M4U!!0T4Z(&YO'0M$$P.SPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[ M(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!7 M3U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P M<'0@)U1I;65S($YE=R!2;VUA;B<[($U!4D=)3BU43U`Z(#!P=#L@3$545$52 M+5-004-)3D'0M"<^#0H@5&AE(&9O;&QO=VEN9R!T86)L92!I;&QU6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO$$P.SPO M<#X-"B`\=&%B;&4@#L@3$545$52+5-004-)3D#L@ M+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@ M.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1C96YT97(^36%R8V@F(WA!,#LS,2P\8G(@+SX-"B`R,#$T/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^36%R8V@F(WA!,#LS,2P\ M8G(@+SX-"B`R,#$S/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&-E;G1E$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX] M,T1C96YT97(^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1&-E;G1E65A$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQD:78^#0H@/'`@'0M6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M2P@;V8@ M;W5R('1O=&%L(')E=F5N=64@9F]R('1H92!T:')E92!M;VYT:',@96YD960- M"B!-87)C:"8C>$$P.S,Q+"`R,#$T+B!!;6]U;G1S(&EN8VQU9&5D(&EN(&%C M8V]U;G1S(')E8V5I=F%B;&4@;VX-"B!-87)C:"8C>$$P.S,Q+"`R,#$T(')E M;&%T:6YG('1O('1H97-E('1H2`D-S@T+"`D,30T(&%N9"`D-32X@4F5V M96YU92!F&EM871E;'D@-SDE+"`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2X-"B!!;&P@;V8@=&AI6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)' M24XM5$]0.B`Q,G!T.R!415A4+4E.1$5.5#H@-"4G/@T*($]U7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO#(P,4,[1D%30B8C>#(P,40[*2!!8V-O=6YT M:6YG(%-T86YD87)D'!A;F1S(&1I'0^)SQD:78^#0H@ M5V4@9F]L;&]W($9!4T(@05-#(%1O<&EC(##L@ M1D].5"U714E'2%0Z(&YO6UE;G1S/"]I/BP-"B!I;B!W:&EC:"!C;VUP96YS871I;VX@97AP M96YS92!IF5D(&]N;'D@9F]R('-H87)E+6)A$$P.S,Q+"`R,#$T(&%N9"`R,#$S+"!R97-P96-T:79E;'DN M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C-&9D830Q,E]B,S`U7S0Y-C%?865C,5\W-#@P,F0Y-#@T,F,-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S1F9&$T,3)?8C,P-5\T.38Q7V%E M8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M2!O9B!);G9E;G1O'0^)SQD:78^#0H@/'`@6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,G!T.R!-05)' M24XM5$]0.B`P<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U) M3D1%3E0Z("TQ96TG/@T*(%)A=R!M871E$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z M(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*($9I;FES:&5D(&=O;V1S/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C@Y-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R M/@T*(#QT"<^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T&-E6QE/3-$)T9/3E0M4TE:13H@ M.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/B@U,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH-3(\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XY,S$\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/"]T7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO#L@0T], M3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[ M($U!4D=)3BU43U`Z(#$R<'0[($Q%5%1%4BU34$%#24Y'.B!N;W)M86P[(%1% M6%0M24Y$14Y4.B`T)3L@+7=E8FMI="UT97AT+7-T'0M M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W#(P,30[)B-X03`[)B-X03`[ M/"]T9#X-"B`\+W1R/@T*(#QT$$P M.WEE87)S/"]T9#X-"B`\+W1R/@T*(#QT3H\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&-E;G1E$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&-E;G1E3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]C-&9D830Q,E]B,S`U7S0Y-C%?865C,5\W-#@P,F0Y M-#@T,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S1F9&$T,3)? M8C,P-5\T.38Q7V%E8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!$:7-C M;&]S=7)E(%M!8G-T2!Q M=6%N=&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U,BD\ M3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]C-&9D830Q,E]B,S`U7S0Y-C%?865C,5\W M-#@P,F0Y-#@T,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S1F M9&$T,3)?8C,P-5\T.38Q7V%E8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@8VAA6UE;G0@07=A'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XD(#4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)S(@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6UE;G0@07=A'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`U7S0Y-C%?865C,5\W-#@P,F0Y M-#@T,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S1F9&$T,3)? M8C,P-5\T.38Q7V%E8S%?-S0X,#)D.30X-#)C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B M=7)N.G-C:&5M87,M;6EC XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments
3 Months Ended
Mar. 31, 2014
Fair Value Disclosures [Abstract]  
Financial Instruments

(3) Financial Instruments

We follow the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

Our financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. The fair values of all financial instruments were not materially different from their carrying values.

XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 2,148 $ 3,276
Investments 30 30
Trade accounts receivable, less allowance for doubtful accounts of $6 on March 31, 2014 and December 31, 2013 1,130 52
Other receivables   1
Inventories, net 931 976
Prepaid expenses and other current assets 250 202
Total current assets 4,489 4,537
Equipment and leasehold improvements, net 2,319 2,464
Other assets, net 27 27
Total assets 6,835 7,028
Current liabilities:    
Current portion of capital lease obligations 31 31
Accounts payable 754 503
Accrued expenses 259 323
Total current liabilities 1,044 857
Long-term portion of capital lease obligations 3 10
Long-term deferred rent 630 633
Asset retirement obligations 161 160
Total long-term liabilities 794 803
Stockholders' equity:    
Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding      
Common stock, $.01 par value, 35,000,000 shares authorized; 28,481,496 shares issued and outstanding on March 31, 2014 and December 31, 2013 285 285
Additional paid-in capital 95,819 95,761
Accumulated deficit (91,107) (90,678)
Total stockholders' equity 4,997 5,368
Total liabilities and stockholders' equity $ 6,835 $ 7,028
XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Basis of Presentation
3 Months Ended
Mar. 31, 2014
Accounting Policies [Abstract]  
Basis of Presentation

(1) Basis of Presentation

The accompanying unaudited interim financial statements of Nanophase Technologies Corporation (“Nanophase” or the “Company”, including “we”, “our” or “us”) reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management, are necessary for a fair presentation of our financial position and operating results for the interim periods presented. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.

These financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2013, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission.

XML 19 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segmentation and Geographical Distribution - Additional Information (Detail) (Non-Domestic Revenue [Member], USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Non-Domestic Revenue [Member]
   
Revenue from External Customer [Line Items]    
Revenue from international sources $ 111 $ 78
XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business
3 Months Ended
Mar. 31, 2014
Accounting Policies [Abstract]  
Description of Business

(2) Description of Business

Nanophase is a nanomaterials and applications developer and commercial manufacturer with an integrated family of nanomaterial technologies. We produce engineered nano and sub-micron materials for use in a variety of diverse existing and developing markets: personal care including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy and a variety of surface finishing technologies (polishing) applications. We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products possible and opened potential new markets. Although our primary strategic focus has been the North American market, we currently sell our material to customers overseas and have been working to expand our reach within foreign markets.

The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation in November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.

While product sales comprise the overwhelming majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason we classify such revenue as “other revenue” in our Statement of Operations, as it does not represent revenue directly from our nanocrystalline materials.

The presentation of certain prior year disclosures has been modified to conform to current year presentation, as financial data is now presented in thousands of dollars rather than in dollars.

XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
BALANCE SHEETS (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Statement Of Financial Position [Abstract]    
Trade accounts receivable, less allowance for doubtful accounts $ 6 $ 6
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 24,088 24,088
Preferred stock, shares issued      
Preferred stock, shares outstanding      
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 35,000,000 35,000,000
Common stock, shares issued 28,481,496 28,481,496
Common stock, shares outstanding 28,481,496 28,481,496
XML 23 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Investments All Other Investments [Abstract]    
Certificates of deposit $ 30 $ 30
XML 24 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
3 Months Ended
Mar. 31, 2014
May 09, 2014
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2014  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q1  
Trading Symbol NANX  
Entity Registrant Name NANOPHASE TECHNOLOGIES CORPORATION  
Entity Central Index Key 0000883107  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   28,481,496
XML 25 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories - Summary of Inventories (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Inventory Disclosure [Abstract]    
Raw materials $ 160 $ 132
Finished goods 823 896
Inventory gross, Total 983 1,028
Allowance for excess inventory quantities (52) (52)
Inventories net, Total $ 931 $ 976
XML 26 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF OPERATIONS (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenue:    
Product revenue $ 2,576 $ 2,976
Other revenue 9 3
Total revenue 2,585 2,979
Operating expense:    
Cost of revenue 1,877 2,073
Gross profit 708 906
Research and development expenses 337 429
Selling, general and administrative expenses 798 960
Loss from operations (427) (483)
Interest expense (2) (7)
Other, net   6
Loss before provision for income taxes (429) (484)
Provision for income taxes      
Net loss $ (429) $ (484)
Net loss per share-basic and diluted $ (0.02) $ (0.02)
Weighted average number of basic and diluted common shares outstanding 28,481,496 28,466,717
XML 27 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Customers and Contingencies
3 Months Ended
Mar. 31, 2014
Text Block [Abstract]  
Significant Customers and Contingencies

(7) Significant Customers and Contingencies

Sales to three customers constituted approximately 80%, 6% and 2%, respectively, of our total revenue for the three months ended March 31, 2014. Amounts included in accounts receivable on March 31, 2014 relating to these three customers were approximately $784, $144 and $57, respectively. Revenue from these three customers constituted approximately 79%, 7% and 5%, respectively, of our total revenue for the three months ended March 31, 2013. Amounts included in accounts receivable on March 31, 2013 relating to these three customers were approximately $857, $201 and $78, respectively. The loss of one of these significant customers or the failure to attract new customers could have a material adverse effect on our business, results of operations and financial condition.

We currently have exclusive supply agreements with BASF Corporation (“BASF”), our largest customer, that have contingencies outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended to provide capacity sufficient to meet the customer’s production needs. This outcome may occur if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants in one of our supply agreements with BASF “trigger” a technology transfer right (license and equipment sale at BASF’s option) in the event (a) that earnings for the twelve month period ending with our most recently published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements with BASF also “trigger” a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment’s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the equipment’s net book value, depending on the contract and related equipment.

We believe that we have sufficient cash, (See Liquidity and Capital Resources in Management’s Discussion and Analysis in Part I, Item 2 of this Form 10-Q for a further discussionto operate our business during 2014. If a triggering event were to occur and BASF elected to proceed with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Given the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.

XML 28 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation
3 Months Ended
Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-Based Compensation

(6) Share-Based Compensation

We follow FASB ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $57 and $69 for the three month periods ended March 31, 2014 and 2013, respectively.

As of March 31, 2014, there was approximately $410 of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.3 years.

Stock Options and Stock Grants

During the three months ended March 31, 2014, no stock options were exercised, compared to proceeds of $3 realized and 10,000 shares of common stock issued pursuant to option exercises during the same period in 2013. For the three months ended March 31, 2014, 568,000 stock options were granted compared to 543,000 stock options granted during the same period in 2013. During the three months ended March 31, 2014, no stock options were forfeited compared to 54,000 stock options forfeited during the same period in 2013.

Stock Appreciation Rights

Prior to 2011, we granted our outside directors stock appreciation rights (SARs). The change in fair value of the awards granted during prior years is included in non-cash compensation expense for the quarters ended March 31, 2014 and 2013. The SARs granted vested immediately and are payable upon the directors’ removal or resignation from the position of director. These awards are accounted for as liability awards, included in accrued expenses as of March 31, 2014 and 2013, and adjusted to fair value each reporting period. The fair value of the liability on March 31, 2014 was $7, compared to $8 on December 31, 2013.

 

As of March 31, 2014, we did not have any unvested restricted stock or performance shares outstanding.

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month periods ended:

 

     March 31,
2014
  March 31,
2013

Weighted-average risk-free interest rates:

   2.01%   1.32%

Dividend yield:

   —     —  

Weighted-average expected life of the option:

   7 years   7 years

Weighted-average expected stock price volatility:

   95.16%   92.27%

Weighted-average fair value of the options granted:

   $0.42   $0.33

XML 29 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation - Additional Information (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation expense $ 57 $ 69  
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted 410    
Weighted-average period over which unrecognized compensation is expected to be recognized 2 years 3 months 18 days    
Proceeds from exercise of stock options   3  
Common stock issued pursuant to option exercises 0 10,000  
Stock options granted 568,000 543,000  
Stock options forfeited 0 54,000  
Common stock, shares outstanding 28,481,496   28,481,496
Stock Appreciation Rights (SARs) [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of the liability $ 7   $ 8
Restricted Stock [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock, shares outstanding 0    
Performance Shares [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock, shares outstanding 0    
XML 30 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories (Tables)
3 Months Ended
Mar. 31, 2014
Inventory Disclosure [Abstract]  
Summary of Inventories

Inventories consist of the following:

 

     March 31,
2014
    December 31,
2013
 

Raw materials

   $ 160      $ 132   

Finished goods

     823        896   
  

 

 

   

 

 

 
     983        1,028   

Allowance for excess inventory quantities

     (52     (52
  

 

 

   

 

 

 
   $ 931      $ 976   
  

 

 

   

 

 

 
XML 31 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segmentation and Geographical Distribution
3 Months Ended
Mar. 31, 2014
Segment Reporting [Abstract]  
Business Segmentation and Geographical Distribution

(8) Business Segmentation and Geographical Distribution

Revenue from international sources approximated $111 and $78 for the three months ended March 31, 2014 and 2013, respectively. All of this revenue was product revenue.

Our operations comprise a single business segment and all of our long-lived assets are located within the United States.

XML 32 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Policies)
3 Months Ended
Mar. 31, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Disclosures

We follow the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

Share-Based Payments
We follow FASB ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $57 and $69 for the three month periods ended March 31, 2014 and 2013, respectively.
XML 33 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Assumptions Used to Calculate Black-Scholes Option Pricing Model for Stock Options Granted

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month periods ended:

 

     March 31,
2014
  March 31,
2013

Weighted-average risk-free interest rates:

   2.01%   1.32%

Dividend yield:

   —     —  

Weighted-average expected life of the option:

   7 years   7 years

Weighted-average expected stock price volatility:

   95.16%   92.27%

Weighted-average fair value of the options granted:

   $0.42   $0.33

XML 34 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Customers and Contingencies - Additional Information (Detail) (USD $)
3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2014
Customer
Dec. 31, 2013
Mar. 31, 2014
Customers One [Member]
Mar. 31, 2013
Customers One [Member]
Mar. 31, 2014
Customers One [Member]
Sales [Member]
Mar. 31, 2013
Customers One [Member]
Sales [Member]
Mar. 31, 2014
Customers Two [Member]
Mar. 31, 2013
Customers Two [Member]
Mar. 31, 2014
Customers Two [Member]
Sales [Member]
Mar. 31, 2013
Customers Two [Member]
Sales [Member]
Mar. 31, 2014
Customers Three [Member]
Mar. 31, 2013
Customers Three [Member]
Mar. 31, 2014
Customers Three [Member]
Sales [Member]
Mar. 31, 2013
Customers Three [Member]
Sales [Member]
Mar. 31, 2014
BASF [Member]
Mar. 31, 2014
BASF [Member]
Maximum [Member]
Mar. 31, 2014
BASF [Member]
Minimum [Member]
Revenue, Major Customer [Line Items]                                  
Number of major customers 3                                
Revenue from top customers         80.00% 79.00%     6.00% 7.00%     2.00% 5.00%      
Accounts receivable $ 1,130,000 $ 52,000 $ 784,000 $ 857,000     $ 144,000 $ 201,000     $ 57,000 $ 78,000          
Supply agreements with BASF Corporation                             The financial condition covenants in one of our supply agreements with BASF “trigger” a technology transfer right (license and equipment sale at BASF’s option) in the event (a) that earnings for the twelve month period ending with our most recently published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million.    
Cash, cash equivalents and investments, maximum                               1,000,000  
Minimum contractual covenant - net earnings previous twelve months                             0    
Principal amount of debt on maturity, minimum                                 $ 10,000,000
Net book value equipment                             115.00%    
Original book value of equipment, Minimum                                 30.00%
XML 35 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating activities:    
Net loss $ (429) $ (484)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 187 226
Gain on disposal of equipment   (6)
Stock compensation expense 57 77
Changes in assets and liabilities related to operations:    
Trade accounts receivable (1,078) (202)
Other accounts receivable 1 25
Inventories 45 117
Prepaid expenses and other assets (48) (119)
Accounts payable 264 54
Accrued expenses (67) (117)
Net cash used in operating activities (1,068) (429)
Investing activities:    
Proceeds from disposal of equipment   6
Acquisition of equipment and leasehold improvements (30) (42)
Payment of accounts payable incurred for the purchase of equipment and leasehold improvements (23) (20)
Net cash used in investing activities (53) (56)
Financing activities:    
Principal payments on capital leases (7) (34)
Proceeds from exercise of stock options   3
Net cash used in financing activities (7) (31)
Decrease in cash and cash equivalents (1,128) (516)
Cash and cash equivalents at beginning of period 3,276 4,124
Cash and cash equivalents at end of period 2,148 3,608
Supplemental cash flow information:    
Interest paid 1 7
Supplemental non-cash investing and financing activities:    
Accounts payable incurred for the purchase of equipment and leasehold improvements $ 10 $ 7
XML 36 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories
3 Months Ended
Mar. 31, 2014
Inventory Disclosure [Abstract]  
Inventories

(5) Inventories

Inventories consist of the following:

 

     March 31,
2014
    December 31,
2013
 

Raw materials

   $ 160      $ 132   

Finished goods

     823        896   
  

 

 

   

 

 

 
     983        1,028   

Allowance for excess inventory quantities

     (52     (52
  

 

 

   

 

 

 
   $ 931      $ 976
XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 29 117 1 false 11 0 false 5 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.nanophase.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - BALANCE SHEETS Sheet http://www.nanophase.com/taxonomy/role/StatementOfFinancialPositionClassified BALANCE SHEETS false false R3.htm 104 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.nanophase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical BALANCE SHEETS (Parenthetical) false false R4.htm 105 - Statement - STATEMENTS OF OPERATIONS (Unaudited) Sheet http://www.nanophase.com/taxonomy/role/StatementOfIncome STATEMENTS OF OPERATIONS (Unaudited) false false R5.htm 106 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.nanophase.com/taxonomy/role/StatementOfCashFlowsIndirect STATEMENTS OF CASH FLOWS (Unaudited) false false R6.htm 107 - Disclosure - Basis of Presentation Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock Basis of Presentation false false R7.htm 108 - Disclosure - Description of Business Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations Description of Business false false R8.htm 109 - Disclosure - Financial Instruments Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Financial Instruments false false R9.htm 110 - Disclosure - Investments Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Investments false false R10.htm 111 - Disclosure - Inventories Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventories false false R11.htm 112 - Disclosure - Share-Based Compensation Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Share-Based Compensation false false R12.htm 113 - Disclosure - Significant Customers and Contingencies Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock Significant Customers and Contingencies false false R13.htm 114 - Disclosure - Business Segmentation and Geographical Distribution Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Business Segmentation and Geographical Distribution false false R14.htm 115 - Disclosure - Financial Instruments (Policies) Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockPolicies Financial Instruments (Policies) false false R15.htm 116 - Disclosure - Inventories (Tables) Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventories (Tables) false false R16.htm 117 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.nanophase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Share-Based Compensation (Tables) false false R17.htm 118 - Disclosure - Investments - Additional Information (Detail) Sheet http://www.nanophase.com/taxonomy/role/DisclosureInvestmentsAdditionalInformation Investments - Additional Information (Detail) false false R18.htm 119 - Disclosure - Inventories - Summary of Inventories (Detail) Sheet http://www.nanophase.com/taxonomy/role/DisclosureInventoriesSummaryOfInventories Inventories - Summary of Inventories (Detail) false false R19.htm 120 - Disclosure - Share-Based Compensation - Additional Information (Detail) Sheet http://www.nanophase.com/taxonomy/role/DisclosureShareBasedCompensationAdditionalInformation Share-Based Compensation - Additional Information (Detail) false false R20.htm 121 - Disclosure - Share-Based Compensation - Schedule of Assumptions Used to Calculate Black-Scholes Option Pricing Model for Stock Options Granted (Detail) Sheet http://www.nanophase.com/taxonomy/role/DisclosureShareBasedCompensationScheduleOfAssumptionsUsedToCalculateBlackScholesOptionPricingModelForStockOptionsGranted Share-Based Compensation - Schedule of Assumptions Used to Calculate Black-Scholes Option Pricing Model for Stock Options Granted (Detail) false false R21.htm 122 - Disclosure - Significant Customers and Contingencies - Additional Information (Detail) Sheet http://www.nanophase.com/taxonomy/role/DisclosureSignificantCustomersAndContingenciesAdditionalInformation Significant Customers and Contingencies - Additional Information (Detail) false false R22.htm 123 - Disclosure - Business Segmentation and Geographical Distribution - Additional Information (Detail) Sheet http://www.nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation Business Segmentation and Geographical Distribution - Additional Information (Detail) false false All Reports Book All Reports 'Monetary' elements on report '122 - Disclosure - Significant Customers and Contingencies - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 104 - Statement - BALANCE SHEETS (Parenthetical) Process Flow-Through: 105 - Statement - STATEMENTS OF OPERATIONS (Unaudited) Process Flow-Through: 106 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) nanx-20140331.xml nanx-20140331.xsd nanx-20140331_cal.xml nanx-20140331_def.xml nanx-20140331_lab.xml nanx-20140331_pre.xml true true XML 38 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation - Schedule of Assumptions Used to Calculate Black-Scholes Option Pricing Model for Stock Options Granted (Detail) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract]    
Weighted-average risk-free interest rates 2.01% 1.32%
Dividend yield      
Weighted-average expected life of the option 7 years 7 years
Weighted-average expected stock price volatility 95.16% 92.27%
Weighted-average fair value of the options granted $ 0.42 $ 0.33